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1.1 Adipose tissue: Physiological and pathophysiological aspects 
The chronic exposure to elevated amounts of lipids and nutrients in modern society has 
made obesity an enormous public health problem and a major cause of morbidity and 
mortality [1–3]. Obesity is defined as an increased adipose tissue accretion to the extent that 
health may be adversely affected [1,4]. Recent surveys indicated that 33-35% of adults in the 
USA and 19-21% in Germany can be considered obese, having a body mass index greater 
than 30 kg/m² [2,5]. Although genetic differences are of importance, and body fat mass is 
dependent on ethnic background, gender, developmental stage and age, the still increasing 
prevalence of obesity can be best explained by changes in the behavioral and environmental 
changes affecting the balance of energy expenditure and intake [4,6,7]. In recent years much 
progress has been made in understanding the molecular basis of adipose tissue mass 
regulation. These new insights are likely to accelerate the identification of new targets, 
eventually leading to the development of safe and effective therapies for obesity [6].  
The great importance of such therapeutic methods derives from the severe complications 
obesity can entail. It is generally accepted that obesity is closely associated with common 
medical conditions such as type 2 diabetes, dyslipidemia and hypertension, which can be 
summarized under the term “metabolic syndrome” [2,8]. Besides an increased risk of  insulin 
resistance and cardiovascular disease, an enhanced incidence of liver steatosis, 
osteoarthritis, Alzheimer’s disease, gallstones, sleep-breathing abnormities and even certain 
forms of cancer has been detected in obese individuals [3,4,9–12]. Thereby, body fat 
distribution rather than adiposity per se is an important risk factor for obesity-related 
disorders, yet the mechanisms responsible for this association are still largely unknown [2,3].  
Adipose tissue is not only directly involved in the development of obesity, but also influences 
the physiology and pathophysiology of many other tissues, including hypothalamus, 
pancreas, liver, skeletal muscle, kidneys, endothelium and immune system, through a 
complex network of endocrine, paracrine, and autocrine signals [1,11]. Therefore, adipose 
tissue possesses great pharmacological and therapeutic potential and is increasingly 
considered as a promising drug discovery target [11,13]. However, in order to use this 
potential, e.g. for the development of novel strategies for the prevention and treatment of 
obesity and the diverse disorders associated with it, a thorough understanding of adipose 
tissue development and adipocyte functions is a prerequisite. 
 
1.1.1 Structure of adipose tissue  
Two types of adipose tissue (AT) exist in mammals: Brown adipose tissue (BAT) and white 
adipose tissue (WAT). In humans, large depots of BAT can only be found during infancy, 
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while in adults, only small amounts of BAT persist, which are dispersed throughout depots of 
WAT [14,15]. BAT is transformed into WAT during development, and conversely, WAT can 
be turned into BAT during cold adaptation or after pharmacological treatment [15]. Brown 
adipocytes, which are able to dissipate energy as heat without producing ATP, exhibit 
multiple small lipid droplets and contain numerous mitochondria [1,14].  
In this work, however, the focus is on WAT, on which current adipose tissue research is 
concentrating. While WAT accounts for approx. 16% of total body weight at birth, its total 
mass is highly variable in adults, ranging from a few percent of body weight in elite athletes 
to more than half of the total body weight in morbidly obese patients. Normally, fat makes up 
10-20% of body mass in males and 20-30% in females [1]. WAT is distributed over various 
depots throughout the body that can have distinct molecular and physiological properties 
[14–16]. Total fat mass can be subcategorized into subcutaneous (approx. 80%) and internal 
(approx. 20%) adipose tissue [1].  
In general, adipose tissue represents a loose, highly vascularized and innervated connective 
tissue, in which adipocytes account for about 35-70% of the mass, but only for 25% of the 
total cell number. Apart from the adipocytes, AT contains a stromal-vascular fraction (SVF) 
composed of macrophages, fibroblasts, pericytes, blood cells, endothelial cells, and adipose 
precursor cells, among others [1]. Mature white adipocytes contain a single large lipid droplet 
which fills 90% of the cell volume, with the thin cytoplasmic ring pushed against the edge of 
the cell, causing the nucleus to assume a flattened morphology and leading to the typical 
unilocular signet-ring form. AT can respond rapidly and dynamically to alterations in nutrient 
deprivation and excess through adipocyte hypertrophy and hyperplasia, with hypertrophic 
growth predominating in adult-onset obesity, and hyperplasic growth only occurring when the 
existing fat cells reach a critical size [1,17]. Depending on the lipid load, the volume of 
adipocytes can change by several thousand-fold, reaching a maximum of approx. 1000 pl in 
hypertrophy, while the cellular diameter can vary between 20 and 200 µm [1]. Multiple 
smaller lipid droplets can be found in developing adipocytes, as well as during periods of 
nutrient deprivation, when triglycerides are mobilized and the central lipid vacuole 
disaggregates. 
The space between the cells present in adipose tissue is filled up with extracellular matrix 
(ECM), which is produced by the adipocytes as well as by the SVF cells and is subject to 
constant turnover, mediated by enzymes promoting construction or involved in the 
degradation of the ECM. Each adipocyte is surrounded by a thick ECM referred to as basal 
lamina, which is mainly composed of collagens, most notably collagen IV, but also contains 
laminin and nidogen, among many other proteins [18–21]. This ECM not only accounts for 
the integrity of the structural system supporting the cells, but also has an impact on 
differentiation and cell migration via interactions with cell-surface receptors [22]. 
Chapter 1  General Introduction 
 
- 6 - 
 
1.1.2 Functions of adipose tissue 
For many years, the role of adipose tissue was considered to be rather simple. Its main 
function was seen in the storage of excess energy as triglycerides and its release in the form 
of free fatty acids (FFA) during periods of nutrient deprivation. For example, the fall in 
glucose levels during fasting stimulates lipolysis, leading to release of FFA for use by a 
variety of tissues, such as muscle, liver and kidney [1,23,24]. Apart from this metabolic role in 
energy homeostasis, functions attributed to fat tissue included the insulation against heat 
loss through the skin as well as mechanical protection of certain organs by forming a 
protective padding [1].  
However, starting with the identification of leptin in 1994, a paradigm shift has taken place, 
and it is now widely recognized that adipose tissue also represents an important endocrine 
organ [24,25]. Over the years, a large number of products secreted by adipocytes have been 
isolated and characterized, including hormones, growth factors, enzymes, cytokines and 
complement factors, which have been collectively termed as adipokines, as well as matrix 
proteins [1,26]. While some of these factors primarily have local auto- or paracrine effects in 
adipose tissue, others are released into the circulation and exert specific effects on target 
organs or systemic effects [24]. At the same time, adipocytes express receptors for most of 
these factors, enabling an extensive crosstalk at a local and systemic level [1]. As a 
consequence, adipose tissue is now known to participate in many physiological processes, 
including not only lipid metabolism and energy balance, but also reproduction, immune 
response, blood pressure control, coagulation, fibrinolysis, and angiogenesis [1,27]. As 
adipocytes also play a role in the regulation of insulin sensitivity and glucose homeostasis, a 
dysregulation of the secretion of certain adipokines, as it occurs in obese individuals, can 
contribute to the development of type 2 diabetes and related disorders, thus representing a 
link between obesity and its associated co-morbidities [1,13,28–30]. Leptin, which is secreted 
by mature adipocytes, acts within a negative feedback loop for the maintenance of energy 
homeostasis by decreasing food intake and increasing energy expenditure. However, 
although leptin levels are high in obese subjects, these patients have developed a central 
leptin resistance, prohibiting the hormone’s regulatory role on body weight [24,25,31]. 
Adiponectin, which is one of the most abundantly expressed genes in adipocytes, has been 
found to play a protective role against several obesity-related disorders through various 
insulin-sensitizing effects on different tissues, such as liver and skeletal muscles. 
Accordingly, in contrast to leptin, the production of adiponectin is reduced in obesity, which 
has been demonstrated to play a role in the pathogenesis of type 2 diabetes and 
cardiovascular disease [24,25,32,33]. Other adipose-derived factors involved in energy 
homeostasis, glucose and lipid metabolism include visfatin, lipoprotein lipase (LPL), 
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apolipoprotein E (apoE), adipsin, adipocyte protein 2 (aP2/FABP4), glucocorticoids and sex 
steroids, among others [1,25]. Moreover, factors like TNF-α, IL-6, plasminogen activator 
inhibitor-1 (PAI-1) or angiotensinogen, play different roles in the regulation of vascular 
homeostasis as well as in the pathogenesis of atherosclerosis [1,34]. Growth factors 
released by adipocytes include insulin-like growth factor I (IGF-I), nerve growth factor (NGF), 
transforming growth factor-β (TGF-β), vascular endothelial growth factor (VEGF) and 
leukemia inhibitory factor (LIF) [1].  
Considering this great variety of adipose-derived factors and their diverse physiological and 
pathophysiological functions, a better understanding of adipokines gene expression and 
secretion may facilitate the development of rational approaches to the treatment of the 
metabolic syndrome and other obesity-related diseases. 
 
1.1.3 Adipocyte differentiation 
Adipogenic differentiation, or adipogenesis, not only occurs during embryonic development, 
but also throughout the lifetime of the organism, both in response to normal cell turnover and 
when the need for additional fat mass storage arises during periods in which caloric intake 
exceeds nutritional requirements. In this process, proliferating, mesenchymal, fibroblast-like 
progenitor cells residing in the SVF become permanently cell cycle-arrested, spherical, lipid-
filled and functionally mature adipocytes. Adipogenesis not only involves extensive 
alterations in cell shape and ECM structure and composition, but is also accompanied by 
molecular changes that lead to dramatic increases in the ability of the cell for lipid synthesis 
and in the hormonal responsiveness specific to the specialized role of the adipocyte in 
energy homeostasis [22,35].  
It is widely accepted that adipocyte development can be divided into two phases (Fig. 1-1). 
The first phase, known as determination, involves the commitment of a pluripotent stem cell 
to the adipocyte lineage. It results in the conversion of the stem cell to a preadipocyte, which 
cannot be distinguished morphologically from its precursor cell but has lost the potential to 
differentiate into other cell types [14]. However, molecular mechanisms regulating this 
process, as well as the identity of committed preadipocytes, have not been extensively 
studied up to now and are still poorly understood [36]. In contrast, the second phase, known 
as terminal differentiation, in which the preadipocyte takes on the characteristics of the 
mature adipocyte, has been extensively studied, mostly using mouse preadipocyte cell lines 
such as 3T3-L1, 3T3-F442A or C3H10T1/2. Especially in recent years, also human 
preadipocyte cell lines as well as human mesenchymal stem cells have been applied for 
adipogenesis research [14,37].  
 
Chapter 1  General Introduction 
 
- 8 - 
 
 
Fig. 1-1: Adipocyte determination and differentiation: overview (reprinted with permission from [37]) 
 
It is now well established that the differentiation of adipocytes is a complex multi-step 
process dependent on the strict temporal regulation of inhibitory and stimulatory signaling 
events [14,22,37]. Using clonal cell lines, it has been found that during the early phase of 
adipogenesis committed preadipocytes undergo at least one round of mitosis before entering 
a state of growth arrest. Although there are some controversial reports after experiments with 
human primary preadipocytes, this step is considered to be required for terminal 
differentiation [14,22,38]. The whole process of adipogenesis involves a highly regulated 
cascade of transcriptional events [14,39]. Several transcription factors have been found to 
play a central role in this cascade, most notably members of the peroxisome proliferator 
activated receptor (PPAR) and CCAAT-enhancer binding protein (C/EBP) families [14,37,40]. 
Specifically, C/EBPβ and C/EBPδ  are transiently expressed very early during adipogenic 
differentiation. By binding to the promoters of the corresponding genes, these factors are 
responsible for the subsequent upregulation of PPAR and C/EBP, which represent the key 
regulators of adipogenesis [14,39]. Interestingly, the continuous expression of these two 
factors is sustained by a positive feedback loop, which serves to maintain the phenotype of 
the mature adipocyte [37,41]. PPAR and C/EBP directly or indirectly trigger the expression 
of many adipocyte-specific target genes, e.g. glucose transporter GLUT4 (also known as 
SLC2A4), fatty-acid-binding protein (FABP4, also known as adipocyte protein 2, aP2), 
lipoprotein lipase (LPL), perilipin, the adipokines adiponectin and leptin and many more [39]. 
Apart from those already mentioned, several other transcription factors have been shown to 
be important for adipogenic differentiation, such as Krox20, Krüppel-like factors, sterol-
regulatory element-binding protein (SREBP)-1c, and Stat5, all of which appear to regulate 
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adipogenesis by regulating the expression or activity of PPAR or the members of the C/EBP 
family [41]. For instance, SREBP-1c, a member of the helix-loop-helix family, has been 
identified to induce PPAR expression and has been suggested to be responsible for the 
generation of an as-yet-unknown endogenous PPAR ligand [14,42,43].  
For a better understanding of adipose tissue development it is also important to know which 
signaling pathways exist upstream of the adipogenic cascade outlined above. In vivo, these 
pathways transduce information about the suitability of intracellular and extracellular 
conditions for adipogenic differentiation, thereby influencing whether adipogenesis is 
triggered in stem cells, or not [14,39,44]. Furthermore, such signals are necessary to mediate 
cross-talk between SVF cells and adipocytes to ensure that growth of existing adipocytes 
and differentiation of new adipocytes are tightly coupled to energy storage demands [44]. 
Although these pathways are less well characterized than the adipogenic program itself, 
many factors have been identified which either promote or block the transcriptional program 
itself [37]. For example, suppression of the Wnt/β-catenin pathway has been shown to be 
essential for adipogenesis to proceed in vitro and in vivo [39,44]. Recently, several other 
mechanisms controlling adipogenesis have been described, including histone modifications, 
microRNAs or post-translational modifications, further contributing to illustrate the complexity 
of the adipogenic program [39]. 
While it remains to be clarified what exactly triggers adipogenesis in vivo, adipogenic 
differentiation can easily be stimulated using a combination of adipogenic inducers in vitro. 
Although the exact composition varies depending on the cell culture model, these induction 
cocktails usually contain insulin (or IGF-1), a glucocorticoid (e.g. dexamethasone), an agent 
increasing intracellular cAMP concentrations (typically 3-isobutyl-1-methylxanthin [IBMX]) 
and often also a PPAR-ligand (e.g. thiazolodinediones or indomethacin) [22,45]. Of these, 
insulin and IGF-1 mediate their adipogenic effect via the IGF-1 receptor pathway, which 
eventually contributes to the upregulation of PPAR and C/EBP [46–48]. While the 
glucocorticoid dexamethasone has been shown to suppress Pref-1, which inhibits 
adipogenesis, and to induce the expression of C/EBPδ, IBMX increases intracellular cAMP 
concentration, which stimulates protein kinase pathways leading to an upregulation of 
C/EBPβ [22,49–52]. Indomethacin, on the other hand, functions as a direct PPAR 
agonist [53]. However, as virtually all studies dealing with the functions of these inducers 
have been performed in a 2-D in vitro system, it is unclear how specific influences of a 
3-dimensional microenvironment, e.g. extensive cell-cell contacts or the presence of a 
prominent ECM, might alter the effectiveness or the necessity of certain components for the 
induction and maintenance of adipogenic differentiation. 
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1.2 Adipose tissue vascularization 
Native adipose tissue is supplied by an extensive vascular network, with every adipocyte 
being associated with one or more capillaries [54,55]. Since AT, unlike most other tissues, 
undergoes continuous expansion and regression during adult life, a parallel remodeling and 
expansion of the capillary network is required. As a consequence, the formation of new blood 
vessels (angiogenesis) it tightly linked with adipogenesis [56]. Interestingly, many obesity-
related disorders, like diabetic ocular and kidney complications, cardiovascular disease, 
stroke, and cancer, are closely connected with vascular dysfunctions [54].  
During embryonic development, the formation of blood vessels is spatially and temporally 
associated with adipogenesis, with the arteriolar differentiation usually preceding adipocyte 
development [57]. The de novo formation of a vascular network in the developing embryo 
involves the differentiation of distinct progenitor cells into endothelial cells and is known as 
vasculogenesis [58]. In contrast, the process through which new blood vessels arise from 
preexisting ones, mainly via sprouting of quiescent vascular EC, has been termed 
angiogenesis. In recent years, it has been found that endothelial progenitor cells are also 
present in adult bone marrow and circulating blood, suggesting that vasculogenesis is not 
limited to the embryo, but also contributes to neovascularization in adults [59]. Therefore, it is 
now recognized that adult neovascularization, as it occurs in adipose tissue, most likely is a 
more complex process involving both angiogenesis and vasculogenesis simultaneously [60].  
The process of angiogenesis involves an extensive cross-talk between vascular cells, the 
extracellular environment and periendothelial cells, i.e. (pre-)adipocytes in the case of 
adipose tissue vascularization. It is regulated by a fine balance between pro- and 
antiangiogenic factors, the “angiogenic switch” [61]. When proangiogenic signals 
predominate, e.g. in hypoxic conditions, quiescent EC are activated and vessel branching 
takes place. For a detailed description of the sequential steps during angiogenic sprouting 
and the molecular mechanisms involved, the reader is referred to comprehensive reviews on 
this topic, e.g. by Carmeliet and Jain [58] or Herbert and Stainier [62].  
There is increasing evidence that (pre-)adipocytes and endothelial cells communicate via  
paracrine signaling pathways, extracellular components, and direct cell-cell interactions in 
order to promote and regulate adipose tissue vascularization. Growing adipocytes are known 
to produce several proangiogenic factors, including VEGF, HGF, IGF-1, bFGF, TGFβ or 
angiopoietins [54,55]. In recent years, it has been described that also in adipose-derived 
stem cells (ASC) the secretion of these factors is strongly upregulated when the appropriate 
molecular stimuli are present [63,64]. Interestingly, not only these classic proangiogenic 
cytokines, but also some adipokines, like leptin, adiponectin and resistin seem to be involved 
in the modulation of AT angiogenesis under both physiological and pathological 
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conditions [61]. For example, leptin has been demonstrated to induce HUVEC migration, 
proliferation and tube formation in vitro [65].  Apart from this direct proangiogenic activity, 
leptin stimulates neovascularization by upregulating VEGF expression and acting 
synergistically with VEGF and bFGF [66,67]. Furthermore, leptin facilitates angiogenesis by 
inducing the activity of MMP-2 and MMP-9.  These and other matrix metalloproteinases play 
an important role in angiogenic sprouting and vessel maturation by contributing to the 
degradation and remodeling of the ECM, which is not only necessary to adapt matrix 
structure to the changing cellular geometry, but is also accompanied by the release of matrix-
bound angiogenic factors like VEGF [54,55]. Controversial reports exist regarding the 
influence of adiponectin on angiogenesis. While it has been found to stimulate blood vessel 
growth in different adipogenesis models [68], inhibiting effects of adiponectin on endothelial 
cell migration and proliferation have been reported in another study [69]. 
The cellular cross-talk during the development of vascularized adipose tissue involves a 
reciprocal regulation of vessel formation and fat cell maturation. However, information about 
the specific influence of endothelial cell signaling on the process of adipogenic differentiation 
from in vitro culture is scarce and partially conflicting. Depending on the experimental 
conditions, either an increase or a reduction of adipogenesis was described in the presence 
of EC (see Chapter 6.5 for a literature overview).  
All in all, in many respects our knowledge in the field of adipose tissue angiogenesis is still 
limited, not only regarding the temporal and spatial interplay between the different cell types 
during in vivo vascularization and vessel remodeling, but also concerning the effects of these 
interactions on metabolic functions of the cell types [70–72]. Further investigations utilizing 
model systems more closely resembling the in vivo situation are necessary to shed more 
light on this aspect of adipose tissue development. 
 
1.3 In vitro adipose tissue models 
Although in vivo approaches such as the use of transgenic animals have contributed 
significantly to our current understanding of adipose tissue development and functions, most 
of our knowledge in this field is based on in vitro model systems, as they represent a 
powerful and versatile tool for a great variety of applications in basic research [14,22]. In this 
context it should not be disregarded that in vitro models can never represent every ascpect 
of native tissues, but all have advantages and limitations. Hence, when performing in vitro 
studies, it is not only necessary to choose an appropriate model system depending on the 
respective research goals, but it would also be desirable that the existing models are 
continuously refined and new model systems are developed. 
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Among others, two of the most relevant parameters which influence the validity of results 
gained from studies applying in vitro models of adipose tissue are (a) the cell source on 
which the culture is based, and (b) the culture dimensionality, both of which will be 
addressed in this section. 
 
1.3.1 Cell sources for adipose tissue research 
In comparison to most other cell types, the isolation and in vitro culture of mature adipocytes 
is difficult and inconvenient to perform. The buoyancy and fragility of these cells resulting 
from their high lipid content and specific morphology makes conventional cell culture almost 
impossible. Special culture methods have been developed, such as ceiling culture or floating 
culture. Interestingly, cultured adipocytes have been found to dedifferentiate and become 
proliferative again, with the potential to re-differentiate into lipid-filled adipocytes as well as 
other cell types [73–76]. However, these protocols are not generally applicable for most 
research purposes [75]. Furthermore, human primary cells only have a limited lifespan in 
culture leading to a constant need for fresh cell supply. 
The introduction of immortalized preadipocyte cell lines in the 1970s represented a great 
step ahead in adipose tissue research. The 3T3-L1 cell line and other mouse cell lines, which 
have a fibroblast-like morphology, are not only easy to culture and expand, but can also be 
efficiently and reproducibly differentiated into adipocytes in vitro using specific induction 
media, even after extensive passaging. Over the years, they have become well-
characterized and have proven to be powerful model systems for studying many aspects of 
adipocyte biology, especially regarding the complex molecular events during adipocyte 
differentiation [14,22,40,75]. 
Nevertheless, these cell lines exhibit significant drawbacks. Most importantly, they are 
unipotent, i.e. already committed to the adipocyte lineage and therefore cannot be used for 
the study of the early phase of adipogenic differentiation [22,40]. Furthermore, being clonal 
rodent cell lines, they are aneuploid and may therefore reflect the in vivo situation less 
accurately than diploid primary cells. Moreover, the use of human cells would eliminate the 
problem of interspecies differences in adipocyte biology that have been shown to exist 
between humans and, for example, rodents [22,75,77].  
Certainly, human embryonic stem cells would be an ideal cell source for adipose tissue 
research due to their pluripotence and proliferation characteristics. However, their application 
is limited because of ethical and legal concerns [78–80]. 
The application of stem cells derived from adult human tissues offers an approach that can 
help to circumvent these constraints. These adult stem cells, which have been isolated from 
various tissues including bone marrow, adipose tissue, muscle, liver, brain, umbilical cord 
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blood, Wharton’s jelly from the umbilical cord, placenta, peripheral blood, and pancreas, still 
have the capacity for self-renewal and are capable of differentiation along multiple lineages 
(multipotency) [78,80–82]. Until recently, bone marrow has been most commonly used as a 
source for adult stem cells, termed bone-marrow derived stem cells (BMSC). However, stem 
cells are rare in bone marrow, as in most other adult tissues, meaning that only small 
amounts of stem cells can be harvested, with isolation procedures being difficult and painful 
[79,82].  
Only in recent years, adipose tissue has been identified as a source of mesenchymal stem 
cells (MSC), which reside within its stromal-vascular fraction [36,78,83]. According to a 
consensus reached by the International Fat Applied Technology Society (IFATS), these cells 
are termed adipose-derived stem cells (ASC) within this work [84]. In contrast to MSC from 
other tissues, adipose-derived stem cells are easily available in large quantities, as they can 
be isolated from lipoaspirates, the waste product of liposuction surgery [82,85–87]. Although 
an exact phenotypic definition of ASC and a clear discrimination against fibroblasts is difficult 
and still disputed, it could be demonstrated that ASC, similar to BMSC, have the ability to 
differentiate into a large variety of cell types, including adipocytes, osteoblasts, chondrocytes, 
myocytes, endothelial cells and neuronal cells, and even pancreatic and hepatocyte-like cells 
[36,88]. Furthermore, this multipotency is retained even after serial passaging [89,90]. 
Especially because of their potential for tissue engineering and regenerative medicine, there 
has been an explosion in research focusing on ASC in recent years [36,91]. As they are 
actually part of the stromal-vascular fraction of adipose tissue in vivo, ASC represent an ideal 
cell source for the use in in vitro models aiming at the investigation of the whole process of 
adipose tissue development, starting with the very early stages such as lineage 
commitment [22,92]. 
 
1.3.2 In vitro models in two and three dimensions 
In most cases, in vitro culture of cells is performed as a monolayer on flat and hard tissue 
culture plastic. As natural tissues are 3-dimensional, it is obvious that these conventional 
culture models are not able to represent the cellular environment that exists in vivo [93,94]. 
While culturing cells in 2-D is fast and simple, it cannot capture the relevant complexity of the 
in vivo microenvironment, and as a consequence many tissue-specific aspects are lost under 
these simplified conditions. Among these are the influence of the extracellular matrix (ECM), 
mechanical and biochemical signals, and cell-cell communication. In contrast, 3-D culture 
models have the potential to more closely reproduce the complex and dynamic 
microenvironments of in vivo tissues, thereby bridging the gap between traditional cell culture 
and animal models [94,95]. Up to now a large number of studies using various cell types and 
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culture systems has clearly demonstrated notable differences between 2-D and 3-D models 
regarding cellular function and behavior. These differences are not limited to morphology, 
adhesion, proliferation and differentiation, but also extend to nuclear structure, signal 
transduction, gene expression and the reaction to external cues as well as mechanical 
stimulation, among other aspects [93–97]. One of the most important advantages of 3-D 
culture systems is the presence of a distinct ECM, which contributes to the 
microenvironmental specificity not only through its mechanical features, but also through its 
own signaling moieties and its ability to bind growth factors, enzymes and other diffusible 
molecules [95,98]. Therefore, it plays an important role in the regulation of many cellular 
functions, as it has for example been shown for WAT differentiation and lipid accumulation 
[99,100]. Cell–cell and cell–ECM interactions establish a 3-D communication network that 
maintains the specificity and homeostasis of the tissue and are therefore of pivotal 
importance for normal cell differentiation and function [93,95,101].  
With respect to adipose tissue culture, a variety of 3-D culture systems has been developed. 
As most of these were intended to serve for tissue engineering applications, they are usually 
based on the seeding of adipocyte precursor cells on scaffold materials or on encapsulating 
them in natural or synthetic hydrogels [102,103]. While these systems have proven to be 
useful also in basic research, especially for investigating the specific influence of ECM 
components and mechanical signals, they also have certain drawbacks. Among these are 
the often unknown influence of carrier materials on cellular functions, the still limited cell-cell 
interactions due to the lack of direct intercellular contacts at least in the first phase of culture, 
and a gradient in nutrition and oxygen supply caused by a limited diffusion within larger 
constructs. 
The application of multicellular spheroid models can be a way to avoid most of these specific 
drawbacks. Originally developed as early as in the 1940´s, these spheroid models have been 
adapted for the investigation of radiation effects in tumor biology in the 1970´s and have 
since then been used mainly in cancer research [101,104–107]. However, they can be a 
valuable tool also in other areas of research, using different cell and tissue types [101]. Over 
the years, various techniques have been developed for the generation and culture of 
spheroids, as reviewed by Lin and Chang [108], making them a versatile model system for 
various applications in basic research. 
Multicellular spheroids have several advantages in comparison with other 3-D culture 
systems. The lack of scaffolds or hydrogels as cell carriers not only obliterates the unknown 
influence of these materials on the cells, but also allows for direct cell-cell contact 
immediately after self-assembly. Furthermore, they can easily be produced in large numbers, 
exhibit a defined and reproducible geometry, and their small size leads to sufficient and 
homogeneous supply with nutrients and oxygen throughout the constructs. Another important 
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feature of spheroid models is the possibility to cocultivate different cell types in a tissue-like 
environment to study heterotypic cell-cell interactions [101,107].  
Apart from that, it also appears possible to utilize multicellular spheroids for drug screening 
applications. Today, high-throughput screening (HTS) is used by most pharmaceutical 
companies in drug lead discovery. However, in the commonly employed 2-D assays cellular 
response to specific agents may vary considerably from the corresponding in vivo effects, 
which limits their value in predicting clinical outcomes [107]. Only in recent years it has been 
acknowledged that it is necessary to develop 3-D cell culture systems suitable for drug 
screening assays [107,109]. In contrast to carrier-based 3-D models, which require complex 
and labor-intensive handling and often exhibit limited reproducibility, spheroids have the 
potential to serve as a basis for the development of improved 3-D HTS systems for drug 
discovery [107]. 
Finally, spheroids can also be used for applications in tissue engineering and regenerative 
medicine. They can either be transferred directly into the host, or they can be incorporated 
into hydrogels, which are subsequently injected or implanted in vivo [101,110–112]. It has 
also been described that spheroids can serve as building blocks for engineering complex 
tissues using the organ-printing technique [101,113].  
In summary, multicellular spheroids represent a stable, reproducible, easy to handle and very 
versatile 3-D culture system providing a more in-vivo-like environment for applications in 
basic research as compared to conventional monolayer culture, and with the potential to be 
used as a basis for tissue engineering. 
 
1.4 Adipose tissue engineering 
Adipose tissue engineering aims at the generation of transplantable and biologically 
functional adipose tissue grafts for the application in reconstructive and plastic surgery. The 
need for adipose tissue reconstruction in regenerative medicine can be the result of soft 
tissue loss after traumatic injuries or operative removal as well as congenital defects. In this 
context, reconstruction after tumor resections alone accounts for a large number of 
surgeries. Moreover, engineered adipose tissue grafts would represent an ideal filling 
material for plastic and aesthetic surgeries [114]. 
To avoid problems with biocompatibility, immune response and tissue rejection, the use of 
autologous fat tissue appears to be ideal for soft tissue reconstruction. However, traditional 
approaches have been of limited success for several reasons. Single cell injections of 
liposuctioned tissue have been used for the treatment of smaller defects, but due to the 
fragility of mature adipocytes, the majority of them are lost during aspiration or preparation. 
Furthermore, cyst formation, local necrosis and the absorption of cells occur at the injection 
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site, making repeated treatments necessary. Transplantation of fat grafts in most cases leads 
to the resorption of large parts of the transplanted tissue, which is mainly caused by 
insufficient vascularization and the resulting lack of nutrient and oxygen supply, and therefore 
often repeated surgery is necessary [103,114,115]. The use of pedicled flaps can help to 
avoid this problem, but involves a complicated and cost-intensive procedure and can cause 
donor site morbidity [103,116].  
Therefore, the development of engineered fat tissue substitutes, which could help to 
overcome these limitations, provides a new clinical prospective in regenerative medicine. 
Two general approaches can be distinguished in adipose tissue engineering: acellular and 
cell-based methods. The former are based on the induction of de novo adipogenesis at the 
site of tissue defects. This has been demonstrated, for example, by the application of 
Matrigel together with pro-adipogenic growth factors such as bFGF, which can indeed lead to 
the development of vascularized adipose tissue. However, besides the fact that Matrigel (a 
mouse tumor product) is unsuitable for clinical applications, size and shape of the developing 
tissue can hardly be controlled in this process [103]. 
In cell-based approaches, various carrier materials are seeded with adipocyte precursor 
cells, which are subsequently implanted in vivo, often following a period of in vitro 
preculturing. Those carrier materials can be porous scaffolds, defining the shape of the 
developing tissue graft. These scaffolds, which should be biocompatible and biodegradable, 
can be composed of synthetic polymers, such as PLGA, or natural materials, e.g. collagen, 
hyaluronic acid, or silk. The type of carrier material, but also physical properties, such as 
pore size and stiffness of these scaffold materials can strongly influence the performance of 
the cells and the development of a functional tissue and therefore have to be optimized 
according to the specific application. For example, surface modifications such as the 
incorporation of cell adhesion proteins can enhance cellular proliferation and tissue growth. 
Apart from these scaffold materials, also hydrogels are a common cell carrier for adipose TE 
approaches. They can either be used in an injectable form, allowing for a minimally invasive 
procedure, or they are implanted after gelation in vitro. It is also possible to combine those 
hydrogels with a solid support structure or scaffold to enhance mechanical stability of the 
construct. Hydrogels that have been applied for adipose TE include PEG and its derivatives, 
but also natural polymers like fibrin, hyaluronan, alginate or collagen. A further approach 
involves the attachment of cells to microspheres, which can then be injected directly or 
embedded into a hydrogel for subsequent injection or implantation [103,114,115]. 
Besides the choice of an appropriate carrier material, the nature of the cells used is an 
important issue in adipose tissue engineering. Here, the discovery of ASC represented an 
important step, as they can be easily harvested from autologous tissue in large numbers, are 
non-immunogenic and have the potential to be expanded and induced to undergo adipogenic 
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differentiation in vitro (see also section 1.3.1). Therefore, ASC are currently seen as the most 
promising cell source not only for adipose tissue basic research, but also applications in 
regenerative medicine. In this context, it is important to note that in vivo the implanted cells 
not only represent building blocks that are used to reconstruct the tissue defect, but can also 
serve as modulators of the local environment at the implantation site, which can contribute to 
the tissue regeneration e.g. by triggering vascularization and by stimulating host cells to also 
differentiate into adipocytes [103]. 
One of the main challenges for tissue engineering in general is the supply of the newly 
generated tissues with nutrient and oxygen by providing sufficient vascularization. As 
adipose tissue is highly metabolically active and is therefore strongly vascularized in its 
native condition, the development of a functional vasculature is of special importance. After 
implantation, blood vessels from the host tissue usually begin to invade the transplant, but as 
this process is slow, especially in larger tissue grafts nutrient deficiencies and hypoxia can 
occur in the center of the tissue. Furthermore, this will lead to nutrient and oxygen gradients, 
resulting in an inhomogeneous cell differentiation [103,117].  
Different strategies are pursued to improve the vascularization of tissue transplants: 
(1) Scaffold design aims at the development of carrier materials facilitating vessel ingrowth 
after implantation. This involves for example the adjustment of pore size and 
interconnectivity, whereas more advanced approaches aim at designing a well-defined 
complex architecture, e.g. by rapid prototyping or fiber deposition. (2) The delivery of 
angiogenic factors can also enhance in vivo vascularization of tissue grafts. Thereby, growth 
factors such as VEGF and bFGF are added to the scaffold biomaterials and are released 
after implantation by diffusion and/or during polymer degradation. (3) In vivo 
prevascularization involves as a first step the implantation of a tissue construct, with an 
arterio-venous vessel loop being surgically integrated into the new tissue. Within several 
weeks, a microvascular network develops within the tissue graft, and after this 
vascularization period the tissue is transplanted to the actual defect site, with the main blood 
vessel being connected to the existing vasculature. (4) Finally, in vitro prevascularization is 
based on the preformation of vascular structures during an in vitro culture period prior to 
implantation. This can be achieved by coculturing tissue specific progenitor cells (e.g. ASC) 
with endothelial cells. In vivo, the prevascular network can then anastomose with the host 
vasculature [103,117–119].  
Whereas the first two strategies are relatively straightforward and have been proven to be 
effective in increasing the vascularization of engineered tissues, they still rely on the ingrowth 
of host vessels. Thus, depending on construct size central areas still are exposed to hypoxia 
and nutrient deprivation in the first days or weeks. With in vivo prevascularization, besides 
the fact that it involves two elaborate surgical procedures, the problem of slow host vessel 
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ingrowth is still present during the first stage of the process. In contrast, in vitro 
prevascularization has the potential to provide a much faster perfusion of the whole 
constructs, as the host vessels only need to grow in until they connect the existing vascular 
structures within the transplant. Thus, the latter, of course also in combination with the other 
approaches, appears to be a promising strategy to tackle the problem of vascularization in 
tissue engineering [117,120]. However, only a limited number of studies have investigated 
the potential of this strategy in adipose TE up to now [121–123]. As the development of 
vascularized adipose tissue is a very complex process depending on reciprocal regulation 
between the involved cell types, the generation of engineered tissue constructs including a 
functional vasculature is not an easy task. Specifically, one of the major obstacles in finding a 
suitable in vitro coculture system is the adjustment of the culture conditions and protocols to 
allow for both the development of functional adipocytes and the formation of the vascular 
network [117,124]. In order to optimize current strategies for vascularization in adipose TE, it 
is crucial to further improve our understanding of the complex physiological processes 
involved in the development of native adipose tissue, which include, but are not limited to, 
adiopogenesis, angiogenesis and their various levels of interplay. 
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The main goal of this work was the development and characterization of a 3-dimensional 
(3-D) adipose tissue model based on human adipose-derived stem cells (hASC). The 
intention was to design a culture system which serves as a tool for basic research to improve 
our understanding of adipose tissue functions, development and pathophysiology. Apart from 
its use in basic research, this model system should not only have the potential to be used for 
applications in tissue engineering and regenerative medicine, but also to be utilized as a 
basis for 3-D drug screening assays. The experimental work performed to achieve this goal 
can be divided into two major parts: 
 
- The first part involved the establishment of culture conditions for a hASC spheroid 
model, which was subsequently applied to investigate differences in adipogenic 
differentiation between 2-D and 3-D culture systems. 
 
- The second part focused on the development of a coculture system of hASC and 
human microvascular endothelial cells (hMVEC) based on the monoculture spheroids 
developed in the first part. These coculture spheroids were then applied to investigate 
the interactions between the two cell types during adipose tissue development, 
primarily focusing on the influence of the endothelial cells on hASC adipogenesis. 
 
 
ASC monoculture spheroids 
The vast majority of our knowledge regarding adipose tissue biology is based on 
conventional monolayer cell culture models [1,2]. It is, however, well recognized that many 
tissue-inherent factors, such as the presence of extracellular matrix, cell-cell contact and 
interaction, as well as the complex 3-dimensional microenvironment, are represented by 
these 2-D culture systems only to a very limited extent [3,4]. 3-D in vitro cell culture using 
multicellular spheroids provides a possibility to overcome these limitations. At the same time, 
some of the disadvantages of scaffold- or hydrogel-based systems, such as the unknown 
influence of the carrier material or the absence of direct cell-cell-contact during the first 
phase of culture, do not apply for spheroid culture [5–7]. In our group, such a 3-D spheroid 
model using the 3T3-L1 mouse preadipocyte cell line has been established previously [8]. To 
resemble the physiology of human adipose tissue even more closely, it would be desirable to 
develop a spheroid model based on human ASC. These cells are multipotent, can easily be 
harvested in large numbers by liposuction, and can be readily differentiated into adipocytes, 
making them an ideal cell source for basic research as well as adipose tissue 
engineering [9,10]. Thus, the first goal of this thesis was the establishment of a culture 
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method for hASC spheroids (Chapter 3). We aimed at the development of a stable, easy-to-
handle and versatile 3-D model system suitable for basic research, drug screening and 
tissue engineering applications. 
To develop therapeutic strategies against adipose tissue-associated diseases, it is of great 
importance to increase our understanding of the complex processes involved in adipogenic 
differentiation. Our newly developed hASC spheroid model was therefore applied to 
investigate adipogenesis on a functional and molecular level (Chapter 4). Specifically, we 
focused on the differences between 3-D spheroids and conventional 2-D monolayer cultures 
regarding their response to and dependence on exogenous stimulation. This was done by 
investigating the influence of different adipogenic induction protocols on lipid accumulation 
and the expression of various marker genes associated with adipogenesis. 
 
ASC/MVEC coculture spheroids 
Native fat is a highly vascularized tissue, and it is well known that adipogenesis and 
angiogenesis are closely associated with each other in vivo [11–13]. Although it has been 
demonstrated that adipocytes as well as their progenitors produce several angiogenic 
factors, the molecular basis of the complex interaction between these two processes during 
adipose tissue development is still poorly understood. Furthermore, most of the studies 
addressing the crosstalk between (pre-)adipocytes and endothelial cells have been 
performed using 2-D monolayer culture [14,15]. Therefore, it was our goal to develop a 3-D 
coculture system consisting of hASC and hMVEC, which could then serve as a more in-vivo-
like model system for studying the interactions between the two cell types. Thus, based on 
the ASC monoculture spheroid model developed during the first part of this work, we aimed 
at establishing culture conditions and protocols for ASC/MVEC coculture spheroids which 
allowed for the ASC to be induced to undergo adipogenesis without compromising MVEC 
viability and proliferation (Chapter 5). 
Subsequently, this 3-D coculture spheroid model was characterized with a special focus set 
on the interactions between the two cell types. Specifically, parameters such as spheroid 
morphology, cell viability, triglyceride accumulation, tissue homogeneity and cellular self-
organization were investigated under mono- and coculture conditions. After establishing a 
method to dissociate the coculture spheroids and separate the cell types, a gene expression 
array was performed on the ASC to study the influence of the MVEC on adipogenesis within 
a 3-D environment on a molecular level (Chapter 6). 
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3.1 Abstract 
Adipose tissue plays an important role in many physiological and pathophysiological 
processes. Current knowledge about adipocyte biology and development is mainly based on 
in vitro monolayer cell culture models. However, three-dimensional (3-D) culture systems 
much better resemble the in vivo situation in terms of cell-cell contact and interactions with 
the extracellular matrix (ECM). The goal of this study was the development of a 3-D cell 
culture model based on the generation of multicellular spheroids from human adipose-
derived stem cells (ASC). 
Using the liquid overlay technique, ASC were seeded in agarose-coated 96-well-plates. This 
method was successfully employed to produce mechanically stable spheroids of defined 
size, in which ASC could be induced to undergo adipogenic differentiation. Cryopreservation 
and multiple passaging did not impair triglyceride accumulation during adipogenesis. 
Different culture conditions were evaluated with the goal of improving flexibility and cost 
effectiveness for routine culture. Spheroids sizes could be adjusted by varying the cell 
numbers seeded per well. After increasing seeding densities from 750 to 5000 cells per well, 
constructs still accumulated lipids homogeneously, while the larger spheroid sizes facilitated 
practical handling. Effective spheroid formation and adipogenic differentiation proved to be 
also possible when ASC from a different provider were applied, with cells remaining viable 
within the constructs. 
The established ASC spheroid model can not only be applied as a drug screening tool 
providing a more in-vivo-like context, but can also serve as a powerful model for the 
investigation and characterization of adipogenesis and adipocyte functions in a 3-D 
environment. Moreover, these spheroids have the potential to serve as building blocks for 
applications in adipose tissue engineering. 
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3.2 Introduction 
In recent years, the relevance of adipose tissue in many physiological processes, but also in 
the pathogenesis of diseases like type 2 diabetes and the metabolic syndrome, has been 
increasingly acknowledged [1–6]. Therefore, a thorough understanding of adipose tissue 
function and development is of great importance.  
The differentiation of multipotent precursor cells towards mature adipocytes is a complex 
process involving a coordinated transcriptional program as well as massive functional and 
morphological changes [7]. This process has been extensively studied in vitro, mainly using 
conventional two-dimensional (2-D) culture models [8–10]. However, in these 2-D systems, 
several aspects of the in vivo situation, especially tissue-inherent factors like cell-cell 
contacts and interactions with the extracellular matrix (ECM), are represented to a very 
limited extent only [11–14]. Three-dimensional (3-D) cultures can provide a model system 
resembling the in vivo context more closely [15]. Mainly for tissue engineering approaches, 
several 3-D culture systems for the cultivation of adipocyte precursor cells have been 
developed. In these models, cells are usually cultured in a 3-D environment either by seeding 
on porous scaffolds made of materials such as PLGA or collagen, or by encapsulating cells 
in hydrogels, predominantly based on PEG or fibrin [16,17]. These systems have proven to 
be useful for the development of implantable or injectable adipose tissue constructs in 
various in-vivo studies [18–22]. However, they exhibit several drawbacks for their use in 
basic research, when the focus is on elucidating the role of cell-cell communication, ECM 
influences and 3-dimensional architecture on adipocyte biology, or simply when the effects of 
certain (pharmacological) substances need to be evaluated in a more in-vivo-like context 
during screening processes. Notably, the presence of scaffold or carrier materials may not 
only affect cell functions and behavior [23], but also limits direct interactions with neighboring 
cells and the ECM, as cells are situated separated from each other, at least in the early 
stages of culture. Also, due to the size of the constructs, a cellular inhomogeneity resulting 
from insufficient nutrient and oxygen supply can occur [18], making cellular and molecular 
analytics difficult and inaccurate.  
One approach to overcome these limitations is the culture of multicellular spheroids. This 
model system, which has been applied in cancer research for many years, is based on the 
formation of cellular aggregates due to the absence of cell-adherent surfaces [24,25]. 
Although various spheroid model systems have been applied not only for tumor cells, but 
also for different types of primary cells [26], literature reports involving adipocyte spheroids 
are still scarce. A 3-dimensional model system based on the generation of such spheroids 
from 3T3-L1 preadipocytes was developed by our group. Characterization of these 3T3-L1 
spheroids, which could be induced to undergo adipogenic differentiation, has already 
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revealed several differences in adipogenic maturation and adipocyte functionality as 
compared to 2-D monolayer cultures [27]. 3T3-L1 cells, an immortalized cell line, are a well-
characterized and reliable model for studying the conversion of preadipocytes into 
adipocytes, representing a homogenous population of cells that are all at the same stage of 
differentiation and can be passaged indefinitely [28,29]. However, there are various 
metabolic and physiologic differences in the aneuploid mouse cell line 3T3-L1 as compared 
to human primary cells, e.g. regarding intracellular signaling pathways, the expression of 
transcription factors or the response to endocrine stimulation [30,31]. Furthermore, 3T3-L1 
cells have already undergone determination and can only be differentiatied towards adipose 
tissue [29].  
In contrast, human adipose-derived stem cells (hASC), which can be isolated from the 
stromal-vascular fraction of adipose tissue, are still multipotent, having the potential to 
undergo differentiation into adipocytes, osteoblasts, chondrocytes, myocytes, endothelial 
cells and neuronal cells, among others [32–35]. As a consequence, ASC may be a better 
model to explore especially the early molecular events during adipogenesis, including the 
lineage commitment [36]. Unlike bone marrow-derived stem cells (BMSC), they are easily 
available and can be harvested in large numbers, e.g. from liposuctions [34,37]. 
In some reports, hASC have already been cultured as spheroids generated by hanging-drop 
culture [38–40], by culturing in spinner flasks [41] or as centrifugation pellet culture [42]. 
However, these methods contain several drawbacks [26]. 
The aim of this chapter was to establish an in vitro hASC spheroid model suitable for long-
term culture and screening applications, in which cells can be easily induced to undergo 
adipogenic differentiation. As these spheroids could also be embedded and further cultured 
within hydrogels, they would not only be a valuable tool for basic research, but also have 
great potential as building blocks for the use in adipose tissue engineering. 
At first, it was evaluated if ASC spheroids can be generated and differentiated using the 
liquid overlay technique. Secondly, in an attempt to make 3-D culture easier, more flexible 
and cost effective, we investigated the influence of cryoconservation and multiple passaging 
as well as different culture conditions on ASC performance. Furthermore, spheroid sizes 
were optimized by variation of the seeding density followed by a histological evaluation of 
tissue homogeneity. After a necessary change of the cell provider due to patent issues, 
spheroid formation, adipogenic differentiation and cell viability were assessed using the new 
cell source.  
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3.3 Materials and Methods 
3.3.1 Materials 
Human adipose derived stem cells (ASC) were obtained from Lonza (Walkersville, MD, USA; 
lot 7F4308) and from PromoCell (Heidelberg, Germany; lot 8073006.12); Preadipocyte 
Growth Medium 2 (PGM2, consisting of PBM2, 10% FBS and 1% penicillin/streptomycin 
solution)  and PGM2 SingleQuots (IBMX, insulin, indomethacin, dexamethasone) were from 
Lonza (Verviers, Belgium). DMEM/Ham´s F12 was purchased from Biochrom (Berlin, 
Germany). Fetal bovine serum (FBS, lot 40A0044K), penicillin-streptomycin solution, 0.25% 
trypsin/EDTA solution and phosphate buffered saline (PBS) were from Invitrogen (Darmstadt, 
Germany). Minimum Essential Medium alpha modification (MEM alpha), agarose, 
indomethacin, dexamethasone, glycerol standard solution, bovine serum albumin (BSA), 
propidiumiodide solution, dimethylsulfoxide (DMSO), calf thymus DNA, Oil Red O, Nile Red 
and osmium tetroxide were purchased from Sigma-Aldrich (Munich, Germany). 3-isobutyl-
methylxanthine (IBMX) was bought from Serva (Heidelberg, Germany), Thesit from 
Gepepharm (Siegburg, Germany). Hoechst 33258 dye was obtained from Polysciences 
(Warrington, PA, USA). Bovine insulin was kindly provided by Sanofi-Aventis (Frankfurt a. 
M., Germany). All other chemicals were from Merck (Darmstadt, Germany). All cell culture 
plastics were from Corning (Bodenheim, Germany).  
 
3.3.2 Methods 
3.3.2.1 Cell culture 
3.3.2.1.1 2-D cell culture 
For 2-D monolayer cultures, human adipose-derived stem cells (ASC) were thawed after 
cryopreservation (passage 3, if not stated otherwise) and seeded in culture flasks. They were 
expanded at 37°C, 5% CO2 in growth medium (GM), i.e. Preadipocyte Basal Medium 2 
(PBM2) containing 10% FBS, penicillin (100 U/ml) and streptomycin (100 µg/ml). At 90% 
confluence cells were trypsinized, seeded in 24-well plates at a density of 30000 cells/cm² 
and cultured in GM for 2 days before adipogenic differentiation was induced. 
 
3.3.2.1.2 3-D cell culture 
For the generation of 3-D spheroid cultures the liquid overlay technique was used 
(Fig. 3-1) [25,27]. ASC were expanded as described in the previous section. After 
trypsinization, cells were resuspended in GM and seeded into 96-well plates coated with 
1.5% agarose at a distinct number of cells per well, ranging from 750 to 15000 cells 
Chapter 3   Establishment of a hASC Spheroid Model 
 
- 36 - 
 
depending on the experiment. As evaporation is higher in the outermost rows and columns 
during prolonged culture, those wells were not seeded with cells, but only filled with PBS 
containing penicillin (100 U/ml) and streptomycin (100 µg/ml) (Fig. 3-1). Culture plates were 
kept on an orbital shaker at 50 rpm during incubation. After 1 day, a single spheroid had 
developed in each well. Like in 2-D culture, adipogenesis was induced after 2 days in GM. As 
spheroids would be lost with complete removal of medium from the wells, all medium 
changes were performed by replenishing only half of the medium volume. For comparability, 
2-D cultures were treated in the same way. 
 
 
Figure 3-1: Generation of hASC spheroids using the liquid overlay technique (from [27], modified). 
Cells were expanded in 2-D culture, trypsinized and seeded into agarose-coated 96-well plates at a 
distinct number of cells per well. As cells cannot adhere to the agarose surface, they accumulated in 
the center of the well and, by attaching to each other, formed a single multicellular spheroid in each 
well. 
 
3.3.2.1.3 Adipogenic differentiation 
In both culture systems (2-D and 3-D), cells were induced to undergo adipogenesis 2 days 
after seeding by exchanging half of the medium with induction medium (IM), consisting of 
GM supplemented with a hormonal cocktail, resulting in final concentrations of 1.7 µM 
insulin, 1 µM dexamethasone, 200 µM indomethacin and 500 µM 3-isobutyl-1-
methylxanthine (IBMX). The time point of induction was always referred to as day 0. Cells 
were kept in IM over the whole culture period. 
 
3.3.2.1.4 Evaluation of culture conditions 
In order to determine optimal culture conditions, the general culture protocol described above 
was modified in several ways.  
Hormonal cocktail: 
The induction cocktail (IBMX, dexamethasone, insulin, indomethacin) originally supplied 
together with PBM2 (“SingleQuots”) was replaced by a self-prepared hormonal mixture 
containing the same substances in corresponding concentrations to induce adipogenesis in 
2-D cultures. 
 
cell expansion
(2-D culture)
cell
suspension
96-well plate
(agarose-coated)
spheroid
agarose
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Feeding strategy: 
As in the manufacturer´s protocol supplied together with the cells no recommendations were 
given regarding the frequency of medium changes after induction, intervals of 7 or 3-4 days 
were applied and compared in 2-D. 
Basal media and fetal bovine serum: 
Besides PGM2, alternative basal media were tested with respect to differentiation efficiency. 
ASC were seeded either in PGM2, in DMEM/Ham´s F12 or in MEM alpha and kept in the 
same media during adipogenic differentiation. Additionally, two different lots of FBS were 
used to supplement the media, keeping the FBS concentration at 10% at all times. 
Spheroid sizes: 
To investigate the influence of different cell numbers on spheroid formation and 
differentiation, cells were seeded in agarose-coated 96-well plates with 1500, 3000, 5000, 
10000 or 15000 cells per well. Adipogenic differentiation was induced as described above. 
 
3.3.2.2 Microscopical determination of spheroid size 
At specific time points, microscopical bright field images of the spheroids were acquired 
using a CCD camera (DS-5M, Nikon, Düsseldorf, Germany) attached to an inverted 
microscope (Leica DM IRB, Leica Microsystems, Wetzlar, Germany). Cross-sectional areas 
of at least 10 randomly selected spheroids were determined with ImageJ software (NIH, 
Bethesda, MD, USA). Equivalent diameters and spheroid volumes were calculated thereof. 
 
3.3.2.3 Lipid staining with Oil Red O or osmium tetroxide 
To visualize triglyceride accumulation, cultures were harvested and staining with Oil Red O 
(ORO) or osmium tetroxide (OsO4) was performed. For this purpose, spheroids were pooled 
in PBS, transferred to microcentrifuge tubes, washed with PBS, fixed in 10% formalin (1h, 
4°C), stained with ORO (3 mg/ml solution in 60% isopropanol) for 4h or with OsO4 (1% 
aqueous solution) for 1 h on ice and washed three times with PBS. Stained spheroids were 
embedded in Tissue-Tek (Hartenstein Laborbedarf, Würzburg, Germany), snap frozen and 
cut into 10-µm-thick cryosections. After removal of Tissue-Tek by washing in water, the 
sections were mounted in glycerol. Serial sections were prepared from all spheroids and 
sections from the center region were used for histological evaluation. For 2-D cultures, 
staining was performed directly in the 24-well plates. Microscopical bright field images were 
acquired using a CCD camera (DS-5M, Nikon, Düsseldorf, Germany) attached to an inverted 
microscope (Leica DM IRB, Leica Microsystems, Wetzlar, Germany).  
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3.3.2.4 Lipid staining with Nile Red 
Nile Red Staining was performed according to a protocol adapted from Greenspan et al. [43]. 
Spheroids were harvested, fixed in 10% formalin and transferred to angiogenesis slides 
(Ibidi, Martinsried, Germany). Remaining medium was removed carefully, followed by the 
addition of the dye solution, which was prepared by adding 10 µl of a Nile Red stock solution 
(500 µg/ml in Acetone) to 1 ml of 75% glycerol. After 1h of incubation at room temperature 
the staining was evaluated with a confocal laser scanning microscope (Zeiss Axiovert 200M 
microscope coupled to a Zeiss LSM 510 scanning device, Carl Zeiss MicroImaging, Jena, 
Germany). Nile Red fluorescence was excited at 488 nm and detected using a 505-550 nm 
band-pass filter. Z-stacks were performed to visualize lipid distribution within the spheroids. 
 
3.3.2.5 Quantitative determination of the intracellular triglyceride (TG) content 
For analysis of the intracellular TG content, 2-D monolayers were washed twice with PBS 
and harvested in 0.5% aqueous Thesit solution. 3-D spheroids were pooled, washed twice 
with PBS and resuspended in 0.5% aqueous Thesit solution. For both culture systems, cells 
were sonicated and spectroscopic quantification of TG was performed using the enzymatic 
Serum Triglyceride Determination Kit from Sigma-Aldrich (Munich, Germany) according to 
the manufacturer’s instructions. Beforehand, assay conditions were adjusted to 96-well plate 
format in a series of comparative measurements. For calibration, different glycerol standard 
dilutions were used. All TG data were acquired from three biological replicates; one replicate 
was derived from one well for 2-D cultures and an exact number of approximately 20 
spheroids for 3-D cultures, respectively. TG contents per spheroid or per well were 
calculated and normalized to the DNA content, which was determined as described below. 
 
3.3.2.6 Determination of the DNA content 
2-D monolayers were washed twice with PBS, harvested in lysis buffer (2 mM EDTA, 2M 
NaCl, 50 mM Na3PO4, pH 7,4) and sonicated. 3-D spheroids were pooled, washed twice with 
PBS, resuspended in lysis buffer and sonicated as well. DNA content was determined using 
the intercalating Hoechst 33258 dye (0.1 µg/ml in 0.1 M NaCl, 1 mM EDTA, 10 mM Tris, pH 
7.4). Fluorescence intensities were determined at an excitation wavelength of 365 nm and an 
emission wavelength of 458 nm with a LS 55 fluorescence spectrometer (PerkinElmer, 
Wiesbaden, Germany) and correlated to DNA contents using standard dilutions of double-
stranded DNA (from calf thymus). All measurements were performed in three biological 
replicates; one replicate was derived from one well for 2-D cultures and an exact number of 
approximately 10 spheroids for 3-D cultures, respectively.  
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3.3.2.7 Live/Dead Assay 
Cell viability within the spheroids was assessed with the Live/Dead Cell Staining Kit II 
(PromoCell, Heidelberg, Germany). Spheroids were pooled, washed three times with 
PBS and incubated with the staining solution (4 µM EthD-III, 2 µM Calcein AM) for 45 
min. The staining was evaluated by imaging with a confocal laser scanning microscope 
(Zeiss Axiovert 200M microscope coupled to a Zeiss LSM 510 scanning device, Carl Zeiss 
MicroImaging, Jena, Germany). Live cells showed green calcein fluorescence (ex. 488 nm, 
em. 505-550 BP), dead cells were indicated by red fluorescence of DNA-intercalating 
EthD-III in the nuclei (ex. 543 nm, em. LP 560). The z-stack mode was used to investigate 
viability inside the spheroids. 
 
3.3.2.8 Statistics 
All quantitative results are expressed as mean values ± standard deviations. Differences 
between multiple groups were analyzed for significance using one-way analysis of variances 
(ANOVA) with subsequent multiple comparisons according to Tukey´s post-hoc test. A value 
of p<0.05 was regarded as statistically significant. Statistical analysis was performed using 
PASW Statistics 18 software (SPSS Inc., Chicago, IL, USA). 
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3.4 Results and Discussion* 
3.4.1 hASC spheroids – proof of principle 
In order to evaluate the general suitability of the liquid overlay technique for the generation of 
3-D ASC spheroids, in a first attempt cells from passage 1 were seeded into agarose-coated 
96-well plates at 750 cells per well. This seeding density was selected based on previous 
results with 3T3-L1 spheroids. In these, a starting cell number of 750 per well had been 
found to be optimal, while larger spheroid sizes had led to gradients in triglyceride 
accumulation after adipogenic induction [27]. The culture conditions were chosen according 
to the cell supplier´s recommendations: PGM2 was used as basic medium, and adipogenic 
induction was performed with the provided SingleQuots kit, with the inducers remaining in the 
medium over the complete culture time. 
 
 
Figure 3-2: Adipogenic differentiation of passage 1 ASC spheroids, 750 cells per well A) Bright field 
images of the whole spheroids at the time point of induction (d0) and after 3 weeks of adipogenic 
differentiation (d21). B) Cryosections of d0 and d21 spheroids, stained for triglycerides with Oil Red O 
(ORO). Scale bars are 100 µm. 
 
One day after seeding, cells had aggregated to form a single spheroid in each well 
(Fig. 3-2 A). These compact 3-D tissue constructs remained mechanically stable over a 
prolonged culture period, independent of a subsequent hormonal induction or cultivation in 
growth medium only. When adipogenesis was induced on day 0, cells started to accumulate 
                                               
*
 As the establishment of the hASC spheroid model was a multi-step process, with each experiment being based 
on the results of the previous one, results and discussion are combined in one section. 
A 
B 
d0 d21 
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more and more triglycerides in droplets up to day 21, which was clearly observable via bright 
field microscopy (Fig 3-2 A). In contrast to day 0, where virtually no triglycerides could be 
detected, Oil Red O staining revealed that on day 21, numerous lipid droplets were 
homogeneously distributed throughout the spheroids (Fig. 3-2 B).  
On day 0, the spheroids had equivalent diameters of under 200 µm, which was comparable 
to 3T3-L1 spheroids which have been generated previously in our group [27]. Interestingly, 
the hASC spheroid diameters did not increase significantly during adipogenic differentiation. 
21 days after induction, they were still in the same range as on day 0. In contrast, 3T3-L1 
spheroids had strongly increased in size when they were induced to undergo adipogenesis, 
which was mainly attributed to the accumulation of lipid droplets [27]. 3T3-L1 is a mouse cell 
line, and the much higher growth rate of the induced spheroids can be explained by the 
faster metabolism and therefore strongly increased speed of adipogenic differentiation as 
compared to human ASC [44].  
In general, for most applications a higher seeding density leading to a larger number of cells 
per spheroid would be advantageous with regard to practical handling, as the total number of 
constructs needed in one experiment would be reduced. As already mentioned, for the 
3T3-L1 spheroids, 750 cells per well had been determined to be optimal, as on account of 
the strong volume increase during adipogenesis higher seeding numbers had led to partially 
inhomogeneous differentiation of the constructs. This was attributed to the limited diffusion of 
oxygen into the center of the spheroids with increasing size [27]. As in the hASC spheroids 
no significant volume increase took place, higher seeding densities may be possible for them 
without compromising construct homogeneity after differentiation. The optimization of 
spheroid sizes will be further addressed in chapter 3.4.4. 
In summary, these first results proved that the spheroid model based on the liquid overlay 
technique is a suitable culture system for the 3-dimensional cultivation of hASC. For our 
intended applications, it bears several advantages over other methods for the generation of 
multicellular spheroids [26]. With hanging drop culture, medium changes, which are 
inevitable during long-term culture or for the induction of adipogenesis, can only be 
performed by transferring the constructs to new well plates, whereas in our model, spheroids 
remain in the culture plates, while half of the medium is exchanged with a multi-channel 
pipette. By seeding a distinct number of cells into each well, spheroids of controlled and 
reproducible sizes can be generated, which is not the case for the culture in spinner flasks or 
rotary systems, or even when cells are cultured on non-adhesive surfaces of larger scale, 
like in petri dishes. As compared to pellet culture in centrifuge tubes, with the model system 
described here a much higher throughput is possible, because it is easier to produce large 
numbers of spheroids and media exchanges can be performed more rapidly.  
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3.4.2 Influence of cryoconservation and multiple passaging 
Since the goal of this project was the establishment of a 3-D culture system suitable for 
routine use and in screening applications, the generation of differentiated constructs should 
also be possible when ASC in higher passages and/or after cryoconservation are applied. To 
characterize cell performance after serial passaging, in a 2-D experiment adipogenic 
differentiation was performed with passage 4 (P4) cells, which had been stored in liquid 
nitrogen after an initial expansion phase at passage 1. 
 
 
Figure 3-3: 2-D cultures of passage 1 (P1) and passage 4 (P4) ASC on day 21 after induction of 
adipogenesis. Triglycerides stained red using ORO. Scale bars are 100 µm. 
 
After seeding in 24-well plates and adipogenic induction, these cells performed comparably 
to those in P1, leading to a similar differentiation rate and lipid accumulation, as determined 
by ORO staining on day 21 (Fig. 3-3). This result was in accordance with literature reports, 
indicating that adipogenic differentiation of ASC can be induced at least up to P10, 
independent of previous cryoconservation [45,46].  
As a consequence, all following experiments were performed with P4 cells, leading to an 
improved flexibility, cost effectiveness and inter-experimental comparability, as 
cryoconserved cells from one batch could be used for several independent experiments. 
 
3.4.3 Evaluation of culture conditions 
The culture protocol which was applied in the first experiments could effectively differentiate 
the ASC towards the adipocyte lineage, but has some drawbacks with regard to routine 
culturing, like a poorly defined hormonal cocktail provided with the PGM2 medium 
(SingleQuots kit) and high cost. Therefore, in a set of 2-D experiments, it was tested whether 
comparable performance and differentiation could also be achieved using alternative culture 
conditions.  
On the one hand, the SingleQuots kit (SQ) was replaced by a self-prepared hormonal 
cocktail (HC), which was composed of the same components as in the SQ (IBMX, 
P1 P4 
100 µm 100 µm 
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dexamethasone, indomethacin, insulin). Concentrations were chosen as described in 
literature [45,47–51]. Differentiation rate and triglyceride content after 21 days of culture were 
comparable in both groups, with a tendency to even stronger adipogenesis when the self-
prepared cocktail (HC) was used (Fig. 3-4, groups 2 and 3). As the self-prepared HC 
provided defined conditions and led to an enhanced flexibility, it was used in all following 
experiments. 
 
 
Figure 3-4: Evaluation of culture conditions: A) 2-D cultures in different groups were induced using 
either the SingleQuots Kit (SQ) supplied with PGM2 or a corresponding self-mixed hormonal cocktail 
(HC). Medium change intervals were either 3-4 days or 7 days. B) Cellular triglyceride contents on day 
21 after induction; * indicates statistically significant differences vs. group 1 (p<0,05) C) Phase 
contrast images and D) ORO staining of the cultures on day 21. Scale bars are 100 µm. 
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On the other hand, medium changes were performed not only every 7 days as in the first 
experiments, but alternatively with a 3-to-4-day interval. The frequency of medium 
exchanges did not influence cell triglyceride accumulation significantly, as determined by 
ORO staining and TG quantification (Fig. 3-4, groups 2 and 4). However, in the majority of 
subsequent experiments, media were exchanged every 3-4 days, as this is more common for 
the cultivation of human primary cells.  
In general, ASC are most frequently cultured using a 1:1-mixture of DMEM and Ham´s F12 
as a basic medium [52–55]. In order to determine if the PGM2, which has been used in the 
previous experiments, can be replaced with the chemically defined DMEM/Ham´s F12 
without compromising adipogenic differentiation, a comparative study was conducted. In 
addition, MEM alpha was included in the experiment as a further alternative medium, which 
has occasionally been used for the culture of mesenchymal stem cells [56,57].  
Not only the basic media, but also the supplemented fetal bovine serum (FBS) can have 
substantial influence on cell proliferation and differentiation [58]. Therefore, in this study two 
different batches of FBS were added to each of the media.  
 
 
Figure 3-5: Influence of different combinations of basic media and FBS batches on adipogenic 
differentiation. TG contents are shown for day 21 after induction. * indicates statistically significant 
differences between the respective groups (p<0,05). 
 
The determination of triglyceride contents on day 21 after induction showed that cells had 
accumulated the largest amount of lipids when cultured with PGM2, independent of the 
supplemented FBS (Fig. 3-5). The exact composition of PGM2 was not revealed by the 
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manufacturer, making it impossible to identify possible reasons for its better performance. 
However, as the establishment of standard conditions leading to an effective adipogenic 
differentiation was an aim of this project, PGM2 was continuously used as basic medium in 
all further steps.  
In summary, it was determined that optimal ASC culture conditions for the current project 
included the basic medium PBM2, containing 10% FBS (batch 40A0044K, Invitrogen), 
medium changes every 3-4 days and adipogenic induction with the hormonal cocktail 
composed of IBMX, dexamethasone, indomethacin and insulin. 
In a next step, this optimized protocol was used for the culture and differentiation of ASC 
spheroids. Here, seeding into the 96-well plates was not only performed with 750 cells per 
well, like in the initial experiments, but also with 1500 cell per well. In both cases, extensive 
lipid accumulation could be observed throughout the constructs, indicating that spatially 
homogeneous adipogenic conversion of the ASC had taken place. This proved that the 
optimized culture conditions could successfully be applied for ASC spheroid differentiation.  
 
 
Figure 3-6: 3-D ASC spheroids cultured according to the optimized protocol. Seeding density was 750 
cells (a) or 1500 cells (b) per well, respectively. Lipid accumulation on day 21 after induction was 
determined by ORO staining. Scale bars are 50 µm. 
 
3.4.4 Evaluation of optimal spheroid sizes 
As already mentioned in chapter 3.4.1, with regard to the 3-D spheroid system, it was 
desirable to increase the number of cells seeded per well, which would lead to higher 
construct volumes. This would not only facilitate practical handling, but also reduce the 
number of spheroids that have to be pooled for subsequent analytics. Since results from 
chapter 3.4.1 had demonstrated that ASC spheroids, in contrast to 3T3-L1 spheroids, did not 
increase significantly in volume up to 3 weeks of culture, we hypothesized that the 
generation and adipogenic conversion of constructs larger than 750 cells should be possible 
without compromising homogeneous adipocyte maturation. In the previous chapter, it could 
already be demonstrated that this was true for a doubling of the seeding density to 1500 cells 
(Fig. 3-6). In a new study, the influence of the cell number per spheroid was investigated in 
more detail. ASC were seeded into agarose-coated 96-well plates with 1500, 3000, 5000, 
a b 
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10000 or 15000 cells per well. In all cases, a single spheroid had formed in each well within 
24h. On the day of adipogenic induction (d0), spheroid volumes increased linearly with the 
cell numbers up to 5000 cells. In contrast, spheroids generated from 10000 or 15000 cells 
had volumes slightly smaller than expected, with higher inter-spheroid variability (Fig. 3-7 A).  
 
 
Figure 3-7: A) Equivalent spheroid volumes on day 0 in dependence of the cell number seeded per 
well. B) Growth kinetics of the spheroids up to day 13 after induction. 
 
This could be a hint that in these groups, not all of the seeded cells in each well were 
included into the aggregation of the spheroids. Another explanation might be a stronger 
compaction of the constructs in the first phase of culture, which has also been observed for 
3T3-L1 spheroids of larger sizes [27] and for MSC spheroids generated by hanging-drop 
culture [38]. During adipogenic differentiation, spheroids of all groups initially decreased in 
size (as detected on day 5, Fig. 3-7 B). Subsequently, up to day 13 a volume increase of 
about 50% as compared to day 5 could be observed for all spheroids, independent of the cell 
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numbers seeded (Fig. 3-7 B). Interestingly, after about 16 days, the largest constructs, 
generated from 15000 cells, in some cases began to show signs of mechanical instability 
and desaggregation.  
On day 16 after induction, cells in all groups treated with the hormonal cocktail had 
accumulated lipids in all areas of the constructs, whereas uninduced groups contained no 
lipid droplets, as determined by staining with OsO4. However, in the spheroids generated 
from 10000 or 15000 cells, adipogenic conversion had occurred to a slightly lesser extent in 
the center regions of the constructs, whereas for the smaller spheroids, triglyceride 
accumulation was homogeneous (Fig. 3-8).  
 
 
Figure 3-8: Cryosections of ASC spheroids on day 16 after induction, stained with OsO4. a) uninduced 
control  b-f) induced with hormonal cocktail. Scale bars are 100 µm. 
 
In summary, spheroids generated from 3000 or 5000 cells appeared to have optimal 
properties for routine culture. These constructs represent a 3-D model system small enough 
to allow for reproducible construct sizes, adipocyte maturation without spatial gradients and 
long term mechanical stability, but large enough to facilitate practical handling and to reduce 
the number of spheroids required for standard analytics. 
 
3.4.5 Introduction of a new cell source 
Due to patent issues, the ASC from Lonza (Verviers, Belgium) were no longer available for 
purchase after the establishment phase of the spheroid culture, which was described in the 
previous sections. Thus, for all future steps of this work, ASC were acquired from PromoCell 
a b c 
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(Heidelberg, Germany). Before cells from the new provider were applied for routine 
experiments, it was tested whether their performance under the previously established 
conditions was comparable regarding proliferation, spheroid formation and adipogenic 
differentiation.  
 
 
Figure 3-9: Adipogenic differentiation of spheroids consisting of 3000 ASC (PromoCell) A) Bright field 
images of the whole spheroids and OsO4-stained cryosections (right) of induced (upper row) and 
control (lower row) spheroids at different time points. Scale bars are 100 µm. B) CLSM images of 
induced spheroids on day 14; Lipids stained with Nile Red. To visualize TG distribution inside the 
constructs, the image shows a series of consecutive optical sections (z-stack) with 10 µm intervals 
(top left to bottom right).  
 
When seeded with 3000 cells per well into agarose-coated 96-well plates, cell aggregation, 
initial volume decrease and subsequent accumulation of lipid droplets were observed via 
bright field microscopy and appeared to be very similar to the Lonza cells. OsO4 staining on 
day 14 after induction revealed extensive and homogeneous adipogenic conversion within 
the constructs when treated with adipogenic induction medium (Fig. 3-9 A).  
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Figure 3-10: Live/Dead-staining of ASC spheroids (d7). Optical sections acquired by confocal 
microscopy are depicted. In each row, green calcein fluorescence indicating live cells is shown on the 
left, red EthD-III fluorescence indicating dead cells in the middle and the overlay image on the right. 
a, c, and e show 3-dimensional projections obtained from z-stacks, b, d and f show single optical 
sections from areas within the spheroids. a/b) uninduced controls c/d) induced spheroids e/f) dead 
control (cells treated with DMSO for 2h). Scale bar is 100 µm. 
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Additionally, day 14 spheroids were stained with Nile Red and optical sections were acquired 
via confocal laser scanning microscopy (CLSM) by using the z-stack function, which 
confirmed that lipid inclusions were evenly distributed throughout the constructs (Fig. 3-9 B).  
Live/dead staining was performed on day 7 after induction to assess cell viability within the 
3-D constructs. In both induced and uninduced spheroids, the vast majority of cells showed 
green fluorescence indicating viability (Fig. 3-10).  
 
3.5 Conclusion 
A 3-D spheroid model capable of adipogenic differentiation after hormonal induction and 
suitable for long-term culture and screening applications was successfully established. It was 
demonstrated with cells from two different providers that, by applying the liquid overlay 
technique in agarose-coated 96-well plates, hASC form mechanically stable spheroids of 
defined size and can be induced to undergo adipogenesis. Subsequently, the influence of 
multiple passaging, FBS supplementation and the type of hormonal induction cocktail was 
assessed, and culture conditions were optimized regarding culture protocol and basic media 
in order to improve flexibility and cost effectiveness without decreasing lipid accumulation 
during adipogenesis. The seeding density could be increased from 750 up to 5000 cells per 
well, resulting in larger spheroids, which still homogeneously accumulated triglycerides when 
induced to undergo adipogenesis, while bearing several advantages with regard to routine 
culture. 
The established human ASC spheroid model not only provides a system for screening the 
effects of pharmacological substances on adipose tissue in a more in-vivo-like context as 
compared to conventional 2-D culture, but can also serve as a powerful tool for the 
investigation and characterization of adipogenesis and adipocyte functions in a 3-D 
environment. It may be useful in order to gain new insights into the way how tissue-inherent 
factors like cell-cell-contact and the influence of ECM, which are much better represented in 
a 3-D model, affect adipose tissue development and adipocyte biology. Furthermore, it opens 
up perspectives for applications in adipose tissue engineering, because the spheroids can 
also serve as building blocks for the generation of coherent tissue, e.g. after embedding in 
hydrogels or by applying the organ printing technique.  
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4.1 Abstract 
For the development of therapies against diseases associated with fat tissue, but also for 
applications in adipose tissue engineering, it is important to shed light on the process of 
adipogenesis. The conversion of mesenchymal stem cells to mature adipocytes is known to 
involve a highly regulated cascade of gene expression events. However, the three-
dimensional (3-D) microenvironment of native tissue is barely represented in monolayer cell 
culture. Therefore, a 3-D spheroid model using human adipose-derived stem cells (ASC), 
which had been established previously, was applied to characterize adipogenesis on a 
functional and molecular level, especially in comparison with conventional 2-D culture.  
Applying short-term adipogenic induction (common hormonal cocktail containing 
dexamethasone, insulin, 3-isobutyl-methylxanthine (IBMX) and indomethacin applied for two 
days only), a strong adipogenic response with a high lipid content on day 14 was observed in 
3-D spheroids, whereas lipid content was only minimal in 2-D culture. Gene expression data 
reflected these results: In 2-D culture, several genes associated with lipid synthesis and 
transport (FASN, ACLY, FATP1) were very weakly expressed, in contrast to high expression 
in 3-D spheroids. Also other fat cell markers and adipokines (e.g., adiponectin, apelin, LPL) 
were more strongly expressed in 3-D. Strikingly, already on day 2, increased expression of 
important transcription factors (PPARγ, C/EBPβ, SREBF1) was determined in 3-D culture, 
which represents, at least in part, a likely explanation for the observed 2-D/3-D-differences at 
later time points. In 2-D, additional exogenous stimulation after day 2 was necessary to 
achieve significant adipogenic differentiation, while the 3-D context provided conditions 
rendering further stimulation unnecessary. Moreover, hormonal induction without either IBMX 
or indomethacin still led to significant lipid accumulation and expression of marker genes like 
PPARγ in the ASC spheroids, but not in 2-D cultures, providing insights into possible 
molecular mechanisms leading to the observed differences. 
In conclusion, adipogenesis in the spheroid system proved to be less dependent on external 
stimulation than in conventional 2-D culture. The characterization of the 3-D spheroids 
provided valuable information for their use in adipose tissue engineering as well as in basic 
research. 
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4.2 Introduction 
The role of white adipose tissue (WAT) is not limited to storing excess energy in the form of 
fat, as it was the established opinion decades ago. On the contrary, it is now known that 
WAT contributes to the regulation of many physiological and pathophysiological processes 
through endocrine, paracrine, and autocrine signals [1–4]. A thorough understanding of 
adipose tissue function and the process of adipogenesis is not only a prerequisite for the 
development of therapeutic strategies against diseases associated with obesity and the 
metabolic syndrome [4–6], but can also help to improve methods in adipose tissue 
engineering. 
The conversion of mesenchymal stem cells towards adipocytes involves a determination 
phase, in which commitment to the adipocyte lineage takes place, followed by terminal 
differentiation. Especially the latter phase, in which cells gradually adopt adipocyte 
morphology and start to express typical fat cell markers and adipokines, has been 
characterized in numerous studies. This has helped to identify more and more genes and 
regulatory mechanisms involved in adipocyte differentiation and maturation [1,2,7–9]. It is 
now well known that adipogenesis is accompanied by a temporally regulated set of gene 
expression events, in which transcription factors like PPAR, the so called master regulator 
of adipogenesis, and members of the CCAAT-enhancer-binding protein family (C/EBPs) play 
an important role [10,11].  
The vast majority of studies in this field was performed using conventional two-dimensional 
(2-D) in vitro culture. However, it is well recognized that cells are strongly influenced by 
tissue-specific aspects such as multiple cell-cell and cell-ECM interactions and the 
3-dimensional structure itself, all of which are not accurately represented in 2-D culture [12–
16].  
Therefore, the main goal of this study was to characterize the process of adipogenesis in a 
3-D culture system in comparison to conventional 2-D culture on a functional and molecular 
level. For this purpose, our previously established hASC spheroid model was applied, as it 
provides a well-defined, homogeneous, scaffold-free 3-D environment, in which adipogenic 
differentiation can be investigated in a more in-vivo-like context (chapter 3). 
Specifically, the main focus of this chapter was set on the influence of a reduced hormonal 
stimulation on adipogenesis in 2-D and 3-D culture. Most common protocols for the in vitro 
adipogenic differentiation of hASC include the application of a hormonal induction cocktail 
consisting of the 4 components dexamethasone, 3-isobutyl-methylxanthine (IBMX), insulin 
and indomethacin [17–21]. Usually, these inducers remain in the medium over the whole 
culture period (permanent induction, IND-P). There have been hints that protocols involving 
only a short-term induction lead to a severely impaired differentiation efficiency in 2-D 
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culture, but this behavior was not further investigated [19]. However, preliminary experiments 
with our spheroid model indicated that such a short-term protocol (IND-S), in which the 
hormonal cocktail was removed at day 2, could be sufficient to induce adipogenic 
differentiation in the 3-D environment. This would mean that adipogenesis is less dependent 
on exogenous stimulation in our spheroid system than in conventional 2-D culture.  
To investigate this hypothesis, lipid accumulation and gene expression of monolayers and 
3-D spheroids were assessed, when cells were induced to undergo adipogenic differentiation 
using either permanent or short-term induction. Moreover, in a different experiment, both 
culture systems were exposed to altered induction cocktails, in which certain components 
were omitted, which also represents conditions with a reduced exogenous stimulus. 
The in vitro pretreatment of cell constructs is also an important issue in adipose tissue 
regeneration, which can significantly influence their subsequent in vivo performance. 
Interestingly, in several studies adipogenic induction performed prior to implantation led to 
strongly increased adipogenesis and better adipose tissue development in vivo [22,23]. With 
regard to clinical applications in regenerative medicine, it is desirable to keep in vitro 
preconditioning as short as possible. Therefore, a further goal of this study was to evaluate 
the suitability of the spheroid model, in combination with modified induction protocols, for a 
possible future use in tissue engineering applications. 
 
4.3 Materials and Methods 
4.3.1 Materials 
Human adipose derived stem cells (ASC) were obtained from PromoCell (Heidelberg, 
Germany; lot 8073006.12); Preadipocyte Growth Medium 2 (PGM2) was from Lonza 
(Verviers, Belgium). Fetal bovine serum (FBS, lot 40A0044K), penicillin-streptomycin 
solution, 0.25% trypsin/EDTA solution, phosphate buffered saline (PBS) and Trizol reagent 
were from Invitrogen (Darmstadt, Germany). Agarose, indomethacin, dexamethasone, 
glycerol standard solution, bovine serum albumin (BSA), propidiumiodide solution, 
dimethylsulfoxide (DMSO), calf thymus DNA, Oil Red O, osmium tetroxide, formaldehyde 
solution, MOPS, RNA sample loading buffer, EDTA, sodium acetate and DEPC water were 
purchased from Sigma-Aldrich (Munich, Germany). 3-isobutyl-methylxanthine (IBMX) was 
bought from Serva (Heidelberg, Germany), Thesit from Gepepharm (Siegburg, Germany). 
Hoechst 33258 dye was obtained from Polysciences (Warrington, PA, USA). Bovine insulin 
was kindly provided by Sanofi-Aventis (Frankfurt a. M., Germany). Turbo DNase and the 
TaqMan Gene Expression Master Mix were from Applied Biosystems (Darmstadt, Germany). 
Chapter 4  Adipogenesis in 2-D and 3-D Cultures 
 
- 59 - 
 
All other chemicals were from Merck (Darmstadt, Germany). All cell culture plastics were 
from Corning (Bodenheim, Germany).  
 
4.3.2 Methods 
4.3.2.1 Cell culture 
4.3.2.1.1 2-D cell culture 
Human adipose-derived stem cells (hASC) were thawed after cryopreservation (Passage 3) 
and seeded in culture flasks. They were expanded at 37°C, 5% CO2 in growth medium (GM), 
i.e. Preadipocyte Basal Medium (PBM2) containing 10% FBS, penicillin (100 U/ml) and 
streptomycin (100 µg/ml). At 90% confluence cells were trypsinized, seeded in 24-well plates 
at a density of 30,000 cells/cm² and cultured in GM for 2 days before adipogenic 
differentiation was induced. 
 
4.3.2.1.2 3-D cell culture 
For the generation of 3-D spheroid cultures the liquid overlay technique was used. hASC 
were expanded as described in the previous section. After trypsinization, cells were 
resuspended in GM and seeded into 96-well plates coated with 1.5% agarose at 3,000 cells 
per well. Culture plates were kept on an orbital shaker at 50 rpm during incubation. After 
1 day, a single spheroid had developed in each well. Like in 2-D culture, adipogenesis was 
induced after 2 days in GM. As spheroids would be lost with complete removal of medium 
from the wells, all medium changes were performed by replenishing only half of the medium 
volume. For comparability, 2-D cultures were treated in the same way. 
 
4.3.2.1.3 Adipogenic differentiation under permanent and short-term induction 
In both culture systems (2-D and 3-D), adipogenic differentiation was performed using two 
different induction protocols (see Fig. 4-1 for an illustration of the experimental design): 
permanent induction (IND-P) and short-term induction (IND-S). 
In both cases, on day 0 (i.e. the day of induction) adipogenesis was induced by exchanging 
half of the medium with induction medium (IM), consisting of GM supplemented with a 
hormonal cocktail, resulting in final concentrations of 1.7 µM insulin, 1 µM dexamethason, 
200 µM indomethacin and 500 µM 3-isobutyl-1-methylxanthine (IBMX). When permanent 
induction (IND-P) was applied, cells were kept in IM over the whole culture period up to 
day 14. Using short-term induction (IND-S), IM was replaced by maintenance medium (MM) 
on day 2 after induction by exchanging half of the medium for three times (in 2-D and 3-D) in 
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order to reduce the concentration of the hormonal inducers. MM consisted of GM 
supplemented with 1.7 µM insulin (final concentration). For both 2-D and 3-D culture, a 
control group (CTRL) was kept in GM for the whole culture time without adipogenic induction, 
but otherwise treated in the same way as the other groups.  
 
 
 
Figure 4-1: Experimental design. hASC were seeded as 2-D monolayers or 3-D spheroids. In both 
culture systems, adipogenic differentiation was performed using two different induction protocols: 
permanent induction (IND-P) and short-time induction (IND-S). In both cases, on day 0 induction 
medium (IM) was applied. Using IND-P, cells were kept in IM over the whole culture period up to day 
14, while for the IND-S groups, IM was replaced by maintenance medium (MM) on day 2 after 
induction. A control group (CTRL) for each culture system (2-D and 3-D) was kept in growth medium 
(GM) for the whole culture time without adipogenic induction. Samples for the analysis of triglyceride 
and DNA contents were taken from each group on day 14 after induction. RNA was isolated on days 
0, 2 and 9. Please note that on day 0 only one group existed in each culture system, because samples 
were taken before the start of the adipogenic induction. Up to day 2, treatment of the groups IND-P 
and IND-S was identical, so that on day 2 we could only distinguish between control (CTRL) and 
induced (IND) groups. 
 
2-D and 3-D cultures were harvested on days 0, 2 and 9 for RNA isolation in triplicates. For 
one biological replicate, one well (2-D) or a pool of 60 spheroids (3-D) were used, 
respectively. On day 14, cells were harvested for the analysis of triglyceride (TG) and DNA 
contents as well as histological staining. 
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4.3.2.1.4 Adipogenic differentiation with altered hormonal cocktails 
2 days after seeding (i.e. on day 0), 2-D and 3-D cultures were treated with 2 different 
induction media, which were equivalent to standard IM (as described above), except that 
either IBMX or indomethacin were not included. Half of the medium was exchanged at day 2 
and then again every 3-4 days. One group of cells was kept in IM without IBMX over the 
whole culture time up to day 14, the other in IM without indomethacin. For both 2-D and 3-D 
culture, a control group (CTRL) was kept in GM for the whole culture time without adipogenic 
induction, but otherwise treated in the same way as the other groups. 2-D and 3-D cultures 
were harvested on days 0, 2 and 9 for RNA isolation and subsequent qRT-PCR analysis in 
triplicates. For one biological replicate, one well (2-D) or a pool of 20 spheroids (3-D) were 
used, respectively. On day 14, cells were harvested for the analysis of triglyceride (TG) and 
DNA contents as well as histological staining. 
 
4.3.2.2 Histological staining and preparation of cryosections 
To visualize triglyceride accumulation, cultures were harvested on day 14 after induction and 
staining with osmium tetroxide (OsO4) or Oil Red O (ORO) was performed. For this purpose, 
spheroids were transferred to microcentrifuge tubes, washed with PBS, fixed in 10% formalin 
(1h, 4°C), stained with OsO4 (1% aqueous solution) or with ORO (3 mg/ml solution in 60% 
isopropanol) for 1h on ice and washed three times with PBS. Stained spheroids were 
embedded in Tissue-Tek, snap-frozen and cut into 10 µm cryosections. After removal of 
Tissue-Tek by washing in water, the sections were mounted in glycerol. Serial sections were 
prepared from all spheroids and sections from the center region were used for histological 
evaluation. For 2-D cultures, staining was performed directly in the 24-well plates.  
 
4.3.2.3 Analysis of intracellular triglyceride (TG) accumulation 
For analysis of the intracellular TG content, 2-D monolayers and 3-D spheroids were washed 
twice with PBS and harvested in 0.5% aqueous Thesit solution. After sonication, 
spectroscopic quantification of TG was performed using the enzymatic Serum Triglyceride 
Determination Kit from Sigma-Aldrich (Taufkirchen, Germany) according to the 
manufacturer’s instructions. All measurements were performed in three biological replicates; 
one replicate was derived from one well for 2-D cultures and an exact number of 
approximately 20 spheroids for 3-D cultures, respectively. TG contents per spheroid or per 
well were calculated and normalized to the DNA content, which was determined as described 
below. 
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4.3.2.4 Determination of DNA content 
2-D monolayers and 3-D spheroids were washed twice with PBS, harvested in lysis buffer 
(2 mM EDTA, 2M NaCl, 50 mM Na3PO4, pH 7,4) and sonicated. DNA content was 
determined using the intercalating Hoechst 33258 dye (0.1 µg/ml in 0.1 M NaCl, 1 mM 
EDTA, 10 mM Tris, pH 7.4). Fluorescence intensities were determined at 365 nm excitation 
wavelength and 458 nm emission wavelength and correlated to DNA contents using 
standard dilutions of double-stranded DNA (from calf thymus). All measurements were 
performed in three biological replicates; one replicate was derived from one well for 2-D 
cultures and an exact number of approximately 10 spheroids for 3-D cultures, respectively. 
 
4.3.2.5 Low Density Gene Expression Array 
Prior to RNA isolation, 2-D monolayers as well as whole spheroids were washed with PBS. 
Total RNA was extracted from the samples using RNeasy Mini Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s instructions. For one biological replicate, 60 
spheroids were pooled and lysed by addition of RLT lysis buffer. 2-D cultures were lysed 
directly in the wells. Genomic DNA was eliminated using TURBO DNase according to the 
manufacturer’s instructions. DNase was subsequently removed by phenol-chloroform 
extraction. RNA concentration was determined spectrophotometrically with a NanoDrop 
analyzer (Thermo Fisher Scientific, Wilmington, DE, USA). RNA quality was tested by 
agarose gel electrophoresis. 
cDNA was synthesized from 100 ng total RNA per sample using High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Darmstadt, Germany) according to the 
manufacturer´s protocol. 
qRT-PCR using custom-made TaqMan Low Density Arrays (Applied Biosystems, Darmstadt, 
Germany) containing primers and probes for a variety of adipogenesis-related genes in 384-
well micro fluidic cards was performed according to the manufacturer’s instructions. cDNA 
samples were mixed with TaqMan Gene Expression Master Mix and filled into the ports of 
the micro fluidic cards. After centrifugation in order to distribute the cDNA samples to the 
reaction wells, the cards were sealed and RT-PCR was performed on a 7900HT Fast Real-
Time System (Applied Biosystems, Darmstadt, Germany) over 40 cycles. Evaluation of 
expression data was carried out according to the ΔΔCt method. All Ct values were 
normalized to GAPDH. Expression values of 2-D cultures on day 0 were used as reference 
for all other groups. If a gene was not detectable in the reference group, a Ct value of 40 was 
assumed (corresponding to one cDNA replicate in the sample). Relative expression levels 
(RQ) were calculated as 2-ΔΔCt. All measurements were performed with three biological 
replicates. Genes specifically mentioned in the text are listed in Table 4-1. 
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Table 4-1: List of gene names, gene symbols, and TaqMan Assay ID’s. 
Gene name Gene symbol Assay ID# 
ATP citrate lyase ACLY Hs00153764_m1 
adiponectin ADIPOQ Hs00605917_m1 
angiotensinogen AGT Hs00174854_m1 
apelin APLN Hs00175572_m1 
apolipoprotein E APOE Hs00171168_m1 
CCAAT/enhancer binding protein (C/EBP), alpha CEBPA Hs00269972_s1 
CCAAT/enhancer binding protein (C/EBP), beta CEBPB Hs00270923_s1 
CCAAT/enhancer binding protein (C/EBP), delta CEBPD Hs00270931_s1 
complement factor D (adipsin) CFD Hs00157263_m1 
fatty acid binding protein 4  (aP2) FABP4 Hs01086177_m1 
fatty acid synthase FASN Hs00188012_m1 
fatty acid transporter 1 FATP1 Hs01587917_m1 
glyceraldehyde-3-phosphate dehydrogenase GAPDH Hs99999905_m1 
facilitated glucose transporter 4 GLUT4 Hs00168966_m1 
lipoprotein lipase LPL Hs00173425_m1 
nicotinamide phosphoribosyltransferase (visfatin) NAMPT Hs00237184_m1 
peroxisome proliferator-activated receptor gamma PPARG Hs00234592_m1 
sterol regulatory element binding transcription factor 1 SREBF1 Hs01088691_m1 
 
4.3.2.6 Quantitative real-time PCR (qRT-PCR) 
Cells were harvested with Trizol reagent and the total RNA was isolated according to the 
manufacturer’s instructions. For one biological replicate, one well (2-D) or a pool of 20 
spheroids was used, respectively. All measurements were performed with three biological 
replicates. RNA concentrations were determined spectrophotometrically with a NanoDrop  
analyzer (Thermo Fisher Scientific, Wilmington, DE, USA). 
First strand cDNA was synthesized from total RNA using ImProm-II Reverse Transcription 
System (Promega, Mannheim, Germany) according to the manufacturer’s protocol. qRT-
PCR was performed with MESA Blue qPCR MasterMix Plus for SYBR® Assay (Eurogentec, 
Köln, Germany) on a Opticon 2 Real-Time PCR Detection System (Bio-Rad, München, 
Germany) using the following cycling conditions: 95 °C for 15 minutes, followed by 40 cycles 
at 95 °C  for 15 seconds, 55 °C for 30 seconds and 72 °C for 30 seconds. Amplification was 
carried out using specific primers for PPAR (QT00029841), C/EBP (QT00203357), aP2 
(=FABP4, QT01667694) and GLUT4 (=SLC2A4, QT00097902) from Qiagen (Hilden, 
Chapter 4  Adipogenesis in 2-D and 3-D Cultures 
 
- 64 - 
 
Germany). Evaluation of expression data was carried out according to the ΔΔCt method. All 
Ct values were normalized to beta-actin (QT01680476) as a housekeeping gene. Expression 
levels were calculated relative to 2-D cultures on day 0. Relative expression levels (RQ) were 
calculated as 2-ΔΔCt. 
 
4.3.2.7 Statistics 
All quantitative results are presented as mean value ± standard deviation. Differences 
between 2-D and 3-D culture at each time point were analyzed for significance using 
unpaired Student’s t-test. Differences within each culture system between time points were 
analyzed for significance using one-way analysis of variances (ANOVA) with subsequent 
multiple comparisons according to Tukey’s post-hoc test. A value of p<0.05 was regarded 
statistically significant. Statistical analysis was performed using PASW Statistics 18 software 
(SPSS Inc., Chicago, IL, USA). 
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4.4 Results 
4.4.1 Effect of short-term hormonal induction on lipid accumulation in 2-D and 
3-D cultures 
3-D spheroid cultures and conventional 2-D cultures of hASC were induced to undergo 
adipogenesis using two different induction protocols (Fig. 4-1). After 14 days, 2-D cultures 
treated according to the permanent induction protocol (IND-P) showed substantial 
triglyceride accumulation which became obvious in phase contrast microscopy and after 
staining with OsO4 (Fig. 4-2 A). Under the same conditions, OsO4-stained cryosections 
revealed that 3-D spheroids also contained many lipid droplets, which were distributed over 
all areas of the constructs (Fig. 4-2 A). However, when the complete hormonal induction 
cocktail (IBMX, dexamethason, indomethacin, insulin) was applied for only 2 days (short-
term induction protocol, IND-S), only a minimal number of lipid droplets could be detected in 
monolayers, whereas in 3-D spheroids triglyceride accumulation was comparable to the 
group treated with the protocol IND-P (Fig. 4-2 A). Uninduced control groups stained 
negative for triglycerides. 
Quantification of the triglyceride (TG) content confirmed these results. Using permanent 
induction, in both culture systems ASC had accumulated triglycerides on day 14, with TG 
levels in 3-D cultures being even higher than in 2-D. With short-time induction a TG level 
comparable to that under IND-P treatment had been reached in 3-D, while in 2-D virtually no 
TG could be detected at all (Fig. 4-2 B). 
 
4.4.2 Adipogenesis in 2-D and 3-D cultures: Gene expression 
To investigate if the observed morphological and functional differences between 2-D and 3-D 
cultures during adipogenesis were also reflected on gene expression level, and to elucidate 
possible reasons for this behavior, qRT-PCR was performed using a TaqMan Low Density 
Array. The custom-made array included several genes related to adipogenesis and adipocyte 
functions like transcription factors, adipokines and other fat cell markers. Samples of the 2-D 
and 3-D cultures were taken at three time points: on day 0, i.e. immediately before hormonal 
induction was performed, to obtain a reference value; on day 2, an early time point during 
adipogenesis at which the groups IND-P and IND-S were still identical (both had received the 
complete hormonal cocktail until then) and were therefore labeled as IND; and finally on 
day 9 to represent a later stage of adipogenesis (Fig. 4-1). 
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Figure 4-2: A) Histological analysis of the triglyceride (TG) accumulation in 2-D and 3-D hASC 
cultures on day 14 after adipogenic induction using the protocols IND-P (middle) or IND-S (right). 
Uninduced controls (CTRL) are shown on the left. 2-D cultures: unstained, viewed with phase contrast 
(a-c) and stained with OsO4 to visualize triglycerides (d-e). 3-D cultures: brightfield images of whole 
spheroids (g-i) and cryosections (from central regions of the constructs) stained with OsO4 (j-l). Scale 
bars are 100 µm. B) Quantification of intracellular TG content on day 14 (n=3). TG contents were 
normalized to DNA contents. 5 independent experiments were performed; representative results from 
one experiment are shown here. Statistically significant differences between 2-D and 3-D cultures are 
indicated by * (p<0.05). 
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Figure 4-3: Relative gene expression data (n=3) of the adipogenesis-related transcription factors 
PPARγ, C/EBP, C/EBPβ, C/EBPδ and SREBF1 as determined by qRT-PCR using TaqMan Low 
Density Arrays. All mRNA levels are expressed relative to the value at d0 in 2-D culture. Statistically 
significant differences between 2-D and 3-D cultures are indicated by * (p<0.05). 
 
Expression of the transcription factor PPAR, the master regulator of adipogenesis, was low 
on day 0 and in all uninduced controls, but highly upregulated by day 9 when permanent 
induction (IND-P) was performed, with the mRNA level in spheroid cultures being only 
slightly higher than in 2-D (Fig. 4-3 A). However, with short-time induction (IND-S) the 
difference between the two culture systems was much more pronounced. Here, expression 
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to IND-P was measured, leading to a prominent difference between the two culture systems. 
Strikingly, already on day 2 PPAR expression was significantly higher in 3-D cultures than in 
2-D. Moreover, for IND-S, gene expression in 2-D was still on the same level on day 9 as it 
had been on day 2, whereas in 3-D it was further upregulated from day 2 to day 9.  
C/EBP, another important transcription factor for adipogenesis, in general showed a similar 
expression pattern (Fig. 4-3 B). Here, gene expression was strongly upregulated by day 2 
independent of culture dimensionality. With IND-P, it was further increased by day 9 and 
reached comparable levels in 2-D and 3-D cultures. By contrast, using IND-S, C/EBP 
expression in 2-D cultures was lower on day 9 than on day 2, but higher in 3-D spheroids, 
where by day 9 it had reached similar values as with IND-P.  
C/EBPβ and C/EBPδ are usually upregulated in the early phase of adipogenic differentiation. 
On day 2 after induction, a significantly higher expression of C/EBPβ (Fig. 4-3 C), but not 
C/EBPδ (Fig. 4-3 D) could be detected in 3-D as compared to 2-D cultures.   
Expression of the SREBF1 gene in 2-D cultures treated according to IND-S was not higher 
than in uninduced controls on day 9 (Fig. 4-3 E). In 3-D however, mRNA levels at that time 
point were comparable to those differentiated under the IND-P protocol. This pattern was 
again similar to the results for PPAR and C/EBP. Furthermore, like for PPAR and 
C/EBPβ, also for SREBF1 gene expression data revealed a significant difference between 
2-D and 3-D culture already on day 2 after induction. 
In principle, comparable expression patterns could also be observed for several fat cell 
marker genes associated with lipid synthesis and lipid or glucose transport, like FAS, ACLY, 
FATP1, GLUT4 and aP2 (Fig. 4-4 A-E). For all of those genes an enormous difference 
between 2-D and 3-D cultures was detected regarding expression levels on day 9 after 
induction, when IND-S was used. In almost all cases, in 3-D spheroids those marker genes 
were nearly equally expressed with IND-S as with IND-P. In contrast, 2-D cultures contained 
much less mRNA of these genes when IND-S was used, but not when IND-P was applied. 
Interestingly, in 2-D cultures for some of these marker genes (FAS, ACLY and FATP1) 
mRNA levels with IND-S on day 9 were barely higher than in uninduced controls (CTRL). In 
contrast, expression of GLUT4 and aP2, while being still much lower than in 3-D cultures 
treated the same way, showed substantial upregulation on day 9 as compared to controls 
(Fig. 4-4). On day 2, significant differences in gene expression during adipogenic 
differentiation could be detected for FATP1 and GLUT4, while this was not the case for FAS, 
ACLY and aP2.  
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Figure 4-4: Relative gene expression data (n=3) of several genes associated with lipid synthesis and 
lipid or glucose transport as determined by qRT-PCR using TaqMan Low Density Arrays: FAS (fatty 
acid synthase), ACLY (ATP citrate lyase), FATP1 (fatty acid transport protein 1), aP2 (fatty acid 
binding protein 4, FABP4) and GLUT4 (glucose transporter type 4). All mRNA levels are expressed 
relative to the value at d0 in 2-D culture. Statistically significant differences between 2-D and 3-D 
cultures are indicated by * (p<0.05). 
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Figure 4-5: Relative gene expression data (n=3) of the adipokines adiponectin, LPL (lipoprotein 
lipase), adipsin (complement factor D, CFD), apoE (Apolipoprotein E), apelin, visfatin (=NAMPT) and 
angiotensinogen as determined by qRT-PCR using TaqMan Low Density Arrays. All mRNA levels are 
expressed relative to the value at d0 in 2-D culture. Statistically significant differences between 2-D 
and 3-D cultures are indicated by * (p<0.05). 
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Several biologically active substances secreted by adipocytes, known as adipokines [3,24–
27], were also included in our Low Density Array. Adiponectin and LPL could not be detected 
at all on day 0 and in all control groups. When adipogenic induction was performed, these 
genes were upregulated on day 2 and even more on day 9 (Fig. 4-5 A,B). For both genes, 
mRNA levels on day 9 showed large differences between the culture systems only when 
IND-S was used. Again, expression in 2-D, but not in 3-D, was strongly reduced under these 
conditions, although still significantly higher than in the control groups, where no expression 
of these genes was detectable. Expression of adipsin, apoE, apelin, visfatin and 
angiotensinogen also was much higher in 3-D than in 2-D cultures on day 9 when IND-S was 
applied (Fig. 4-5 C-G). For apoE and apelin, a significantly higher expression in 3-D was 
already detectable on day 2. For visfatin, LDA data revealed a higher gene expression in 3-D 
cultures also in the control groups and on d0 (Fig. 4-5 F). Nevertheless, by day 9 mRNA 
values reached the same level in both culture systems when IND-P was applied. With IND-S 
however, expression in 2-D, but not in 3-D, was again much lower.  
 
4.4.3 Induction without IBMX or indomethacin: Effect on adipogenesis in 2-D 
and 3-D cultures  
To investigate the influences of a reduced hormonal induction in 2-D and 3-D cultures, we 
not only utilized alternative induction protocols involving short-term induction, as described 
above, but also evaluated the effects of modified cocktail compositions providing a reduced 
stimulus. In preliminary experiments, 2-D and 3-D cultures were exposed to induction 
cocktails containing only 3 of the 4 components of the standard mixture over a period of 14 
days. Interestingly, when dexamethasone was omitted from the induction medium, neither in 
2-D nor in 3-D cultures any lipid accumulation occurred. In contrast, after induction without 
insulin substantial development of lipid droplets could be observed in both culture systems 
(data not shown). However, when the ASC were induced without IBMX or without 
indomethacin, the response was different for 2-D and 3-D cultures, respectively. Therefore, 
these two groups were analyzed more closely.  
After induction without IBMX and also without indomethacin, histological staining with 
Oil Red O at day 14 revealed only minimal lipid inclusions in 2-D cultures (Fig. 4-6 A). Only 
very few cells appeared to have accumulated triglycerides at all. However, in spheroid 
cultures treated in the same way numerous lipid droplets could be detected; here, ORO-
positive cells seemed to be present mainly in the outer regions of the constructs, becoming 
fewer towards the center. 
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Determination of triglyceride contents supported those observations. For both groups, i.e. 
induction without IBMX or without indomethacin, TG levels on day 14 were significantly 
higher in 3-D than in 2-D (Fig 4-6 B).  
 
 
Figure 4-6: A) Histological analysis of the triglyceride (TG) accumulation in 2-D and 3-D hASC 
cultures at day 14 after treatment with induction medium, either without IBMX (middle) or without 
indomethacin (right). Uninduced controls are shown on the left. 2-D cultures: stained with ORO to 
visualize triglycerides (a-c). Scale bars are 100 µm. 3-D cultures: cryosections (from central regions of 
the constructs) stained with ORO (d-f). Scale bars are 50 µm. B) Quantification of intracellular TG 
accumulation on day 14 (n=3). TG contents were normalized to DNA contents. 2 independent 
experiments were performed; representative results from one experiment are shown here. Statistically 
significant differences between 2-D and 3-D cultures are indicated by * (p<0.05). 
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and 9 for both cocktail mixtures (w/o IBMX and w/o indomethacin) as compared to 2-D 
(Fig. 4-7 A,B). When cells were cultured without IBMX in 2-D, expression levels more or less 
remained at the level of uninduced controls, whereas in 3-D they were strongly upregulated. 
Interestingly, when indomethacin was omitted, also in 2-D PPAR and C/EBP expression 
was somewhat higher than in controls by day 2, but mRNA levels did not increase further 
until day 9, as it was the case for the 3-D cultures, leading to even larger differences 
between the culture systems at the later time point. The adipocyte marker GLUT4 was 
initially upregulated in 2-D and 3-D when cells were cultivated without indomethacin, but only 
in 3-D expression a further increase up to day 9 could be observed (Fig. 4-7 C). For cultures 
not receiving IBMX, large differences in GLUT4 expression were already detectable on 
day 2, which had become even more prominent at day 9. aP2, another important adipocyte 
marker, also was expressed to a much higher level in spheroid cultures than in 2-D cultures 
by day 9, when either IBMX- or indomethacin-free induction was performed (Fig. 4-7 D).  
 
 
Figure 4-7: Relative gene expression data (n=3) of PPARγ, C/EBPα, GLUT4 and aP2 as determined 
by qRT-PCR. All mRNA levels are expressed relative to the value at d0 in 2-D culture. Statistically 
significant differences between 2-D and 3-D cultures are indicated by * (p<0.05). 
 
0.1
1
10
100
CTRL w/o
IBMX
w/o
Indo
CTRL w/o
IBMX
w/o
Indo
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
2-D
3-D
d0 d2 d9 
* 
* 
* 
* * 
0.1
1
10
100
1000
CTRL w/o
IBMX
w/o
Indo
CTRL w/o
IBMX
w/o
Indo
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
2-D
3-D
d0 d2 d9 
* * 
* * 
0.1
1
10
100
CTRL w/o
IBMX
w/o
Indo
CTRL w/o
IBMX
w/o
Indo
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
2-D
3-D
d0 d2 d9 
* 
* * 
0.1
1
10
100
1000
10000
CTRL w/o
IBMX
w/o
Indo
CTRL w/o
IBMX
w/o
Indo
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
2-D
3-D
d0 d2 d9 
* 
* 
* 
PPAR A C/EBP B 
GLUT4 C aP2 D 
Chapter 4  Adipogenesis in 2-D and 3-D Cultures 
 
- 74 - 
 
4.5 Discussion 
It is increasingly acknowledged that tissue-inherent factors like cell-cell interactions or the 
influence of the extracellular matrix (ECM) can strongly affect the biology of various cell 
types. However, these and other typical aspects of a 3-D microenvironment are barely 
present in conventional 2-D in vitro culture models [16,28,29]. Recently, multicellular 
spheroids, originally applied mainly as tumor models, have become popular as a more in-
vivo-like model system also for primary or progenitor cells [30].  
In this study, we applied our previously established spheroid model of human ASC to 
investigate adipogenic differentiation in a 3-dimensional (3-D) environment in comparison to 
conventional 2-D culture. This model system offers defined and reproducible conditions for 
ASC culture and adipocyte conversion in a 3-D environment (chapter 3). In contrast to most 
scaffold or gel-based approaches, our spheroid model allows direct cell-cell contacts shortly 
after seeding and, due to small construct sizes, provides sufficient nutrient and oxygen 
supply also in central areas of the agglomerates. Moreover, the possible influence of carrier 
materials on cell functions is also eliminated.  
In some studies, similar spheroid cultures of human mesenchymal stem cells (hMSC) were 
compared to 2-D monolayers with respect to their influence on endothelial cells [31], their 
anti-inflammatory properties [32] or their therapeutic potential in ischemic disease [33]. 
However, to our knowledge this is the first time that the process of adipogenesis and its 
dependence on culture conditions are characterized in 3-D spheroid cultures as well as 2-D 
monolayers on a functional and molecular level. 
Many common protocols for adipogenic differentiation of hASC include the application of a 
hormonal induction cocktail consisting of the 4 components dexamethasone, 3-isobutyl-
methylxanthine (IBMX), insulin and indomethacin [17–21]. Here, in both 2-D and 3-D culture, 
we used two different induction protocols for the adipogenic differentiation: With permanent 
induction (IND-P), the 4 inducers remained in the medium over the whole culture period, 
whereas with short-term (IND-S) induction, the hormonal cocktail was removed at day 2, and 
was replaced by insulin only for the rest of the culture time. In a previous study employing 2-
D culture only, protocols similar to IND-S led to only minimal differentiation efficiency in 2-D 
culture [19].  
Our results supported these observations: For hASC cultured as 2-D monolayers, only with 
IND-P extensive lipid accumulation could be detected after 14 days, as assessed by 
histological staining and determination of the triglyceride content. Using IND-S, TG levels 
were only minimal at the same time point. However, this huge difference with respect to the 
induction protocol was completely absent in the 3-D spheroid culture, where both IND-S and 
IND-P led to substantial TG accumulation, which proved to be even higher than the value 
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reached in 2-D culture with IND-P. Obviously, short-term application of the hormonal cocktail 
was sufficient for the development of adipocyte morphology in the 3-D environment of the 
spheroids, but not in conventional monolayers of hASC.  
To further investigate this striking difference between 2-D and 3-D models on a molecular 
level, a gene expression low density array (LDA) was used to determine the expression 
levels of several adipogenesis-related genes. When IND-P was applied, many genes, 
including the transcription factors PPAR, C/EBP and SREBF1, showed an expression 
pattern which was, in general, comparable between 2-D and 3-D cultures and typical for 
adipogenic differentiation as reported in the literature. For example, expression of PPAR, 
the master regulator of adipogenesis, which is involved in the regulation of many adipocyte 
marker genes [2,34,35], had strongly increased by day 9 in both culture systems. With 
IND-S, however, expression was much lower in monolayers than in spheroids, in which it 
reached a similar level as under IND-P. A similar mRNA expression could be detected for 
other central adipogenic transcription factors like C/EBP, another key player in 
adipogenesis which is regulated by PPAR and vice versa [34], and SREBF1. The latter 
mainly codes for SREBP1-c in fat tissue, which is known to directly or indirectly increase the 
production of an endogenous ligand for PPAR [36–38].  
Furthermore, many genes associated with fat and glucose metabolism and transport, such 
as FASN, FATP1, aP2 and GLUT4, which are known to be partially regulated via PPAR [1] 
were expressed much higher in 3-D cultures than in 2-D under short-term induction. The low 
expression level of these genes in monolayer cultures at day 9 may provide an explanation 
for the observed minimal lipid accumulation under IND-S. In addition, also many adipokines, 
which are usually produced by developing and mature adipocytes [3,24–27], were 
upregulated to a much lower degree in 2-D cultures than in 3-D with IND-S, whereas with 
IND-P expression levels were similar between the two culture systems or differed only 
slightly. All of these results on mRNA level support the lipid accumulation data in suggesting 
that under short-term induction, normal adipogenesis involving the differentiation of a large 
fraction of cells and leading to a typical adipocyte morphology is only possible in the 3-D 
spheroids, but not in conventional 2-D culture of ASC.  
In this context it is noteworthy that under IND-S expression levels of some marker genes, like 
GLUT4 and aP2, but also adiponectin and LPL were indeed much lower in 2-D than in 3-D at 
day 9, but nevertheless significantly upregulated as compared to uninduced controls. This 
was also true for the transcription factors PPARγ and C/EBP. However, this upregulation 
obviously did not lead to the ASC adopting adipocyte morphology. This suggests that in 
these cultures, the adipogenic cascade was not taking place to its full extent, but only 
partially, so that the expression levels of typical marker genes could not reach the level 
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necessary for the cells to become functional adipocytes. An upregulation of PPARγ without 
adipogenic conversion of the cell has, e.g., also been observed in C/EBPβ-deficient 
preadipocytes, when an exogenous PPAR ligand was not present [39], as well as in 3T3-L1 
preadipocytes, when they were cultured with pyruvate instead of glucose [40]. 
Gene expression data from day 2 can give further insight into the differentiation process. At 
that time point, permanent and short-term induction protocols were still identical. 
Interestingly, mRNA levels of PPAR and SREBF1 showed a significantly higher expression 
in spheroid culture already at day 2. This was also the case for C/EBPβ, a transcription factor 
which is especially important in the early phase of adipogenesis and, together with C/EBPδ, 
induces the expression of PPARγ and C/EBP [2,35]. Furthermore, it has been reported that 
C/EBPβ activates a program, which leads to the synthesis of molecules that can act as 
activators of PPAR, conceivably via the activation of SREBP-1 [39]. These findings could 
possibly explain the higher TG accumulation in 3-D cultures as compared to 2-D by day 14 
even when permanent induction was performed, because the higher expression levels of 
these genes at day 2 may have led to an earlier onset of TG accumulation in 3-D cultures, so 
that over time more lipids were stored in the differentiating cells.  
Without further exogenous stimulation via the hormonal cocktail (under IND-S), in most 
cases mRNA levels did not show a further increase up to day 9 in 2-D cultures, but rather 
stayed on the same level as on day 2 or even decreased with time. In 3-D spheroids, 
however, expression levels further increased from day 2 on, independent of the continual 
presence of hormonal inducers.  
We can conclude from these facts that the 3-dimensional environment of the ASC in 
spheroid culture is responsible for its differential response to reduced exogenous adipogenic 
stimulation. This suggests that certain tissue-specific aspects of the 3-D culture provide 
conditions for the cells that make adipogenic differentiation of ASC possible even in a setup 
that is not sufficient for normal adipogenesis in conventional 2-D culture.  
To further elucidate the tissue-inherent properties causing this behavior, we also used a 
different approach to reduce the adipogenic stimulus besides a short-term induction protocol. 
By changing the composition of the hormonal induction cocktail, i.e. omitting specific 
substances from the mixture, we aimed at getting further insight into the different 
prerequisites for adipogenic differentiation in 3-D and 2-D cultures. 
The glucocorticoid dexamethasone, which has been reported to induce the expression of 
C/EBPδ in preadipocytes [9,39], proved to be essential for adipogenic induction in both 
culture systems. In contrast, when IBMX or indomethacin were excluded from the hormonal 
cocktail, both lipid accumulation and the expression of PPAR and C/EBP as well as 
GLUT4 and aP2, as assessed by qRT-PCR, were significantly higher in spheroids than in 
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monolayer culture at days 14 and 9, respectively. In fact, in 2-D cultures almost no lipid-
containing cells could be detected by day 14, while there was a substantial amount of TG 
detectable in 3-D. On gene expression level, the trends mentioned above could already be 
observed at day 2. These results indicate that the adipogenic cascade can be initiated in our 
spheroid culture without the presence of specific components which are essential for the 
differentiation of ASC monolayers. Thus, it can be concluded that adipogenesis in 3-D 
spheroids is less dependent on exogenous stimulation than in 2-D culture, not only regarding 
the length of the induction period,  but also concerning the complete presence or absence of 
certain factors. 
As already mentioned, the treatment with altered induction cocktails can also be a tool to 
identify possible molecular reasons for the observed 2-D/3-D differences, when the specific 
functions of the cocktail components within the adipogenic cascade are taken into account. 
For example, it is commonly acknowledged that indomethacin functions as a PPARγ ligand, 
similar to thiazolidinediones (TZDs) [41]. The addition of exogenous PPARγ ligands is not 
necessarily required for the in vitro differentiation of 3T3-L1 cultures, suggesting that 
preadipocytes have acquired the ability to produce an endogenous ligand for PPARγ. 
However, when preadipocytes were cultured without IBMX, adipogenic differentiation 
became dependent on the addition of exogenous PPAR ligands [39]. IBMX is known to 
increase intracellular cAMP concentrations, which stimulates cAMP-dependent protein 
kinase pathways. These pathways not only involve the upregulation of C/EBPβ expression 
[9], but have also been suggested to produce one or more specific endogenous PPAR 
ligands [42]. In 3T3-L1 cells, ligand activation of PPAR is only required transiently during 
adipogenesis, but not in mature adipocytes [2,42]. Interestingly, although several synthetic 
PPARγ ligands are known, a natural, high-affinity agonist has not been identified up to 
now [42,43]. In contrast to preadipocytes, differentiation of ASC has been shown to always 
require the presence of an exogenous ligand, indicating that the endogenous synthesis of 
PPAR ligand(s) is insufficient to trigger adipogenesis [44].  
This corresponds to our results with ASC 2-D cultures, where adipogenesis was also strongly 
impaired when indomethacin was omitted from the induction cocktail. Furthermore, in our 
study, the addition of indomethacin without stimulating the endogenous ligand production via 
IBMX also proved to be insufficient to induce adipocyte conversion. In 3-D spheroid cultures, 
however, adipogenesis was still possible when either of these two factors was omitted, thus 
resembling the behavior previously associated with preadipocytes, as described above. 
These results suggest that in the 3-D environment, upregulation of PPAR and, in turn, the 
start of the adipogenic program, requires less stimulation by either exogenous agonists (like 
indomethacin) or endogenous ligands produced via the IBMX-induced pathway involving 
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C/EBPβ. This implies that in the spheroid model, (a) endogenous PPAR ligands are 
produced also through different pathways not involving IBMX, (b) lower concentrations of 
these ligands are required to effectively upregulate PPAR expression, or (c) local 
concentrations of these factors are higher than in 2-D cultures as a result of the compact, 
tissue-like structure of the spheroids. 
 
 
4.6 Conclusion 
In summary, this study revealed that the requirements for the induction of adipogenic 
differentiation of hASC vary greatly depending on the culture dimensionality. Our human 
ASC spheroid model, which was established previously (chapter 3), was applied to 
characterize adipogenesis in a scaffold-free 3-D environment on a functional and molecular 
level, especially in comparison to conventional 2-D culture. The application of a short-term 
induction protocol limiting the exposure time of the cells to the complete hormonal cocktail, 
as well as the use of induction media without IBMX or indomethacin, were sufficient for the 
development of functional adipocytes in 3-D spheroids, but not in 2-D monolayers. In strong 
contrast to the latter, the spheroids induced with these protocols, which provide reduced 
exogenous stimulation, were comparable to those differentiated under standard conditions. 
Taken together, our results demonstrated that in 3-D ASC spheroids, adipogenesis proved to 
be less dependent on exogenous stimulation than in conventional 2-D culture. 
Beyond its contribution to a better understanding of adipogenic differentiation, the outcome of 
this study also has some relevance for applications in regenerative medicine. For their use in 
tissue engineering, spheroid cultures can be embedded into hydrogels as carrier materials 
with the goal of a subsequent implantation or injection [45,46]. Moreover, they can also be 
transplanted directly [47], or used as building blocks for engineering larger tissues using the 
organ printing technique [48]. As several studies have demonstrated, for the generation of 
functional adipose tissue an in vitro precultivation period including adipogenic induction leads 
to better adipose tissue development in vivo after implantation [22,23]. Our results show that 
in ASC spheroids the treatment with a hormonal cocktail for only 2 days is sufficient for a 
sustainable induction of the adipogenic cascade. As in clinical practice a short precultivation 
time span is of advantage, spheroid-based culture of hASC in combination with a short-term 
induction protocol could serve as a fast, flexible and reproducible method for the generation 
of engineered adipose tissue. 
Furthermore, this study may also have implications for the cocultivation of ASC with other 
cell types (chapters 5&6). As the generation of a functional vasculature is an important 
aspect in the engineering of almost all tissue types [49], especially for those as highly 
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vascularized as fat [50,51], the development of coculture models of adipocytes with 
endothelial cells (EC) is highly desirable. Such models could also contribute to shedding 
further light on the close interplay between adipogenesis and angiogenesis, particularly in a 
3-D environment [52,53]. Direct cocultures of adipocyte precursor cells with EC, in which 
adipogenesis can be induced, are difficult to establish not only due to the different 
requirements for media and supplements in general, but also because of concerns that 
specific components of the hormonal adipogenic cocktail like IBMX could impair EC 
proliferation [54]. Our work has not only demonstrated that for 3-D spheroid cocultures the 
exposure time of the EC to the induction cocktail may be kept short without affecting 
adipogenesis, but also that certain components could be omitted from the cocktail at all.  
In conclusion, these first results demonstrate that our spheroid model not only represents a 
powerful tool to investigate adipose tissue development and functions in a 3-D context, but 
can also serve as a starting point to establish a 3-D coculture model combining ASC with, for 
example, endothelial cells. Moreover, it has the potential to be used for applications in tissue 
engineering aiming at the regeneration of soft tissue defects. 
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CHAPTER 5 
3-D Cocultures of hASC and hMVEC – 
Establishment of Culture Conditions 
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5.1 Abstract 
Native adipose tissue is not only highly vascularized, but undergoes continuous expansion 
and regression. It is well known that adipogenesis and angiogenesis are closely associated 
in vivo, with their reciprocal regulation being based on an intensive cellular crosstalk between 
(pre-)adipocytes and endothelial cells. However, the molecular basis of adipose tissue 
angiogenesis is still poorly understood. Therefore, our goal was to adapt our previously 
established ASC monoculture spheroid model for its use as a sustainable in vitro coculture 
system. 
As a main challenge, suitable culture conditions for the coculture spheroids had to be 
established. Since simple mixtures of PGM2 and EGM2 turned out to largely inhibit 
adipogenic differentiation, protocols including a pre-induction step of the ASC were applied, 
but could not solve the problem of low lipid accumulation. Subsequently, different media 
formulations were evaluated and EGF (which is usually included in EGM2) could be identified 
as the factor responsible for the reduced adipogenesis. Accordingly, elimination of EGF from 
the culture medium led to strongly improved adipocyte conversion without affecting MVEC 
proliferation. Components of the adipogenic induction cocktail, however, proved to have a 
negative effect on MVEC viability. Therefore, it was necessary to keep MVEC exposure to 
the hormonal cocktail short, which could be accomplished by using a short-term induction 
protocol. With the newly established conditions, including a PGM2/EGM2 mixture without 
EGF as a basic medium and a 2-day adipogenic induction period, ASC/MVEC cocultures 
could successfully be maintained and differentiated towards the adipogenic lineage. 
This 3-D spheroid coculture model can serve as a valuable tool for characterizing the cellular 
interactions of developing adipocytes and endothelial cells in a 3-D system, which can help 
to gain further insight into the development of vascularized adipose tissue. 
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5.2 Introduction 
Native adipose tissue is highly vascularized, with every adipocyte being associated with at 
least one capillary [1–3]. During adipose tissue development, adipogenesis and 
angiogenesis are spatially and temporally tightly associated. The close interaction between 
(pre-)adipocytes and endothelial cells (the central cell type in angiogenesis) is characterized 
by cellular crosstalk not only in the embryonic stage, but also in adult organisms, where 
adipose tissue undergoes continuous expansion and regression [3–5]. The reciprocal 
regulation of adipogenic differentiation and vascular development has been demonstrated in 
vivo after the implantation of murine preadipocytes [6,7]. In in vitro studies it could be shown 
that ASC and (pre-)adipocytes produce several angiogenic factors like VEGF, HGF or TGF-β 
or leptin [3,8–10].  
However, the molecular basis of adipose tissue angiogenesis is still poorly understood. To 
gain further knowledge about the interactions between adipose tissue and its vasculature, 
the development of suitable in vitro models is desirable. The insights gathered from such in 
vitro systems can also provide valuable information for applications in tissue engineering, as 
the development of a functional vasculature is crucial for the generation of larger tissue 
equivalents and still remains one of the big challenges in regenerative medicine [11].  
Up to now, only a few studies focused on the crosstalk between (pre-)adipocytes and 
endothelial cells in a controlled in vitro setting. Several of those have been performed using a 
2-D approach, with both cell types cocultured either directly or indirectly via Transwell inserts 
[12]. Alternatively, conditioned media or culture plates coated with EC matrix were applied 
[12–14]. However, in these 2-D models many important aspects of the in vivo situation are 
poorly represented, including extensive direct cell-cell contacts and the influence of the 
extracellular matrix, which are both part of the 3-D microenvironment [15–17].  
In some previous 3-D studies 3T3-L1 cells, human preadipocytes, hASC or mature human 
adipocytes were cocultured with endothelial cells after embedding them in collagen or fibrin 
gels [18–20] or after seeding them on silk scaffolds [21], all of which still could not provide 
immediate cell-cell contacts and contained exogenous matrix or scaffold materials with 
unknown effects. In contrast, a spheroid-based coculture system could serve as a powerful 
tool to study the interactions between developing adipocytes and endothelial cells in a 
3-dimensional system without these drawbacks. Such coculture spheroid systems have 
already been described for the combination of EC with human osteoblasts or with MSC 
subsequently induced to undergo osteogenic differentiation [22,23]. 
The goal of this chapter was to modify our previously established ASC monoculture spheroid 
model (chapters 3&4) for its use in coculture applications. In this 3-D system, hASC would be 
combined with human microvascular endothelial cells (hMVEC) to form coculture spheroids 
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containing both cell types. Within these it should be possible to perform hormonal induction 
of adipogenesis to generate constructs which resemble native developing adipose tissue. 
These constructs could then be used to investigate the interdependence of adipogenic 
differentiation and angiogenesis in an in vivo-like system. 
One of the main challenges for the development of such a direct coculture model was the 
establishment of suitable culture conditions. As the different cell types included in the 
coculture have different requirements, a compromise medium had to be found which 
provides acceptable conditions for both ASC and MVEC maintenance, a process for which 
no fixed formulae exist [24]. In our case, it was not only necessary to determine culture 
conditions suitable to maintain the cells, but also to develop a protocol for the induction of 
adipogenesis in the ASC without impairing MVEC viability and proliferation. The different 
steps taken towards the establishment of such a coculture protocol are described in this 
chapter. 
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5.3 Materials and Methods 
5.3.1 Materials 
Human adipose derived stem cells (ASC) were obtained from PromoCell (Heidelberg, 
Germany; lot 8073006.12); Adult Human Dermal Blood Microvascular Endothelial Cells 
(MVEC) were purchased from Lonza (Verviers, Belgium; lot 0000122821). Preadipocyte 
Growth Medium 2 (PGM2, consisting of PBM2, 10% FBS and 1% penicillin/streptomycin 
solution) and EGM2-MV BulletKit (containing Endothelial Basal Medium 2 [EBM2], 5% FBS, 
GA-1000 [Gentamicin, Amphotericin-B], hydrocortisone, ascorbic acid, EGF, VEGF, IGF and 
bFGF) were also from Lonza (Verviers, Belgium). Fetal bovine serum (FBS, lot 40A0044K), 
penicillin-streptomycin solution, 0.25% trypsin/EDTA solution and phosphate buffered saline 
(PBS) were from Invitrogen (Darmstadt, Germany). Agarose, indomethacin, dexamethasone, 
glycerol standard solution, dimethylsulfoxide (DMSO), calf thymus DNA, Oil Red O and 
osmium tetroxide were purchased from Sigma-Aldrich (Munich, Germany). 3-isobutyl-
methylxanthine (IBMX) was bought from Serva (Heidelberg, Germany). Hoechst 33258 dye 
was obtained from Polysciences (Warrington, PA, USA). Bovine insulin was kindly provided 
by Sanofi-Aventis (Frankfurt a. M., Germany). All other chemicals were from Merck 
(Darmstadt, Germany). All cell culture plastics were from Corning (Bodenheim, Germany).  
 
5.3.2 Methods 
5.3.2.1 Cell culture 
5.3.2.1.1 Expansion of ASC and MVEC 
Human adipose-derived stem cells (ASC) were thawed after cryopreservation (passage 3) 
and seeded in culture flasks. They were expanded in Preadipocyte Growth Medium (PGM2), 
i.e. Preadipocyte Basal Medium (PBM2) containing 10% FBS, penicillin (100 U/ml) and 
streptomycin (100 µg/ml). P4 cells were used for all experiments. Microvascular endothelial 
cells (MVEC) were also thawed after cryopreservation (passage 2) and expanded in culture 
flasks with complete EGM2-MV medium (referred to as EGM2 in this chapter). All cells were 
passaged at 90% confluency. Passage 3 or 4 cells were used for all experiments. 
 
5.3.2.1.2 ASC/MVEC cocultures – initial protocol 
For 3-D spheroid cocultures, after expansion in culture flasks ASC and MVEC were 
trypsinized and equal cell numbers of both cell types (750 cells) were seeded into 96-well-
plates coated with 1.5% agarose according to the liquid overlay technique. From this time 
point, the culture medium was composed of 50% PGM2 and 50% EGM2 (50:50 growth 
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medium). Culture plates were kept on an orbital shaker at 50 rpm during incubation. 
Adipogenic induction was performed after 2 days by exchanging half of the medium with 
induction medium (IM), consisting of 50:50 growth medium supplemented with a hormonal 
cocktail, resulting in final concentrations of 1.7 µM insulin, 1 µM dexamethasone, 200 µM 
indomethacin and 500 µM 3-isobutyl-1-methylxanthine (IBMX). The time point of induction 
was always referred to as day 0. Cells were kept in IM over the whole culture period. As 
spheroids would be lost with complete removal of medium from the wells, all medium 
changes were performed by replenishing only half of the medium volume. All cultures were 
incubated at 37°C, 5% CO2. Medium was exchanged every 3-4 days. 
ASC monocultures were performed accordingly, with the total cell numbers per spheroid 
being equal to the total cell numbers in the cocultures. Culture media were either the same 
as for the cocultures for comparability, or PGM2 alone when explicitly stated. 
For 2-D cocultures, ASC and MVEC were trypsinized and equal numbers of both cell types 
were seeded into 24-well-plates at a total density of 30.000 cells/cm². Otherwise, culture 
protocols were identical to those used for the 3-D cultures. 
 
5.3.2.1.3 ASC/MVEC cocultures with “pre-induction” protocols 
Using “pre-induction” protocols, ASC were expanded in culture flasks as described above 
and induced to undergo adipogenesis before the start of the cocultures. For 2-D pre-
induction, ASC were treated with induction medium (PGM2 containing the standard hormonal 
cocktail) for 7 days while still in the culture flasks. Subsequently, they were trypsinized and 
seeded into agarose-coated 96-well-plates together with an equal amount of MVEC to form 
spheroids of 3000 cells. From this time point, medium was 50:50 growth medium, and culture 
conditions for the spheroids were as described in the previous section. In parallel, pre-
induced ASC and MVEC were cocultured in 24-well-plates as monolayers, applying the 
same culture conditions as for the spheroids. For pre-induction in 3-D, at first monoculture 
spheroids (1500 cells) were generated from ASC. After 2 days adipogenic differentiation was 
induced with the standard hormonal cocktail in PGM2. On day 6 after induction, an MVEC 
suspension of 1500 cells per well was added to the pre-induced ASC spheroids. Media and 
culture protocols were the same as described in the previous section from this time point. 
 
5.3.2.1.4 Evaluation of culture media and EGF effects 
To optimize culture media for adipogenic differentiation, at first different media containing 
varying proportions of EGM2 were applied for ASC monocultures in 2-D and 3-D. Cells were 
seeded as monolayers or as spheroids using either PGM2 alone, PGM2 with 20% EGM2 or 
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PGM2 with 50% EGM2. After 2 days, the hormonal induction cocktail was added to all 
groups up to day 14, when cultures were harvested for histological staining. Media were 
exchanged every 3-4 days.  
In a different experiment, the influence of epidermal growth factor (EGF) on lipid 
accumulation was assessed. Normally, EGF is included in the complete EGM2. ASC were 
seeded in 2-D using 50:50 growth medium with or without EGF, PGM2 alone or EGM2 
without EGF. Adipogenic induction with the hormonal cocktail was performed 2 days later 
(referred to as day 0). A Live/Dead assay was performed on day 5, histological staining for 
lipids on day 14. 
 
5.3.2.1.5 Influence of the hormonal cocktail on the MVEC 
The influence of the hormonal induction cocktail (HC) on MVEC viability and proliferation was 
investigated using 2-D MVEC cultures in 24-well-plates. All cells were cultured in a 50:50 
mixture of PGM2 and EGM2 without the addition of EGF. Starting at day 0 (i.e. 2 days after 
seeding), cells in one group were treated with the HC for 5 days, in another group for 2 days 
and subsequently with insulin only, and in a third group cells were not exposed to the HC at 
all. On day 5, cell viability was determined with a Live/Dead assay, and the cell number per 
well was assessed by measuring the DNA content.  
 
5.3.2.1.6 ASC/MVEC cocultures – final protocol 
For 3-D spheroid cocultures, after expansion in culture flasks, ASC and MVEC were 
trypsinized and equal cell numbers of both cell types (2500 cells) were seeded into 96-well-
plates coated with 1.5% agarose according to the liquid overlay technique. From this time 
point, the culture medium was composed of 50% PGM2 and 50% EGM2. Culture plates were 
kept on an orbital shaker at 50 rpm during incubation. As spheroids would be lost with 
complete removal of medium from the wells, all medium changes were performed by 
replenishing only half of the medium volume. Adipogenic induction was performed after 2 
days by exchanging half of the medium with induction medium (IM), consisting of 50:50 
growth medium (still without EGF) supplemented with a hormonal cocktail, resulting in final 
concentrations of 1.7 µM insulin, 1 µM dexamethasone, 200 µM indomethacin and 500 µM 
3-isobutyl-1-methylxanthine (IBMX). The time point of induction was referred to as day 0. On 
day 2 after induction, IM was replaced by 50:50 growth medium (without EGF) containing 
1.7 µM insulin only (final concentration). This was done by exchanging half of the medium for 
three times in order to reduce the concentration of the hormonal inducers. All cultures were 
incubated at 37°C, 5% CO2. Medium was exchanged every 3-4 days.  
Chapter 5  Establishment of 3-D hASC/hMVEC Cocultures 
 
- 90 - 
 
ASC monocultures were performed accordingly, with the total cell numbers per spheroid 
being equal to the total cell numbers in the cocultures. Culture media were either the same 
as for the cocultures for comparability, or PGM2 alone when explicitly stated. 
 
5.3.2.2 Lipid staining with Oil Red O or osmium tetroxide 
To visualize triglyceride accumulation, cultures were harvested and staining with Oil Red O 
(ORO) or osmium tetroxide (OsO4) was performed. For this purpose spheroids were pooled 
in PBS, transferred to microcentrifuge tubes, washed with PBS, fixed in 10% formalin (1h, 
4°C), stained with ORO (3 mg/ml solution in 60% isopropanol) for 4h or with OsO4 (1% 
aqueous solution) for 1 h on ice and washed three times with PBS. Stained spheroids were 
embedded in Tissue-Tek (Hartenstein Laborbedarf, Würzburg, Germany), snap frozen and 
cut into 10-µm-thick cryosections. After removal of Tissue-Tek by washing in water, the 
sections were mounted in glycerol. Serial sections were prepared from all spheroids and 
sections from the center region were used for histological evaluation. For 2-D cultures, 
staining was performed directly in the 24-well plates. Microscopical bright field images were 
acquired using a DS-5M camera (Nikon, Düsseldorf, Germany) attached to a Leica DM IRB 
microscope (Leica Microsystems, Wetzlar, Germany) or an Olympus BX51 microscope with 
a DP71 camera (Olympus, Hamburg, Germany). 
 
5.3.2.3 Determination of the DNA content 
2-D monolayers were washed twice with PBS, harvested in lysis buffer (2 mM EDTA, 2M 
NaCl, 50 mM Na3PO4, pH 7,4) and sonicated. 3-D spheroids were pooled, washed twice with 
PBS, resuspended in lysis buffer and sonicated as well. DNA content was determined using 
the intercalating Hoechst 33258 dye (0.1 µg/ml in 0.1 M NaCl, 1 mM EDTA, 10 mM Tris, 
pH 7.4). Fluorescence intensities were determined at an excitation wavelength of 365 nm 
and an emission wavelength of 458 nm with a LS 55 fluorescence spectrometer 
(PerkinElmer, Wiesbaden, Germany) and correlated to DNA contents using standard 
dilutions of double-stranded DNA (from calf thymus). All measurements were performed in 
three biological replicates; one replicate was derived from one well for 2-D cultures and an 
exact number of approximately 10 spheroids for 3-D cultures, respectively.  
 
5.3.2.4 Live/Dead assay 
Cell viability in 2-D cultures was assessed with the Live/Dead Cell Staining Kit II 
(PromoCell, Heidelberg, Germany). Cultures were washed three times with PBS and 
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incubated with the staining solution (4 µM EthD-III, 2 µM Calcein AM) for 45 min. Live 
cells showed green calcein fluorescence, dead cells were indicated by red fluorescence of 
DNA-intercalating EthD-III in the nuclei. The staining was evaluated by imaging with an 
Olympus IX51 inverted fluorescence microscope with an XC30 camera using CellSens 
Dimension software (all from Olympus, Hamburg, Germany). Different filters were used for 
the imaging of calcein and EthD-III fluorescence (ex./em. 460-490 nm/520 nm and ex./em. 
510-550 nm/590 nm, respectively). 
 
5.3.2.5 Statistics 
Quantitative results are presented as mean value ± standard deviation. Differences between 
multiple groups were analyzed for significance using one-way analysis of variances (ANOVA) 
with subsequent multiple comparisons according to Tukey’s post-hoc test. A value of p<0.05 
was regarded statistically significant. Statistical analysis was performed using PASW 
Statistics 18 software (SPSS Inc., Chicago, IL, USA). 
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5.4 Results and Discussion* 
5.4.1 ASC/MVEC cocultures: spheroid formation and culture medium 
When coculturing two or more different cell types, the establishment of suitable culture 
conditions is a crucial, yet usually time-consuming step [24]. In our case, ASC and MVEC 
have different requirements with regard to the medium composition, inevitably leading to the 
utilization of a medium mixture. Endothelial cells usually require the presence of several 
growth factors, like VEGF, IGF, bFGF and EGF to remain viable and to proliferate, which are 
included in the commercially available Endothelial Growth Medium 2 (EGM2). As these 
factors logically also promote ASC proliferation, it cannot be excluded that adipogenic 
differentiation, which is accompanied by a growth arrest [25–27], may be impaired. On the 
other hand, the hormonal cocktail usually applied to induce adipogenic differentiation could 
have negative effects on MVEC viability [21]. However, the relevance of these influences for 
our specific application was difficult to predict. Therefore, in a first attempt of culturing ASC 
together with MVEC in the spheroid model, a protocol similar to the standard conditions for 
ASC monoculture spheroids was utilized, using a 50:50 mixture of PGM2 and EGM2 as 
culture medium. The components of the adipogenic cocktail were applied in the same 
concentrations as in ASC monoculture. At the same time, ASC alone were cultured as 
spheroids in the 50:50 mixture and in PGM2 to evaluate the influence of the medium mixture 
on adipogenesis in monocultures. Uninduced coculture spheroids were used as controls. 
In all cases a single spheroid formed in each well one day after seeding. Volumes of 
coculture spheroids in an uninduced control group strongly increased over time, indicating a 
high proliferation rate which can be attributed to the growth factors present in the medium 
mixture (Fig. 5-1 a). However, in the cocultures treated with the hormonal cocktail a volume 
increase could not be observed (Fig. 5-1 b. Furthermore, spheroid sizes were smaller than 
in the corresponding monocultures at day 13 (Fig. 5-1 c). Interestingly, in both mono- and 
cocultures kept in 50:50 medium, cells contained barely any lipid droplets after 2 weeks of 
culture, as detected by microscopical observation. In contrast, ASC spheroids in PGM2 
showed prominent lipid accumulation without a significant volume increase (Fig. 5-1 d), 
which was consistent with previous experiments. Also in 2-D cocultures of the two cell types 
extensive proliferation, but only minimal lipid inclusions could be observed when a 50:50 
(PGM2:EGM2) medium mixture was used (data not shown). Obviously, under these 
conditions ASC in 2-D and 3-D culture kept proliferating despite the presence of the 
adipogenic cocktail. Since usually a growth arrest occurs after the induction of adipogenesis, 
                                               
*
 As the establishment of suitable culture conditions for the 3-D ASC/MVEC coculture model was a multi-step 
process, with each experiment being based on the results of the previous one, results and discussion are 
combined in one section. 
Chapter 5  Establishment of 3-D hASC/hMVEC Cocultures 
 
- 93 - 
 
this could be an explanation for the strongly reduced lipid accumulation under the coculture 
conditions applied here. Most likely the extensive proliferation was caused by one or more of 
the growth factors included in EGM2, e.g. the epidermal growth factor (EGF) [28,29]. 
 
 
Figure 5-1: Whole Spheroids (1500 cells) on day 0 (i.e. the day of induction) and day 13. Cocultures 
of ASC and MVEC, uninduced (a) and induced (b) to undergo adipogenesis. ASC monocultures, 
induced, in a PGM2/EGM2 mixture (c) and in PGM2 only (d). Lipid droplets are indicated by arrows. 
Please note that only lipid droplets in the periphery of the spheroids appear on the images, while they 
could be observed also in the center of the constructs during live microscopy. Scale bars are 100 µm. 
 
In conclusion, these first experiments suggested that the spheroid model is in principle 
suitable for the cocultivation of ASC and MVEC in a 3-dimensional environment. However, 
with the goal of a better understanding of the interdependence of adipogenesis and 
angiogenesis, the ability to perform adipogenic differentiation within such a coculture system 
is highly desirable. Therefore, in the next steps of this project the focus was set on optimizing 
culture protocols in order to make adipogenesis possible to a significant extent under 
coculture conditions. 
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5.4.2 Cocultivation using a pre-induction protocol 
5.4.2.1 Pre-induction in 2-D 
The growth factors contained in the EGM2 can not only stimulate proliferation of the 
endothelial cells, but also of the ASC [30]. Therefore, the growth arrest, which is required for 
the initiation of the adipogenic cascade, possibly did not occur in our first experiments, 
resulting in attenuated adipogenesis. 
In an attempt to circumvent this problem without changing media compositions, alternative 
induction protocols involving an ASC pre-induction step were applied, similar to those 
described for cocultures on silk scaffolds [21]. Pre-induction means that prior to starting the 
coculture, ASC monolayers were cultured separately in PGM2 and adipogenesis was 
induced at confluence. After several days in monoculture, these pre-induced cells were 
trypsinized and seeded as 3-D spheroids (and additionally as 2-D cultures) together with 
endothelial cells. The trypsinization step had to be performed before the cells became too 
fragile as a result of the increasing lipid inclusions. At the start of the cocultures, the 
hormonal inducers were replaced by insulin only. 
 
 
Figure 5-2: 3-D cocultures of ASC and MVEC (a) and ASC monocultures (b,c); 3000 cells per 
spheroid. Microscopical brightfield images on day 9 after the start of the 3-D culture (i.e. day 16 after 
induction). Culture media were as indicated. The culture protocol included a 7-day “pre-induction” step 
in 2-D. Scale bars are 100 µm. 
 
Microscopical observation revealed that neither the cocultures, nor the ASC monocultures 
developed significant amounts of lipid droplets 9 days after uniting both cell types (i.e. 16 
days after adipogenic induction of the ASC). This was not only true for the spheroid cultures 
(Fig. 5-2), but also for the 2-D monolayers (not shown). Interestingly, also for the groups 
receiving PGM2 only, no significant lipid accumulation took place (Fig. 5-2 c). As 
adipogenesis usually can be readily induced under the latter conditions, we could conclude 
that the trypsination step necessarily performed after the 2-D pre-induction was the cause for 
the lack of adipogenic conversion. Thus, the application of a 2-D pre-induction step proved to 
be unsuitable for achieving a significant lipid accumulation within the cocultures. 
Coculture  
PGM2:EGM2 50:50 
ASC monoculture  
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5.4.2.2 Pre-induction in 3-D 
In order to avoid the additional trypsinization after pre-induction, the culture protocol was 
again altered. In a new experiment, a pre-induction phase in 3-D was introduced, meaning 
that in a first step ASC were seeded as spheroids and adipogenesis was induced with the 
hormonal cocktail in PGM2 alone. After 6 days, an MVEC suspension was added to all pre-
induced ASC spheroids in their respective wells, with the culture medium being a 
PGM2:EGM2 (50:50) mixture including insulin.  
When cultures were harvested 14 days after adipogenic induction, i.e. 8 days after starting 
the coculture, OsO4-stained cryosections revealed that overall very little fat was accumulated 
within the constructs (Fig. 5-3 B). Interestingly, only in the central areas of the spheroids a 
significant amount of lipid droplets could be detected, which can be explained by the fact that 
the endothelial cells formed a layer around the pre-formed ASC spheroids after their addition. 
This “two-layer structure” could also be observed by bright field microscopy (Fig. 5-3 A). 
Furthermore, a strong volume increase under coculture conditions occurred, which 
apparently could again be related to the presence of the different growth factors within the 
EGM2 medium. 
 
 
Figure 5-3: ASC/MVEC coculture spheroids. ASC monocultures were pre-induced for 6 days, 
followed by the addition of MVEC. A) Bright field images of the spheroids on the days 1 and 8 after 
starting the coculture. B) Cryosection from day 8, stained for triglycerides with OsO4. Scale bars are 
100 µm each. 
 
In conclusion, the utilization of a culture protocol including a pre-induction phase was not 
successful with regard to an improved lipid accumulation in the coculture spheroids, 
regardless whether it was performed in 2-D with a subsequent trypsination, or directly in ASC 
spheroids. Therefore, it appeared to be inevitable to alter the media composition in order to 
find suitable culture conditions for the cocultures. 
 
5.4.3 Optimization of the culture medium – the role of EGF 
As the application of a pre-induction step did not lead to the desired results, in a different 
approach the focus was set on optimizing the medium composition in order to make direct 
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4
 
A B 
Chapter 5  Establishment of 3-D hASC/hMVEC Cocultures 
 
- 96 - 
 
coculturing possible. As already mentioned, one or more of the growth factors present in 
EGM2, and therefore also in the coculture media used in the previous experiments, possibly 
have a negative effect on adipogenic differentiation in our system. As a consequence, 
reducing the proportion of EGM2 within the medium mixture might increase adipogenesis 
efficiency. To test this hypothesis, cocultures as well as ASC monocultures were kept in 
different medium mixtures in the form of either 2-D monolayers or 3-D spheroids. 
Representative images of the monocultures on day 14 after induction are depicted in 
Fig. 5-4. When a PGM2:EGM2 mixture with a 50:50-ratio was used, in mono- as well as 
cocultures (2-D and 3-D) strong proliferation and only minimal lipid accumulation could be 
detected, which was in accordance with the previous results. A reduction of the EGM2 
proportion to 20% led to a comparably higher number of lipid droplets in both culture 
systems. However, especially in the 2-D cultures it could be observed that under these 
conditions proliferation was still very high, and cells did not exhibit the typical morphology of 
developing adipocytes, as they did with PGM2 only. Instead, single cells only contained very 
few lipid droplets, with the cell density being much higher than in PGM2. Also in 3-D 
spheroids lipid accumulation was still drastically reduced as compared to PGM2 only. 
All in all, changing the EGM2 proportion within the coculture medium did not lead to the 
desired results regarding adipogenic differentiation. With all culture conditions involving 
complete EGM2 within the medium, adipogenesis was strongly impaired. 
 
 
Figure 5-4: ASC monocultures in 2-D and 3-D on day 14 after induction of adipogenesis. Triglycerides 
stained with ORO (in 2-D) or with OsO4 (in 3-D, cryosections), respectively. The culture media were as 
indicated. Scale bars are 100 µm. 
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Therefore, it was necessary to identify the specific component(s) within the EGM2 which 
were responsible for the inhibition of adipogenesis in order to adjust culture conditions 
accordingly. Most likely, the epidermal growth factor (EGF) included in the medium was the 
main cause for the reduced lipid accumulation, as it has been reported in literature that EGF 
can, dependent on its concentration, inhibit adipogenic differentiation in 3T3-L1 cells [29] and 
in primary preadipocytes [31] as well as in vivo [28]. 
To verify this hypothesis, in a 2-D experiment ASC were cultured and induced using different 
media, either with or without the addition of EGF. When a PGM2:EGM2 mixture including 
EGF was used, ORO staining revealed that the accumulation of triglycerides was again very 
low (Fig. 5-5 c). In contrast, the elimination of EGF from the medium led to extensive 
adipogenic conversion (Fig. 5-5 d), with the differentiation rate being similar to PGM2 only 
(Fig. 5-5 a). Interestingly, when EGM2 alone (not including PGM2) without EGF 
supplementation was used, adipogenic differentiation was again much lower, and the cells 
had developed an elongated morphology, which is untypical for maturing adipocytes 
(Fig. 5-5 b). These results not only indicated that the presence of PGM2 is necessary for 
adipogenesis, but also proved our hypothesis that EGF was a crucial factor for the inhibition 
of adipogenic differentiation in ASC. As a consequence, cultivation without EGF was a 
promising option also for adipogenesis in ASC/MVEC cocultures.  
 
 
Figure 5-5: ASC monocultures on day 14 after induction of adipogenesis. Culture media were as 
indicated. Bright field images after staining with Oil Red O (ORO). Scale bars are 100 µm. 
PGM2:EGM2 (50:50)  
w/o EGF 
EGM2, w/o EGF PGM2 
PGM2:EGM2 (50:50)  
incl. EGF 
a b 
c d 
Chapter 5  Establishment of 3-D hASC/hMVEC Cocultures 
 
- 98 - 
 
However, before EGF-free media were actually used for cocultures, we tested if endothelial 
cell viability and proliferation were impaired under these conditions. When EGM2 alone, yet 
without EGF, was used, no differences regarding MVEC morphology and viability could be 
detected in comparison to complete EGM2 (Fig. 5-6 A, a+b). Interestingly, DNA content on 
day 5 was even higher, indicating an increased proliferation rate (Fig. 5-6 B). With an EGF-
free PGM2:EGM2 mixture, cells also remained viable (Fig. 5-6 A, c), and proliferation was 
comparable to EGM2 (Fig. 5-6 B). Thus, the elimination of EGF from the culture media, as 
well as the addition of the PGM2 fraction, appeared to have no negative effects on MVEC 
culture. In conclusion, a medium mixture of PGM2 and EGM2, but without EGF, was chosen 
as basic medium for the following coculture experiments, as it allowed for adipogenic 
differentiation of the ASC without damaging the MVEC. 
 
5.4.4 Influence of the hormonal induction cocktail on the MVEC 
In order to induce adipogenic differentiation of the ASC within the cocultures, it was 
necessary to expose the cells to the usual hormonal induction cocktail. However, the effect 
these inducers could have on the endothelial cells had to be considered, too. It has already 
been reported for human umbilical vein endothelial cells (HUVEC) that particularly IBMX and 
thiazolidinediones (which are, like indomethacin, PPARγ agonists) can significantly reduce 
endothelial cell proliferation and viability [21]. 
To evaluate the influence of the adipogenic cocktail on the MVEC, they were cultured in 2-D 
in PGM2/EGM2 medium mixture with or without the addition of hormonal inducers. Strikingly, 
the addition of the hormonal cocktail (HC) over the whole period of 5 days caused most of 
the MVEC to detach from the culture plate, with the remaining cells showing a low viability 
rate (Fig. 5-6 A, d). Accordingly, DNA content on day 5 was strongly reduced (Fig. 5-6 B). 
However, when the HC was only applied for 2 days, and then replaced by insulin only, no 
negative effect on the MVEC could be observed on day 5. Cell viability and DNA contents 
were comparable to the untreated group (Fig 5-6). These results indicated that a 2-day-
period of HC supplementation did not significantly impair MVEC viability and proliferation, 
while irreversible cell damage appeared to result when the inducers stayed on the cultures 
for a longer time span. 
In the first part of this project it had been demonstrated that for our 3-D ASC spheroids a 
short-term induction period of 2 days was sufficient to induce adipogenesis (Chapter 4). For 
the cocultivation with MVEC, this represents a great advantage, because exposure time to 
the HC can be kept short in order to induce ASC differentiation without significantly affecting 
MVEC viability and proliferation. 
Chapter 5  Establishment of 3-D hASC/hMVEC Cocultures 
 
- 99 - 
 
In summary, it was determined that optimal culture conditions for ASC/MVEC coculture 
spheroids include PGM2:EGM2 (50:50) – without the addition of EGF – as a basic medium, 
as well as the usage of a short-term induction protocol for adipogenic differentiation with an 
initial HC supplementation period of 2 days. 
 
 
Figure 5-6: MVEC were seeded in 2-D monolayers using different media as indicated. After 2 days 
(i.e. on day 0), the hormonal induction cocktail was added to some groups for 2 or 5 days, 
respectively. A) Live/Dead-staining on day 5. Green calcein fluorescence indicates live cells, red 
EthD-III fluorescence indicates dead cells. Scale bars are 200 µm. B) Quantification of the DNA 
content per well on day 5. * indicates statistically significant differences compared with all other groups 
(p<0.05). 
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5.4.5 Coculture spheroids: Application of the new culture protocol 
Based on the results from the previous sections, the newly established culture conditions 
were applied to 3-D ASC/MVEC cocultures: 50% ASC and 50% MVEC were seeded into 
agarose-coated 96-well-plates with PGM2:EGM2 (50:50) to form spheroids and induced with 
the standard hormonal cocktail for 2 days, followed by supplementation with insulin only. For 
comparison, ASC monocultures were kept under the same conditions or in PGM2 only. 
After a single spheroid had formed in each well, cells in all induced groups began to 
accumulate lipids, which could be observed via bright field microscopy. After 15 days, 
histological staining for triglycerides on cryosections revealed that cocultures had developed 
lipid inclusions in a similar manner to ASC monocultures. For the monocultures lipid 
accumulation did not appear to be impaired when a PGM2:EGM2 medium mixture, and not 
PGM2 alone, was used (Fig. 5-7).  
These results proved that the culture conditions established previously were indeed suitable 
for the 3-D cocultivation of ASC and MVEC, as adipogenesis could be successfully induced 
in the cocultures using the short-term induction protocol. 
 
 
Figure 5-7: Cryosections of OsO4-stained spheroids (5000 cells) on day 15 after induction. a) 
Cocultures uninduced in 50:50 medium b) Cocultures induced in 50:50 medium c) ASC monocultures 
induced in 50:50 medium d) ASC monocultures induced in PGM2. Scale bars are 50 µm.  
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5.5 Conclusion 
In a multi-step process, it was possible to develop a culture protocol for the cocultivation of 
ASC and MVEC in a 3-D spheroid model. A suitable medium formulation was found after 
eliminating EGF from a 50:50 mixture of PGM2 and EGM2, which had attenuated adipogenic 
differentiation in the cocultures. As different culture methods involving a pre-induction step 
failed to produce satisfying results with regard to lipid accumulation, direct coculture using 
the improved media was determined as an optimal protocol. Furthermore, the application of a 
short-term induction protocol proved to be ideal, as the exposure time of the MVEC to 
potentially harmful components of the adipogenic cocktail could be kept short, yet ASC could 
still undergo adipogenesis.  
With the newly developed coculture system, it is possible to investigate the interactions of 
ASC and MVEC in a more in-vivo-like context. Since the ASC can be differentiated towards 
the adipogenic lineage (and potentially also other lineages), our model system can be 
applied to further study the reciprocal regulation of adipogenesis and angiogenesis, as it 
occurs during adipose tissue development. Specifically, a critical point, which will be 
addressed in the following chapter, is how the presence of endothelial cells affects 
ASC/preadipocytes on a functional and molecular level in a 3-D microenvironment, for 
example with regard to lipid accumulation and gene expression. Moreover, our coculture 
system can potentially be used as the basis for the development of vascularized tissue grafts 
for applications in regenerative medicine. 
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6.1 Abstract 
Vascularization of engineered tissue transplants remains one on the biggest challenges in 
regenerative medicine. A possible strategy to generate prevascularized tissues in vitro 
involves the coculturing of tissue specific cells with endothelial cells in a 3-dimensional 
culture system. A coculture model of human adipose tissue using spheroids composed of 
adipose-derived stem cells (ASC) and microvascular endothelial cells (MVEC) was 
established previously in this project. In this chapter, our goal was to characterize this model 
system and to utilize it for gaining new insights into the cellular crosstalk between the two cell 
types. 
Cellular self-organization and spheroid composition at different time points were evaluated 
via membrane staining, confocal microscopy and immunohistology. Although coculture 
spheroids were in general smaller than ASC monocultures, both cell types were included 
within the constructs, which remained stable and viable during prolonged culture. While 
MVEC were at first preferentially located on the surface of the spheroids, after a few days 
they gradually accumulated in specific regions of the constructs and began forming network-
like structures. At the same time, the proportion of MVEC strongly decreased over time. An 
angiogenesis assay, in which the 3-D constructs were embedded in Matrigel, revealed that 
not only cocultures, but also ASC monocultures showed extensive sprouting, which was not 
significantly influenced by the presence of MVEC. When induced to undergo adipogenesis, 
ASC within coculture spheroids accumulated less triglycerides than in corresponding 
monocultures. A gene expression array after spheroid dissociation and magnetic bead-based 
separation supported these data, as most adipogenic marker genes were expressed less 
strongly in the cocultures on days 2 and 9 after induction. In contrast, some other genes 
associated with angiogenesis exhibited higher mRNA levels in cocultured ASC. Cryosections 
revealed an interesting regional separation, with lipid droplets developing only in those parts 
of the constructs not containing endothelial cells, while adipogenesis was inhibited in ASC 
close to the MVEC structures. These results suggest that the inhibitory effect on adipogenic 
differentiation is transmitted either via direct cell-cell contact or through short-range paracrine 
signaling. 
In conclusion, the newly established 3-D coculture model was successfully applied to shed 
more light onto the complex cellular crosstalk and reciprocal regulation between developing 
adipocytes and endothelial cells within a 3-D microenvironment. Moreover, we gained further 
knowledge regarding cellular self-arrangement, which can help in the process of designing 
vascularized adipose tissue constructs. 
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6.2 Introduction 
Blood vessel formation by angiogenesis is a complex multistep process. Under the influence 
of pro-angiogenic signals, which are for example released by a hypoxic, inflammatory or 
tumor cell, quiescent endothelial cells (EC) initiate angiogenic sprouting. As a first step, this 
process involves the loosening of EC-EC junctions, degradation of the ECM and the 
detachment of pericytes [1,2]. Subsequently, a small proportion of EC is selected to become 
“tip cells”, which lead vessel sprouting, and are followed by EC termed “stalk cells”, which 
form the trunk of the new capillary and eventually establish a vascular lumen. Finally, on 
contact with other EC, tip cells fuse with recipient vessels to from a continuous lumen 
allowing for blood flow [1].  
In vivo, adipogenesis and angiogenesis are closely associated [3,4]. Angiogenic activity of 
adipose tissue has been known and clinically used for treating wounds and ischemic organs 
for more than 400 years [5]. In recent years, it was discovered that a number of angiogenic 
factors, such as VEGF, HGF, bFGF or TGFβ, are produced by growing adipocytes and also 
by adipose-derived stem cells (ASC) [6–8]. Of these, VEGF has been accepted to be 
responsible for most of the angiogenic activity in adipose tissue [8]. However, little is known 
about the temporal and spatial interplay between these factors necessary for angiogenesis 
and subsequent vessel remodeling during adipose tissue development [3,5].  
Of course, the interaction between adipocytes and endothelial cells is not a one-way street. 
EC not only form passive conduits for delivering oxygen, but also establish organ-specific 
vascular niches, which stimulate organogenesis by the production of paracrine-tropic 
‘angiocrine’ factors [2,9]. Thus, for a better understanding of adipose tissue development, it is 
not only necessary to further investigate how EC respond to signals derived from adipocytes, 
but also to explore the influence of EC on adipogenesis.  
In general, cellular nutrient and oxygen supply within tissues can be provided by diffusion 
only up to a distance of 100-200 µm. For tissue engineering, this means that the survival of 
cells within larger transplants requires vascularization, which remains one of the main 
obstacles in regenerative medicine [10–12]. As spontaneous vessel ingrowth from the host is 
often too slow, additional strategies are needed to ensure sufficient supply of such tissue 
grafts. These strategies include scaffold design, the application of angiogenic factors, in vivo 
prevascularization, in vitro prevascularization and, of course, combinations of these. The first 
two approaches still rely on the ingrowth of host vessels. In vivo prevascularization can 
quickly provide perfusion, but has disadvantages regarding clinical practicality, as it requires 
two separate surgeries. In vitro prevascularization is based on 3-dimensional cocultures of 
EC with tissue specific cells under conditions suitable to induce the formation of a 
prevascular network. After implantation, this network can anastomose to the ingrowing host 
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vessels and therefore reduce the time needed for complete vascularization [10,13]. Studies 
dealing with the development of in vitro prevascularized tissues have been published for 
several tissues including skin, bone, skeletal and cardiac muscle, as reviewed by Rouwkema 
et al. [10]. 
In this project, initially a human ASC spheroid model suitable for the investigation of 
adipogenesis in a 3-dimensional context was developed (Chapter 3). Based on that, a 
coculture model using ASC and MVEC, which can be induced to undergo adipogenesis, 
could be established (Chapter 5). This model could represent a promising basis for the 
development of in-vitro-prevascularized adipose tissue grafts.  
In this chapter, our primary goal was to characterize this newly developed 3-D coculture 
model and to utilize it for gaining new insights into the cellular crosstalk between 
ASC/adipocytes and endothelial cells. Therefore, we at first evaluated spheroid morphology, 
cell viability, triglyceride accumulation and its homogeneity, as well as cellular self-
organization at different time points. Moreover, a Matrigel-based sprouting assay was applied 
to assess angiogenic function. Finally, the influence of the MVEC on adipogenic 
differentiation within the 3-D environment was examined on a molecular level by measuring 
gene expression of the ASC after dissociation of the spheroids and subsequent removal of 
the MVEC via magnetic bead-based sorting. 
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6.3 Materials and Methods 
6.3.1 Materials 
Human adipose derived stem cells (ASC) were obtained from PromoCell (Heidelberg, 
Germany; lot 8073006.12); Adult Human Dermal Blood Microvascular Endothelial Cells 
(MVEC) were purchased from Lonza (Verviers, Belgium; lot 0000122821). Preadipocyte 
Growth Medium 2 (PGM2, consisting of PBM2, 10% FBS and 1% penicillin/streptomycin 
solution) and EGM2-MV BulletKit (containing Endothelial Basal Medium 2 [EBM2], 5% FBS, 
GA-1000 [Gentamicin, Amphotericin-B], hydrocortisone, ascorbic acid, EGF, VEGF, IGF and 
bFGF) were also from Lonza (Verviers, Belgium). Fetal bovine serum (FBS, lot 40A0044K), 
penicillin-streptomycin solution, 0.25% trypsin/EDTA solution, phosphate buffered saline 
(PBS), Trizol reagent and Dynabeads CD31 were from Invitrogen (Darmstadt, Germany). 
Agarose, indomethacin, dexamethasone, bovine serum albumin (BSA), glycerol standard 
solution, dimethylsulfoxide (DMSO), calf thymus DNA, Oil Red O, Mayer´s hematoxylin 
solution and the membrane dyes PKH26 and PKH67 were purchased from Sigma-Aldrich 
(Munich, Germany). 3-isobutyl-methylxanthine (IBMX) was bought from Serva (Heidelberg, 
Germany), Thesit from Gepepharm (Siegburg, Germany). Hoechst 33258 dye was obtained 
from Polysciences (Warrington, PA, USA). Bovine insulin was kindly provided by Sanofi-
Aventis (Frankfurt a. M., Germany). Matrigel (Growth Factor Reduced) was obtained from BD 
Biosciences (Heidelberg, Germany). Monoclonal mouse anti-human CD31 and polyclonal 
rabbit anti-mouse IgG/HRP antibodies as well as Glycergel mounting medium were 
purchased from Dako (Hamburg, Germany). Cy3-coupled donkey anti-mouse IgG antibody 
and IS mounting medium DAPI were bought from Dianova (Hamburg, Germany). All other 
chemicals were from Merck (Darmstadt, Germany).  
 
6.3.2 Methods 
6.3.2.1 Cell culture 
6.3.2.1.1 Expansion of ASC and MVEC 
Human adipose-derived stem cells (ASC) were thawed after cryopreservation (passage 3) 
and seeded in culture flasks. They were expanded in Preadipocyte Growth Medium (PGM2), 
i.e. Preadipocyte Basal Medium (PBM2) containing 10% FBS, penicillin (100 U/ml) and 
streptomycin (100 µg/ml). P4 cells were used for all experiments. Microvascular endothelial 
cells (MVEC) were also thawed after cryopreservation (passage 2) and expanded in culture 
flasks with complete EGM2-MV medium (referred to as EGM2 in this chapter). EGM2 
contained 5% FBS, GA-1000 (Gentamicin, Amphotericin-B), hydrocortisone, ascorbic acid, 
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EGF, VEGF, bFGF and IGF. All cells were passaged at 90% confluence. Passage 3 or 4 
cells were used for all experiments. 
 
6.3.2.1.2 ASC/MVEC coculture spheroids 
For 3-D spheroid cocultures, after expansion in culture flasks ASC and MVEC were 
trypsinized and equal cell numbers of both cell types (2500 cells) were seeded into 96-well-
plates coated with 1.5% agarose according to the liquid overlay technique. From this time 
point, the culture medium was composed of 50% PGM2 and 50% EGM2 (without EGF). 
Culture plates were kept on an orbital shaker at 50 rpm during incubation. As spheroids 
would be lost with complete removal of medium from the wells, all medium changes were 
performed by replenishing only half of the medium volume. Adipogenic induction was 
performed after 2 days by exchanging half of the medium with induction medium (IM), 
consisting of 50:50 growth medium (without EGF) supplemented with a hormonal cocktail, 
resulting in final concentrations of 1.7 µM insulin, 1 µM dexamethasone, 200 µM 
indomethacin and 500 µM 3-isobutyl-1-methylxanthine (IBMX). The time point of induction 
was referred to as day 0. On day 2 after induction, IM was replaced by 50:50 growth medium 
(without EGF) containing 1.7 µM insulin only (final concentration). This was done by 
exchanging half of the medium for three times in order to reduce the concentration of the 
hormonal inducers. All cultures were incubated at 37°C, 5% CO2. Medium was exchanged 
every 3-4 days.  
ASC monocultures were performed accordingly, with the total cell numbers per spheroid 
being equal to the total cell numbers in the cocultures. Culture media were the same as for 
the cocultures for comparability. 
 
6.3.2.2 Microscopical determination of spheroid size 
At specific time points, microscopical bright field images of the co- and monoculture 
spheroids were acquired with a XC30 CCD camera attached to a IX51 inverted microscope 
using CellSens Dimension software (all from Olympus, Hamburg, Germany). Cross-
sectional areas of at least 10 randomly selected spheroids were determined with ImageJ 
software (NIH, Bethesda, MD, USA). Equivalent diameters and spheroid volumes were 
calculated thereof. 
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6.3.2.3 Live/Dead Assay 
Cell viability within the spheroids was assessed with the Live/Dead Cell Staining Kit II 
(PromoCell, Heidelberg, Germany). Spheroids were pooled, washed three times with 
PBS and incubated with the staining solution (4 µM EthD-III, 2 µM Calcein AM) for 45 
min. The staining was evaluated by imaging with a confocal laser scanning microscope 
(Zeiss Axiovert 200M microscope coupled to a Zeiss LSM 510 scanning device, Carl Zeiss 
MicroImaging, Jena, Germany). Live cells showed green calcein fluorescence (ex. 488 nm, 
em. 505-550 BP), dead cells were indicated by red fluorescence of DNA-intercalating 
EthD-III in the nuclei (ex. 543 nm, em. LP 560). The z-stack mode was used to investigate 
viability inside the spheroids. 
 
6.3.2.4 Determination of the intracellular triglyceride (TG) content 
For analysis of the intracellular TG content 3-D spheroids were pooled, washed twice with 
PBS and resuspended in 0.5% aqueous Thesit solution. Subsequently, cells were sonicated 
and spectroscopic quantification of TG was performed using the enzymatic Serum 
Triglyceride Determination Kit from Sigma-Aldrich (Munich, Germany) according to the 
manufacturer’s instructions, with assay conditions being adjusted to the 96-well plate format. 
For calibration, different glycerol standard dilutions were used. All TG data were acquired 
from three biological replicates; one replicate was derived from an exact number of 
approximately 20 spheroids for 3-D cultures. TG contents per spheroid were calculated and 
normalized to the DNA content, which was determined as described below. 
 
6.3.2.5 Determination of the DNA content 
3-D spheroids were pooled, washed twice with PBS, resuspended in lysis buffer (2 mM 
EDTA, 2M NaCl, 50 mM Na3PO4, pH 7,4) and sonicated as well. DNA content was 
determined using the intercalating Hoechst 33258 dye (0.1 µg/ml in 0.1 M NaCl, 1 mM 
EDTA, 10 mM Tris, pH 7.4). Fluorescence intensities were determined at an excitation 
wavelength of 365 nm and an emission wavelength of 458 nm with a TECAN Genios Pro 
plate reader (Männedorf, Switzerland) and correlated to DNA contents using standard 
dilutions of double-stranded DNA (from calf thymus). All measurements were performed in 
three biological replicates; one replicate was derived from an exact number of approximately 
10 spheroids for 3-D cultures.  
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6.3.2.6 Lipid staining with Oil Red O 
To visualize triglyceride accumulation, cultures were harvested and staining with Oil Red O 
(ORO) was performed. For this purpose, spheroids were pooled in PBS, transferred to 
microcentrifuge tubes, washed with PBS, fixed in 10% formalin (1h, 4°C), stained with ORO 
(3 mg/ml solution in 60% isopropanol) for 4h and washed three times with PBS. Stained 
spheroids were embedded in Tissue-Tek (Hartenstein Laborbedarf, Würzburg, Germany), 
snap frozen and cut into 10-µm-thick cryosections. After removal of Tissue-Tek by washing in 
water, the sections were mounted in glycerol. Serial sections were prepared from all 
spheroids and sections from the center region were used for histological evaluation. 
Microscopical bright field images were acquired with a DP71 camera attached to a BX51 
microscope using CellSens Dimension software (all from Olympus, Hamburg, Germany).  
 
6.3.2.7 Staining with PKH dyes and visualization of cellular distribution 
To visualize the distribution of the two cell types in cocultures, ASC and MVEC were stained 
with different PKH membrane dyes according to the manufacturer´s protocol before starting 
the spheroid cultures. Both cell types were trypsinized, counted and washed with PBS. After 
centrifugation, cells were resuspended in Diluent C, and freshly mixed solutions of PKH26 or 
PKH67 were added, resulting of a dye concentration of 5 µM. After 3 min incubation at room 
temperature the reaction was stopped with FBS. Subsequently, cells were centrifuged and 
washed 3 times with full culture medium. After that, co- and monocultures were seeded as 
usual.  
To evaluate cellular distribution, imaging was performed using a confocal laser scanning 
microscope (Zeiss Axiovert 200M microscope coupled to a Zeiss LSM 510 scanning device, 
Carl Zeiss MicroImaging, Jena, Germany). PKH26 was excited at 543 nm (He-Ne-Laser) and 
detected with a 560 nm longpass filter. PKH67 was excited at 488 nm (Ar-Laser) and 
detected with a 505-550 nm bandpass filter. Z-stacks were acquired to assess cell 
arrangement inside the constructs. 
 
6.3.2.8 Sprouting in Matrigel 
To investigate cellular sprouting, co- and monoculture spheroids were embedded in Matrigel 
1 day after seeding. 8-well chamber slides (Ibidi, Martinsried, Germany) were at first coated 
with Matrigel on ice according to the manufacturer´s instructions and subsequently incubated 
for 15 min at 37 °C to induce gelation. After that, 5-10 spheroids (mono- or cocultures) were 
added to each well, and more Matrigel was pipetted into the wells to completely enclose the 
constructs. After gelation at 37 °C for 30 min, either EGM2 or a 50:50-mixture of PGM2  and 
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EGM2 was added to the wells and replaced with fresh medium after 3 days. Cultures were, 
as usual, incubated at 37 °C and 5% CO2. Sprouting was visualized on day 5 after 
embedding into Matrigel using bright field microscopy as described in section 6.3.2.2.  
 
6.3.2.9 Immunohistochemical staining for CD31 
Cryosections of spheroids were histologically stained for CD31. Sections were fixed in 
acetone of -20 °C for 10 min, air dried for 10 min at room temperature (RT) and rehydrated 
with PBS for 5 min. Then, slides were incubated with blocking solution (1% BSA in PBS) for 
20 min, followed by incubation with the primary antibody (mouse anti-human CD31, dilution 
1:100) at RT overnight. After washing 3 times with PBS, they were incubated with the 
secondary antibody (rabbit anti-mouse HRP) for 30 min and again washed 3 times with PBS. 
Slides were developed with diaminobenzidine (Liquid DAB Substrate Pack, Biogenex, 
Fremont, CA, USA), counterstained with hematoxylin, mounted with Glycergel and imaged 
as described in section 6.3.2.6. 
 
6.3.2.10 Immunofluorescence staining for CD31 
For immunofluorescence, cryosections were fixed, air dried, rehydrated, treated with blocking 
solution and incubated with the primary antibody as described in the previous section. 
Subsequently, they were washed three times with PBS and incubated with the Cy3-coupled 
secondary antibody (donkey anti-mouse IgG) for 30 min in the dark. After washing 3 times 
with PBS, slides were mounted with DAPI mounting medium. All steps were performed at 
RT. Images were taken with an Olympus BX51 fluorescence microscope combined with a 
DP71 camera using CellSens Dimension software (all from Olympus, Hamburg, Germany). 
Different filters were used for the imaging of DAPI and Cy3 fluorescence (ex./em. 
330-385 nm/420 nm and ex./em. 510-550 nm/590 nm, respectively). 
 
6.3.2.11 Separation of MSC and MVEC using magnetic beads 
To separate ASC and MVEC after 3-D coculture for subsequent analytics, spheroids had to 
dissociated at first. To do this, they were pooled, transferred to a microcentrifuge tube, 
washed 2 times with PBS and incubated with 0.25% trypsin/EDTA for 15 min while shaking. 
The reaction was stopped with FBS, and the resulting cell suspension was centrifuged (500g, 
7 min). Cells were resuspended in PBS containing 1% BSA and incubated with 10 µl of 
anti-CD31 Dynabeads per sample at 4 °C for 30 min under vertical rotation. Subsequently, 
samples were placed in a magnet for 2 min to separate the cells and the supernatant 
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(containing CD31-negative cells) was transferred to another tube. The process was repeated 
several times to completely remove all CD31-positive cells. Then, each sample was 
centrifuged, and the pellet was used for further analysis. 
 
6.3.2.12 Low Density Gene Expression Array 
Gene expression of co- and monoculture spheroids was measured before adipogenic 
induction (i.e. on day 0) and on days 2 and 9 after induction. Uninduced constructs were 
used as control group. At each time point, 30 spheroids were harvested and pooled to result 
in one biological replicate. Samples were dissociated and MVEC were separated from the 
ASC using magnetic beads as described in the previous section. Monocultures were treated 
in the same way to ensure comparability. From the ASC fraction, total RNA was extracted 
using Trizol reagent according to the manufacturer´s instructions. RNA concentrations were 
determined spectrophotometrically with a NanoDrop 2000c analyzer (Thermo Fisher 
Scientific, Wilmington, DE, USA). 
First strand cDNA was synthesized from total RNA using ImProm-II Reverse Transcription 
System (Promega, Mannheim, Germany) according to the manufacturer’s protocol. qRT-
PCR using custom-made TaqMan Low Density Arrays (Applied Biosystems, Darmstadt, 
Germany) containing primers and probes for several adipogenesis-related genes in 384-well 
micro fluidic cards was performed according to the manufacturer’s instructions. cDNA 
samples were mixed with TaqMan Gene Expression Master Mix and filled into the ports of 
the micro fluidic cards. After centrifugation in order to distribute the cDNA samples to the 
reaction wells, the cards were sealed and RT-PCR was performed on a 7900HT Fast Real-
Time System (Applied Biosystems, Darmstadt, Germany) over 40 cycles. Evaluation of 
expression data was carried out according to the ΔΔCt method. All Ct values were 
normalized to GAPDH. Expression values of ASC monocultures on day 0 were used as 
reference for all other groups. If a gene was not detectable in the reference group, a Ct value 
of 40 was assumed (corresponding to one cDNA replicate in the sample). Relative 
expression levels (RQ) were calculated as 2-ΔΔCt. All measurements were performed with 
three biological replicates. Genes specifically mentioned in the text or figures are listed in 
Table 6-1. 
 
Table 6-1: List of gene names, gene symbols, and TaqMan Assay ID’s. 
Gene name Gene symbol Assay ID# 
adiponectin ADIPOQ Hs00605917_m1 
angiopoietin 1 ANGPT1 Hs00375822_m1 
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angiopoietin 2 ANGPT2 Hs00169867_m1 
angiotensinogen AGT Hs00174854_m1 
apelin APLN Hs00175572_m1 
apolipoprotein E APOE Hs00171168_m1 
CCAAT/enhancer binding protein (C/EBP), alpha CEBPA Hs00269972_s1 
CCAAT/enhancer binding protein (C/EBP), beta CEBPB Hs00270923_s1 
CCAAT/enhancer binding protein (C/EBP), delta CEBPD Hs00270931_s1 
complement factor D (adipsin) CFD Hs00157263_m1 
cytochrome P450, fam, 19, subf. A, polypept. 1 (aromatase) CYP19A1 Hs00240671_m1 
fatty acid binding protein 4  (aP2) FABP4 Hs01086177_m1 
fatty acid synthase FASN Hs00188012_m1 
fatty acid transporter 1 FATP1 Hs01587917_m1 
facilitated glucose transporter 4 GLUT4 Hs00168966_m1 
glyceraldehyde-3-phosphate dehydrogenase GAPDH Hs99999905_m1 
insulin-like growth factor 1 IGF1 Hs01547657_m1 
interleukin 1, beta IL1B Hs00174097_m1 
interleukin 6 IL6 Hs00985639_m1 
leukemia inhibitory factor LIF Hs00171455_m1 
lipoprotein lipase LPL Hs00173425_m1 
nicotinamide phosphoribosyltransferase (visfatin) NAMPT Hs00237184_m1 
peroxisome proliferator-activated receptor gamma PPARG Hs00234592_m1 
sterol regulatory element binding transcription factor 1 SREBF1 Hs01088691_m1 
transforming growth factor, beta TGFB Hs00234244_m1 
vascular endothelial growth factor A VEGFA Hs00173626_m1 
 
6.3.2.13 Statistics 
All quantitative results are presented as mean value ± standard deviation. Differences 
between multiple groups were analyzed for significance using one-way analysis of variances 
(ANOVA) with subsequent multiple comparisons according to Tukey’s post-hoc test. In the 
LDA differences between mono- and coculture at each time point were analyzed for 
significance using unpaired Students t-test. Differences within each culture system between 
time points were analyzed for significance using ANOVA with subsequent multiple 
comparisons according to Tukey’s post-hoc test.  
For all comparisons, a value of p<0.05 was regarded statistically significant. Statistical 
analysis was performed using PASW Statistics 18 software (SPSS Inc., Chicago, IL, USA). 
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6.4 Results 
6.4.1 Cell viability, spheroid sizes and triglyceride accumulation in cocultures 
ASC/MVEC coculture spheroids were produced and kept under the conditions determined in 
the previous chapter (chapter 5), i.e. using a PGM2/EGM2 mixture without EGF and applying 
a short-term induction protocol. Live/Dead staining was performed on day 7 after adipogenic 
induction in both uninduced and adipogenically induced cocultures and revealed that in both 
cases the vast majority of cells exhibited green fluorescence indicating viability (Fig. 6.1). 
Single dead cells were present primarily on the surface of the spheroids and often did not 
appear to be properly integrated into the 3-D constructs. This was in general comparable to 
the results from ASC monoculture spheroids (Fig. 3-10, chapter 3). 
 
 
Figure 6-1: Live/Dead-staining of uninduced (a/b) and adpogenically induced (c/d) coculture 
spheroids (d7). Optical sections acquired by confocal microscopy are depicted. In each row, green 
calcein fluorescence indicating live cells is shown on the left, red EthD-III fluorescence indicating dead 
cells in the middle and the overlay image on the right. a and c show 3-dimensional projections 
obtained from z-stacks, b and d show single optical sections from central regions of the spheroids. 
Scale bar is 100 µm. 
a 
b 
c 
d 
Live Dead Overlay 
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Cells were seeded as cocultures and ASC monocultures with a total number of 5000 cells 
per construct, which had previously been determined to be an optimal spheroid size for ASC 
monocultures (chapter 3), and the progression of spheroid sizes over culture time was 
monitored by the determination of construct volumes at different time points (Fig. 6-2 A). 
When 3-D spheroids had formed in each well after 1 day (i.e. on day -1), it became obvious 
that cocultures were of smaller size than ASC monocultures, with cocultures reaching about 
72% of the monoculture volumes.  
 
 
Figure 6-2: A) Growth kinetics of coculture and ASC monoculture spheroids (induced on day 0 or 
uninduced) up to day 14. Spheroids were seeded with a total number of 5000 cells per construct. 
B) DNA content per spheroid of co- and monocultures on day 14. 
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During the first days of culture, all spheroids decreased in size at least up to day 2. For both 
mono- and cocultures, the volume reduction was even more pronounced when cultures were 
induced to undergo adipogenesis. At later time points, volumes stabilized and remained 
within a certain range up to day 14 for each group. After two weeks of culture, volumes of the 
cocultures were approx. 81% of the corresponding monocultures for uninduced control 
groups and approx. 55% for induced groups.  
In addition, DNA contents of the spheroids were determined after harvesting all groups on 
day 14 (Fig. 6-2 B). These data also revealed significant differences between the culture 
types, with DNA levels in cocultures reaching 71% and 63% of the corresponding ASC 
monocultures for control and induced groups, respectively. It is also worth mentioning that 
control and induced groups within one culture system were not significantly different. 
 
 
Figure 6-3: A) Quantification of the intracellular TG content in co- and monoculture spheroids on 
day 9. TG contents were normalized to DNA contents (in cocultures corrected for the percentage of 
ASC). Statistically significant differences between co- and monocultures are indicated by * (p<0.05). + 
denotes significant differences compared to control groups (p<0.05). B) Histological analysis of the TG 
accumulation on day 14 after staining of cryosections with ORO. Scale bars are 100 µm. 
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normalized to corresponding DNA contents, which were (in case of the cocultures) corrected 
for the percentage of ASC present at that time point, as determined by immunostaining for 
CD31 after dissociating the spheroids. In both culture types ASC had accumulated significant 
amounts of TG as compared to uninduced controls, but strikingly the total TG level after 
adipogenic induction was significantly lower in cocultures than in ASC monoculture spheroids 
(Fig. 6-3 A). Oil Red O staining of cryosections supported these data; while ASC 
monoculture spheroids exhibited lipid droplets homogeneously distributed throughout the 
constructs on day 9, in the cocultures triglycerides appeared to have been accumulated 
predominantly in specific areas of the spheroids, leading to an inhomogeneous distribution 
and overall to a smaller number of lipid inclusions (Fig. 6-3 B). 
 
6.4.2 Cell distribution in coculture spheroids 
In order to distinguish ASC and MVEC and to evaluate cellular distribution in situ within the 
spheroids, it was necessary to label both cell types before mixing them to form the 
cocultures. For this purpose, the non-toxic fluorescent membrane dyes PKH26 and PKH67 
were used to stain the ASC and MVEC, respectively. Imaging via confocal laser scanning 
microscopy (CLSM) could efficiently depict cell type arrangement up to optical sections lying 
about 70 to 80 µm below the surface of the constructs.  
2 days after seeding the labeled cells as cocultures in a 50/50 ratio (ASC/MVEC), CLSM 
images revealed that both cell types had been integrated into the spheroids and were 
present in what appeared to be almost equal quantity, with the ASC seeming to be in a slight 
majority (Fig. 6-4 A). Interestingly, the surface region of the spheroids was apparently mainly 
constituted of endothelial cells, which arranged in a layer-like fashion. Nevertheless, MVEC 
could also be found in central areas of the constructs (Fig. 6-4 A,B). Cultures were induced 
with the adipogenic hormonal cocktail on day 0 and CLSM imaging was again performed on 
several time points later in culture. On day 3 after induction, the internal structure of the 
spheroids had changed as compared to day 0. By then, MVEC had started to accumulate in 
distinct regions within the constructs and to form cellular clusters. Moreover, the surface 
layer of MVEC could no longer be detected, and the overall proportion of endothelial cells 
appeared to be lower than on day 0. Images from days 5 and 7 indicated a further decrease 
of the MVEC proportion, accompanied by prominent cluster formation. Apart from the 
clusters, few MVEC could be found throughout the constructs at all by day 7, resulting in 
rather large EC-free regions (Fig. 6-5).  
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Figure 6-4: Visualization of cellular assembly within ASC/MVEC (50/50) coculture spheroids on day 0 
(i.e. 2 days after seeding) via confocal microscopy (CLSM). ASC were stained with PKH26 before 
seeding and exhibit red fluorescence, while MVEC were stained with PKH67 and show green 
fluorescence. A) Z-stack images of the cocultures, displaying optical sections of the spheroids with 10 
µm intervals as indicated. B) Both fluorescence channels are shown separately and as an overlay for 
the optical section at 50 µm. C) 3-dimensional projections of the spheroids calculated from the 
z-stacks. Scale bars are 100 µm. 
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Figure 6-5: Confocal images of the ASC/MVEC (50/50) coculture spheroids on days 0, 3, 5 and 7 
after adipogenic induction. Cell staining was performed as described in Fig. 6-4 (ASC red, MVEC 
green). For each time point, both fluorescence channels are shown separately and as an overlay for 
the optical section at 50 µm. Scale bars are 100 µm. 
 
In a different experiment, coculture spheroids were produced with an ASC/MVEC ratio 
different from the usual 50/50. Here, only 20% ASC and 80% MVEC were used. Cells were 
again stained with the membrane dyes before seeding, but in contrast to the previous 
experiment the green PKH67 dye was used for the ASC, while MVEC were stained with the 
red PKH26. One day after seeding, i.e. on day -1, spheroids of smaller size than in the case 
of 50/50 cocultures had formed in each well.  
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Figure 6-6: Confocal images of ASC/MVEC (20/80) coculture spheroids on days 0, 3 and 6 after 
adipogenic induction. In contrast to Fig. 6-4 and 6-5, ASC were labeled with green PHK67 and MVEC 
with red PKH26. A) Optical sections at 50 µm (single channels and overlay) acquired with the z-stack 
function B) 3-dimensional projections of the spheroids calculated from z-stacks. Scale bars are 100 
µm. 
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At this early time point, it could again be observed that the EC had accumulated in the 
periphery of the constructs, forming a surface layer (Fig. 6-6 A,B). As expected, the overall 
percentage of MVEC present in the spheroids was higher than in 50/50 cultures, yet cells 
were still randomly distributed over the central regions (Fig. 6-6 A). However, similar to the 
50/50 cocultures, endothelial cells began to aggregate and form clusters during prolonged 
culture. The surface layer of MVEC could no longer be observed by day 3. The proportion of 
EC also decreased between days -1 and 6, but was still higher after 1 week than in the 50/50 
spheroids (Fig. 6-6 A,B).  
 
 
Figure 6-7: Visualization of endothelial cell distribution and arrangement in 50/50 coculture spheroids.  
EC in cryoesctions were detected by immunohistochemical staining for CD31 (brown). Nuclei were 
counterstained with hematoxylin (blue). Scale bars are 200 µm. 
 
To investigate the cellular distribution in more detail, immunostaining was performed on 
cryosections of the spheroids, which were either induced to undergo adipogenesis on day 0 
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or not. On day -1 MVEC were distributed all over the sections, yet not randomly, but with a 
tendency to associate with other endothelial cells (Fig. 6-7). This behavior was even more 
obvious on day 0, when coherent MVEC networks could be detected, which appeared 
preferentially in certain regions of the spheroids, leaving the rest of the constructs virtually 
MVEC-free. The presence of endothelial cell structures could persistently be observed for the 
duration of the experiment (Fig. 6-7). The total amount of endothelial cells, however, 
decreased during ongoing culture, as it had been shown with the CLSM images. When 
immunofluorescence instead of immunohistochemical staining was applied, the process of 
EC structuring was also clearly detectable. In addition, some of the MVEC structures even 
appeared to contain lumen-like areas on day 2 and later (Fig. 6-8).  
 
 
Figure 6-8: Immunofluorescence staining of cryosections from ASC/MVEC (50/50) coculture 
spheroids. Endothelial cells were labeled with CD31 antibody and detected via Cy3 fluorescence (red). 
Nuclei were counterstained with DAPI (blue). Lumen-like areas are indicated by arrows. Scale bar is 
50 µm. 
 
Based on these results, the question arose in which way the observed regional structuring of 
the MVEC within the spheroids was linked to the previously detected inhomogeneous 
triglyceride accumulation (cf. section 6.4.1). This was of particular interest, as on 
CD31/hematoxylin-stained sections of day 9, cocultures often appeared to contain lipid 
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droplets (appearing as circular cavities) predominantly in those parts of the constructs that 
were free of endothelial cells (Fig. 6-9 A).  
 
 
Figure 6-9: A) Cryosection of cocultures stained for CD31 and counterstained with hematoxylin on 
day 9 after adipogenic induction (image identical to Fig 6-7, yet in higher magnification). Arrows 
denote some of the lipid droplets (appearing as cavities). B) Cryosections of cocultures on day 12 
after induction. Sections were alternatingly attached to 2 different slides and stained with either ORO 
(left) or CD31/hematoxylin (right). In each row, both images represent two consecutive sections from 
the central region of the constructs.  
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To address these observations in more detail, in a new experiment coculture spheroids 
(50/50 cell type ratio) were generated, induced with the adipogenic cocktail on day 0 and 
harvested on day 12. As ORO staining would get lost when staining for CD31 was performed 
on the same sections, cryosections were alternatingly attached to two different glass slides. 
Subsequently, these slides were either used for evaluating the ORO distribution or for 
immunohistochemical CD31 staining. In this way, it was possible to assess both lipid 
accumulation and MVEC structuring on consecutive sections (Fig. 6-9 B). Results from these 
experiments supported the previous observations: Again, lipid droplets could be detected 
almost exclusively in those areas of the constructs which did not contain any endothelial 
cells. On the other hand, in regions of the spheroids where MVEC were present, the 
surrounding ASC obviously had not accumulated any lipids (Fig 6-9 B, images a-f). 
Consequently, on sections which included no MVEC at all, triglycerides were distributed 
more or less homogeneously (Fig 6-9 B, images g, h).  
 
6.4.3 Cellular sprouting in Matrigel-embedded coculture spheroids 
Sprouting assays after embedding of cells or tissues into hydrogels can be used as in vitro 
angiogenesis models and have already been applied for coculture spheroid systems, e.g. of 
EC and fibroblasts or osteoblasts [14,15]. Our goal was to utilize a Matrigel sprouting method 
to evaluate EC functionality within the coculture spheroids. After optimizing the embedding 
method to make sure that the spheroids were surrounded with gel and did not sink to the 
bottom of the wells, reproducible sprouting could be observed. Co- and ASC monoculture 
spheroids were embedded into Matrigel one day after seeding and further cultured within the 
gel for 5 days. 
At this time point, radially outgrowing sprouts originating from the spheroids had developed, 
with their length and number being dependent on the culture medium used. In case of the 
cocultures, these sprouts had reached a medium length of 330 µm when gel-embedded 
spheroids were supplemented with complete EGM2, but only few outgrowing structures of 
about 50 µm length had developed under culture with a PGM2/EGM2 mixture (50:50, w/o 
EGF; Fig 6-10 A, images a, b).  
Surprisingly, when EGM2 was used as culture medium, extensive sprouting occurred not 
only with the cocultures, but also for the ASC monoculture spheroids. Length and density of 
the outgrowing structures were comparable between these two groups (Fig. 6-10 A, 
images a, c).  
To investigate the sprouting process and the composition of the outgrowing structures more 
closely, ASC and MVEC were labeled with membrane dyes before seeding as coculture 
spheroids and embedding into Matrigel. After 5 days in the gel, confocal images of the 
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spheroids, including the sprouts, were acquired. The evaluation of z-stacks revealed that 
both cell types contributed to the sprout formation. However, the sprouts were mainly 
composed of ASC, whereas MVEC could be found within the sprouts only sporadically 
(Fig. 6-10 B). 
 
 
Figure 6-10: Cellular sprouting after embedding of coculture (50/50) and ASC monoculture spheroids 
in Matrigel. A) Spheroids were embedded into Matrigel 1 day after seeding and cultured with EGM2 
w/o EGF (a;c) or with PGM2:EGM2 (50:50) w/o EGF(b). Bright field images were acquired five days 
later. Scale bars are 100 µm. B) Cells were stained with green PKH67 (ASC) and red PKH26 (MVEC) 
before seeding as coculture spheroids, which were embedded into Matrigel 1 day later and cultured 
for 5 days with PGM2:EGM2 (50:50) w/o EGF. Confocal z-stack images of the gel-embedded 
spheroids were acquired via CLSM. The upper row shows a series of optical sections from the central 
region of the spheroids. Scale bar is 200 µm. A larger version of the area marked by the white box is 
depicted below. Arrows denote MVEC contributing to the sprouts. 
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6.4.4 Gene expression of ASC in co- and monocultures during adipogenesis 
To investigate how the presence of endothelial cells influenced ASC gene expression in our 
3-D model system, a TaqMan Low Density Array was performed. The custom-made array 
contained several genes associated with adipogenesis and adipocyte functions as well as 
some angiogenesis-related genes. Co- and monoculture spheroids were either induced to 
undergo adipogenesis on day 0 (IND) or not (CTRL). On three time points, samples of the 
co- and monocultures were taken: on day 0 (before hormonal induction was performed) to 
obtain a reference value, on day 2, an early time point during adipogenesis, and finally on 
day 9 to represent a later stage of differentiation.  
However, to be able to compare mRNA expression of the ASC between the two culture 
systems an isolation step had to be introduced after harvesting the cultures, in which MVEC 
had to be removed from the cultures. Therefore a cell separation protocol using anti-CD31-
conjugated magnetic beads was established. It could be demonstrated that an ASC/MVEC 
mixture was successfully separated into a bead-free fraction that contained only CD31-
negative cells and a bead-bound fraction including only CD31-positive cells (Fig. 6-11, a-c). 
When ASC and MVEC were labeled with 2 different PKH dyes prior to mixing, subsequent 
magnetic separation led to pure ASC and MVEC fractions, respectively, which proved that all 
EC, but no ASC were actually coupled to the beads (Fig. 6-11, d&e). To utilize this method 
for the 3-D cocultures, spheroids had to be dissociated by treating them with trypsin before 
magnetic separation. For comparability, this was also done for the ASC monocultures. 
Magnetic bead separation was also successful after the dissociation step (data not shown). 
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Figure 6-11: Cell separation with magnetic beads: proof of principle. Anti-CD31-conjugated 
Dynabeads were added to an ASC/MVEC suspension and allowed to bind (a). The CD31-positive 
(c,e) and -negative (b,d) fractions were separated with a magnet. Immunostaining for CD31 (brown in 
images a-c) proved that the beads specifically bound to cells exhibiting the CD31 antigen (a), which 
could be completely removed from the ASC fraction (b) and were accumulated in the MVEC fraction 
(c). When cells were stained with PKH membrane dyes before mixing them (ASC: green; MVEC: red), 
it could be shown by immunofluorescence that indeed no MVEC remained in the non-binding fraction 
(d) and no ASC ended up in the bead-binding fraction (e). Please note that the beads (bound to cells 
or free) appear as brown dots in the IHC images (a-c) and as weakly red fluorescing dots in the IF 
images (d,e). Red MVEC fluorescence in (e) is strongly attenuated as cells are covered by the beads. 
 
For the LDA analysis, spheroids were harvested and dissociated at the specific time points 
mentioned above. ASC were depleted of MVEC by the newly established magnetic 
separation step, and total RNA was isolated from these samples, followed by reverse 
transcription and gene expression measurement with the 384-well arrays.  
Data analysis revealed that the central adipogenic transcription factors PPARγ and C/EBP 
were, as expected, strongly upregulated in all induced groups by day 2 and even more by 
day 9. The expression pattern was comparable for mono- and cocultures, and as a 
consequence no significant differences between the two culture types could be detected at 
any time point (Fig. 6-12 A,B). This was in general also true for other transcription factors like 
C/EBPβ and C/EBPδ (Fig. 6-12 C,D), which are usually upregulated during early 
adipogenesis, as well as SREBF1 (coding for SREBP1-c). Yet, the latter exhibited a 
significantly decreased expression in cocultures on day 9 when induced, but an increase 
when not induced (Fig. 6-12 E). 
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Figure 6-12: Relative gene expression data (n=3) of the adipogenesis-related transcription factors 
PPARγ, C/EBP, C/EBPβ, C/EBP and SREBF1 as determined by qRT-PCR using TaqMan Low 
Density Arrays. All mRNA levels are expressed relative to the value at d0 in monoculture. Statistically 
significant differences between co- and monocultures are indicated by * (p<0.05). 
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Figure 6-13: Relative gene expression data (n=3) of several adipocyte marker genes as determined 
by qRT-PCR using TaqMan Low Density Arrays. All mRNA levels are expressed relative to the value 
at d0 in monoculture. Statistically significant differences between co- and monocultures are indicated 
by * (p<0.05). 
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Figure 6-14: Relative gene expression data (n=3) of several genes associated with lipid synthesis and 
transport (A-D) as well as other genes with reduced expression in cocultures (E,F) as determined by 
qRT-PCR using TaqMan Low Density Arrays: All mRNA levels are expressed relative to the value at 
d0 in monoculture. Statistically significant differences between co- and monocultures are indicated 
by * (p<0.05). 
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day 9. In other cases (e.g. for adipsin, FAS or aP2), at least a tendency, albeit not significant, 
could be observed at both post-induction time points. By contrast, none of these genes were 
expressed significantly higher in the induced cocultures at any time point. Apart from the 
mentioned differences, the general gene expression pattern of the ASC in the cocultures was 
comparable to monocultures. 
 
 
Figure 6-15: Relative gene expression data (n=3) of several genes associated with angiogenesis as 
well as other genes with increased expression in cocultures as determined by qRT-PCR using 
TaqMan Low Density Arrays: All mRNA levels are expressed relative to the value at d0 in 
monoculture. Statistically significant differences between co- and monocultures are indicated by * 
(p<0.05). 
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In addition to the adipogenesis-related genes mentioned above, also several other genes 
were included in our LDA. Interestingly, some of these genes were expressed on a higher 
level in cocultures as compared to ASC monocultures. For angiopoietin 2, IL-1β, IL-6, LIF 
and VEGF A, mRNA data revealed a significant difference between the two culture systems 
already on day 0, and in most of these also at later time points at least a tendency towards a 
higher expression could be observed, mostly independent of adipogenic induction 
(Fig. 6-15). This was in strong contrast to almost all of the genes associated with 
adipogenesis, for which a decreased expression had been detected in cocultures as 
described above.  
 
 
6.5 Discussion 
6.5.1 Structure of coculture spheroids: Cellular self-assembly, cell type 
distribution and EC networks 
When ASC were cocultured with MVEC in our 3-D spheroid model using the optimized 
culture conditions established previously (Chapter 5), long-term stable constructs could be 
generated successfully. Over the whole culture time, these coculture spheroids were of 
smaller size than corresponding monocultures. This difference may partly be attributed to the 
fact that some of the MVEC seeded into the agarose-coated wells did not contribute to the 
formation of the spheroids. Indeed, a small number of single cells not included into the 
constructs could be observed within the wells after coculture spheroid formation (data not 
shown). However, confocal images of PKH-stained cocultures as well as cryosections 
stained for CD31 revealed that on early time points a large proportion of endothelial cells 
were present within the 3-D constructs, implying that the majority of the MVEC was included 
in the constructs. Instead, the main cause for the smaller volumes of the coculture spheroids 
can possibly be found in the different properties of the two cell types regarding cell size, 
cellular aggregation and tissue self-assembly. For fibroblast/HUVEC cocultures, Kunz-
Schughart et al. hypothesized that the majority of EC were located in the extracellular space 
of the 3-D fibroblast structure and thus did not contribute to an overall increase in spheroid 
size [16]. As the ASC possess a morphology which is very similar to fibroblasts, this 
hypothesis may also play a role for our model. 
It can be assumed that the distinct functional and morphological properties of the ASC and 
MVEC also account for the development of specific 3-dimensional patterns. In the first phase 
after spheroid formation, the surface layer of our constructs was predominantly composed of 
MVEC. Similar observations have been made for coculture spheroids of HUVEC with smooth 
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muscle cells (SMC) by Korff et al. [17]. For human osteoblasts (hOB) cocultured with 
HUVEC, it was also demonstrated that EC accumulated predominantly in the peripheral 
regions of spheroids, albeit this pattern developed only after several days of culture [14,18]. 
In contrast, when cocultured with fibroblasts, EC were located preferentially in the center of 
the constructs [15]. However, while in these studies an almost completely segregated 
distribution of the cell types was observed, in our coculture system EC were not only located 
in the surface layer, but also in central regions of the constructs shortly after spheroid self-
assembly. This is in accordance with a recent study in which spheroids from BMSC and 
HUVEC were generated using a medium containing methylcellulose [19]. Herein, the authors 
suggest that the relative positioning of the different cell types may, among other factors, be 
determined by differences in cell-cell-adhesion and surface tension, as first proposed in the 
differential adhesion hypothesis in 1962 [20]. According to this hypothesis, the cells with the 
highest cohesion form the inner core of a spheroid, while those with a lower cohesion 
accumulate at the periphery [19–21]. The lower cellular cohesion of the MVEC as compared 
to the ASC also becomes obvious through the fact that the generation and maintenance of 
MVEC monoculture spheroids was, in strong contrast to ASC monocultures, not possible in 
our liquid overlay culture system due to a much lower tendency to self-aggregate and, as a 
consequence, a low mechanical stability of the resulting constructs.  
For the cocultures, it became obvious that with increasing culture time the proportion of 
MVEC within the spheroids gradually decreased, both with and without adipogenic induction. 
Nevertheless, a small, but significant population of MVEC remained in the spheroids up to 
day 14, as confirmed by immunostaining and confocal microscopy. This observation was 
supported by total DNA measurement, which indicated that cell numbers in cocultures were 
significantly lower than in ASC monocultures at this time point, yet remained above 50% of 
those values. As only small numbers of dead cells were detected in the cocultures, which 
were not higher than in ASC monocultures, we can assume that the EC loss was mainly 
based on MVEC migrating out of and/or losing contact to the 3-D construct rather than 
apoptosis within the spheroid. This hypothesis is supported by the observation that the 
surface layer of endothelial cells was no longer present on day 3, which could indicate that 
the majority of EC forming this outer layer had detached from the spheroid, strongly reducing 
the overall number of MVEC. 
A loss of endothelial cells during culture was also reported in other studies involving 
coculture spheroids. Interestingly, with fibroblast/HUVEC spheroids it was found that 
independent of the initial seeding ratio, eventually a constant proportion of 10% EC was 
detected after prolonged culture [16], suggesting that in the 3-D environment cells migrate 
and self-assemble in a certain way, so that an optimal cell-type-ratio is achieved. A similar 
behavior of EC loss after high seeding ratios was also observed with large BMSC/HUVEC 
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spheroids, however with the final EC proportion not being constant and reaching a minimum 
of 5% [22]. In this project, the dependence on initial seeding ratio was not extensively 
studied, but our data suggest that the use of 80% MVEC instead of 50% resulted in a higher 
proportion of endothelial cells after 7 days of culture. 
While the overall MVEC proportion decreased in our spheroids over time, the remaining 
endothelial cells began to organize themselves, forming a network of vascular-like structures. 
At the same time, they started to accumulate in specific regions of the constructs, leaving 
other parts almost free of EC. Interestingly, the cells aligned in a similar way, regardless of 
whether the cultures were adipogenically induced or not. In immunofluorescence images, 
some of the MVEC clusters even appeared to contain lumina as early as 4 days after 
seeding, which suggests that indeed capillary-like structures had developed at least in parts 
of the MVEC network. The formation of an extensive endothelial cell network has also been 
described for EC grown on fibroblast sheets or in fibroblast/HUVEC spheroids, and in both 
cases some of the structures contained lumina [16,23]. For BMSC/EC spheroid cultures, 
Rouwkema et al. reported the development of organized EC structures when only 2% of the 
seeded cells were HUVEC, with lumina developing after implantation of the constructs into 
nude mice [22]. For ASC/HUVEC spheroids, an EC proportion of 80% was reported to be 
necessary for the formation of prevascular structures [24]. Kang et al. cocultured hASC and 
HUVEC on silk fibroin scaffolds and observed extensive lumen formation after 2 weeks of 
culture [25]. In general, the formation of EC structures was observed in all of these studies. 
However, the experimental setup applied in them was different from ours, regarding either 
the cell types used (HUVEC vs. MVEC), the method of 3-D culture, the spheroid sizes, the 
culture media or combinations of these, which may account for the observed differences. 
HUVEC are embryonic and may not only differ from organ-specific EC, but with respect to 
clinical applications, the use of HUVEC is problematic due to incompatibility with the host’s 
immune system, whereas MVEC could be isolated from autologous adipose tissue together 
with ASC [26,27].  
 
6.5.2 Cellular sprouting of co- and monocultures: Angiogenesis assays 
Several in vitro angiogenesis assays have been described in literature for the evaluation of 
endothelial cell functionality and its dependence on exogenous factors [28–30]. In most of 
these, the outgrowth of cellular strands from cultures embedded into a gel-based matrix is 
evaluated. In this project, we utilized a sprouting assay in which our co- and monoculture 
spheroids were embedded into Matrigel. The outgrowth of cellular strands from the spheroids 
was more prominent when EGM2 alone was applied instead of EGM2/PGM2 mixture, which 
can be explained by the higher concentrations of growth factors present [31–33]. However, it 
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was remarkable that under EGM2 treatment extensive sprouting not only took place for the 
cocultures, but also for ASC monoculture spheroids, with strand length and density being 
comparable between the two groups. As ASC are pluripotent, they can be differentiated 
towards the endothelial lineage by providing appropriate culture conditions. In principle, this 
might be an explanation for the observed sprouting of ASC monocultures [34,35], although it 
is highly unlikely to have occurred to such a large extent in a rather short time period. 
Outgrowth of cellular strands from BMSC and ASC spheroids in fibrin gels has already been 
described by Verseijden et al., however possible reasons for this behavior were not 
discussed [36]. Wenger et al. observed sprouting after embedding hOB/HUVEC coculture 
and hOB monoculture spheroids into collagen gel. They suggested that hOB outgrowth was 
of a different type that HUVEC sprouting: While the latter would involve a linear alignment of 
migrating endothelial cells, sprouts from hOB monocultures did not contain nuclei and 
therefore could represent cell filopodia invading the surrounding matrix [14]. However, in our 
coculture model, PKH-staining revealed that the sprouts of co- and monocultures were 
indeed composed of multiple cells. In the case of cocultures both ASC and MVEC could be 
detected within the outgrowing strands (with ASC being in a vast majority), and branching 
occurred frequently. All in all, cellular sprouting did not appear to be influenced by the 
presence of endothelial cells within the spheroids. In general, with respect to the observed 
outgrowth also from ASC monocultures, the significance of this type of in vitro assays for the 
evaluation of angiogenesis should be carefully considered in future applications. 
 
6.5.3 Adipogenic differentiation of coculture spheroids: Influence of the 
endothelial cells 
Concerning the cellular crosstalk between (developing) adipocytes and endothelial cells, one 
of the major questions we intended to address was the influence of the EC on the adipogenic 
differentiation of the ASC. Although there have been several studies describing the 
cocultivation of (pre)adipocytes and EC as described above, only a small number of reports 
dealing with the specific effects of the coculture environment on ASC functions in more detail 
can be found in the literature. Some of these have described an increase in preadipocyte 
proliferation, e.g. after exposing human preadipocytes to hMVEC-conditioned medium [37], 
after combining these two cell types in a fibrin matrix [38], or when 3T3-L1 cells were 
cocultured with HUVEC in 2-D [39].  
With respect to adipogenesis, results from previous studies were rather conflicting, and 
appeared to be strongly influenced by culture conditions. For example, an earlier study 
reported that exposure to EC-conditioned medium stimulated adipogenic differentiation of 
human preadipocytes, however the effect was completely masked by the application of an 
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exogenous induction cocktail [40]. In contrast, Hutley et al. observed an increased 
differentiation after direct coculture with EC [41], while in another report, direct coculture of 
ASC with HUVEC significantly reduced adipogenesis [42]. When evaluating these reports, 
one has to consider that these studies were conducted using 2-D culture. Taking into 
account our results from Chapter 4, the process of adipogenesis may however differ 
significantly in a 2-D culture system as compared to a 3-D environment.  
There are also some studies in which hydrogel-based 3-D culture techniques were utilized. 
Coculturing rat lung EC and mature adipocytes in a collagen gel led to a dedifferentiation of 
the adipocytes, but not treatment with conditioned medium [43]. Lai et al. combined 3T3-L1 
preadipocytes with HUVEC, also in collagen gels, and observed an elevated triglyceride 
accumulation, but only with a very high seeding density and using a preadipocyte/HUVEC 
ratio of 90:10, whereas in most other cases adipogenesis was rather reduced as compared 
to monocultures [39]. Whereas the culture systems applied in these studies either lacked 
direct cell-cell-contact or a 3-dimensional environment, our spheroid model was able to 
provide both of these prerequisites and therefore more closely mimicked conditions that can 
be found in vivo. We could demonstrate that the cocultivation with MVEC significantly 
reduced the triglyceride accumulation within ASC in comparison to monoculture spheroids 
when they were induced to undergo adipogenesis. Furthermore, cryosections revealed a 
distinct spatial distribution of lipid accumulation, which occurred preferentially in regions of 
the constructs that were free of endothelial cells – a phenomenon which will be discussed 
later in more detail. The observed decrease in adipogenic differentiation was in accordance 
with a recent study, which utilized coculture spheroids of BMSC and HUVEC. Interestingly, 
therein the authors report that at the same time osteogenic differentiation was elevated under 
coculture conditions [19], an observation supported also by several studies using 2-D culture 
models [44–46]. Thus, it is possible that EC signaling plays a role in the determination of 
mesenchymal cell fate. 
While many of the above studies were primarily based on qualitative data, in this project our 
goal was to investigate the effects of a direct 3-D coculture of ASC with MVEC for the first 
time also on gene expression level, with our focus being on adipogenic differentiation. In 
order to assess mRNA levels of the ASC only, it was necessary to remove the MVEC from 
our cocultures after harvesting the samples. Therefore, the two cell types were separated 
using CD31-coupled magnetic beads after enzymatic dissociation of the spheroids. 
Beforehand, the efficiency of this magnetic sorting method, which has already been 
demonstrated for cocultures of HUVEC and human osteoprogenitor cells [45], was verified in 
our culture system.  
Gene expression analysis was performed using TaqMan Low Density Arrays, which 
included, among others, many adipogenesis-related genes. mRNA levels of the central 
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transcription factors that regulate adipogenesis, PPARγ and C/EBPα, were comparable 
between mono- and cocultures. However, gene expression levels of various adipogenic 
markers and adipokines, such as adiponectin, angiotensinogen, apelin, ApoE, LPL or visfatin 
were significantly lower in the ASC when cocultured with endothelial cells than in 
monoculture spheroids after adipogenic induction. For the genes mentioned, the difference 
between the two culture systems was not only evident on day 9, but already on day 2 after 
application of the adipogenic cocktail. For other genes, e.g. adipsin, FAS, aP2 and FATP1, 
such a significant difference was detected at least for one of the time points. For virtually all 
of the adipogenic markers, there was at least a trend towards a lower expression in the 
cocultures. Thus, we could show that the significantly reduced ASC lipid accumulation 
detected within the cocultures was reflected also on gene expression level. The fact that the 
relevant genes were only reduced to a certain degree is supported by the results from 
histological staining, which had shown that lipid accumulation in the cocultures was more or 
less limited to MVEC-free areas. These data may indicate that in the coculture spheroids, 
adipogenesis is strongly inhibited in the ASC which are close to the MVEC, while normal 
differentiation takes place within the more distant ASC, resulting in the partially reduced 
expression of marker genes that has been observed in the LDA. 
Interestingly, genes not directly associated with adipogenesis did not exhibit a decrease in 
expression in the cocultures. On the contrary, for some of these genes even higher mRNA 
levels could be detected in the presence of endothelial cells. For example, expression of 
angiopoietin 1 (Ang-1), which is known as a potent angiogenic factor [2,8,37], was 
significantly elevated on days 2 and 9 after induction. Furthermore, expression of VEGF A as 
well as angiopoietin 2 (Ang-2), IL-1β, IL-6 and LIF was increased in coculture already on 
day 0, i.e. 2 days after seeding. Ang-2 plays an important role in angiogenesis, as in the 
presence of VEGF it may stimulate vessel growth by loosening endothelial-periendothelial 
cell interactions, degrading the ECM and enabling EC migration and proliferation [2,8,37]. 
The interleukins IL-1β [47,48] and IL-6 [49,50] have also been described to be involved in 
stimulating angiogenesis. Upregulation of Ang-1 and IL-1β was also observed by Aguirre et 
al., who cocultured BMSC and bone marrow-derived endothelial progenitor cells (BM-EPCs) 
in 2-D, yet without adipogenic differentiation and without separating the two cell types before 
PCR analysis [51]. Although our data require further confirmation through additional 
experiments and/or analytical methods, the observed gene expression patterns suggest an 
upregulation of pro-angiogenic factors in ASC within coculture spheroids in response to the 
presence of MVEC.  
Apart from these findings, the regional selectivity of TG accumulation in the coculture 
spheroids was of special interest. As described above, about 2 days after seeding the EC 
began organizing in a network-like fashion, while at the same time accumulating in certain 
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regions of the spheroids. Strikingly, the evaluation of consecutive cryosections stained for 
triglycerides and CD31, respectively, revealed that after adipogenic induction lipid droplets 
developed mainly in those areas of the constructs not containing endothelial cells anymore. 
While the reduction of adipogenesis was obviously caused by the MVEC included in the 
spheroids, the observed spatial selectivity can also help to understand the nature of the 
interplay between the two cell types. In general, it is possible that the EC communicate with 
the ASC through paracrine signaling pathways, ECM components or direct cell-cell-
interactions [7]. However, paracrine regulation via the secretion of growth factors and 
cytokines from the EC should have affected all of the ASC within the spheroid. While it 
cannot be ruled out that adipogenic differentiation was also somewhat reduced in ASC 
distant from the MVEC, a complete absence in TG accumulation only occurred for ASC in 
close proximity to the endothelial cell structures and clusters. These findings suggest that the 
signaling events involved in the inhibition of adipogenic differentiation are only effective over 
a short distance around the endothelial cells. The effective range of the responsible factors 
may, for example, be limited due to their fast degradation, as a result of their almost 
complete uptake by the surrounding cells, or because their transport is hindered by the 
dense ECM present in the 3-D spheroids. Another explanation would be that direct cell-cell 
contact is necessary for EC to influence adipogenic differentiation.  
Other studies have also shown that spatial proximity can be necessary for certain MVEC 
influences to come into effect. For example, using 2-D cultures, it was demonstrated in two 
independent studies that MVEC only enhanced osteogenic differentiation of BMSC in direct 
coculture, but not when conditioned media were applied, or when EC were cultured on 
transwell inserts in the same medium [44,52]. In another report, these findings could be 
attributed to the formation of gap junctions between the two cell types being necessary for 
signal transduction [53]. Similarly, conditioned media from HUVEC were shown to have no 
effect also on MSC adipogenesis [46].  
Further investigations are needed to elucidate the specific signaling pathways involved in the 
cellular crosstalk between ASC and EC during adipose tissue development. In this context, in 
previous work, the Wnt pathway has been suggested to play a role [19,42]. Recent research 
has established Wnt/β-catenin signaling as a potent inhibitor of adipogenesis [54,55]. 
Moreover, it has also been suggested that this pathway is an important regulator of 
mesenchymal cell fate, e.g. by stimulating osteogenesis and inhibiting adipogenesis [56,57]. 
An enhanced osteogenesis has, as already mentioned, also been detected using coculture 
models more or less similar to ours [19]. In a similar way, the Wnt pathway could be 
responsible for the reduction of adipogenic differentiation observed in our spheroid system. 
On the other hand, we also have to consider previous findings demonstrating that an 
increase of Wnt signaling also occurred after exposing ASC to EC-conditioned medium, 
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albeit with a different expression pattern of the single Wnt genes as compared to direct 
coculture, meaning that at least part of the EC-mediated reduction of adipogenesis can be 
attributed to effects not requiring direct cell-cell contact [42]. However, these results, which 
are based on 2-D cultures, are not in disagreement with our data, because as mentioned 
above, it is possible that in our 3-D spheroid model secreted factors were trapped within the 
ECM or quickly taken up by the surrounding ASC, which could explain that the inhibiting 
paracrine effect on adipogenesis was limited to ASC close to the EC. 
Nevertheless, we could not detect a downregulation of PPARγ or C/EBP in our cocultures, 
whereas in other reports the Wnt effector β-catenin was found to suppress expression of 
these transcription factors [57,58]. Consequently, further studies have to be performed to 
clarify the role of the Wnt/β-catenin signaling pathway in the regionally selective reduction of 
adipogenic differentiation within the ASC/MVEC coculture spheroids. 
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6.6 Conclusion 
In this chapter, the 3-D ASC/MVEC coculture model established previously (Chapter 5) was 
characterized with regard to spheroid properties, cellular self-organization within the 
constructs and especially the regulatory interplay between the two cell types. The main focus 
was set on the influence of the endothelial cells on adipogenic differentiation. 
While coculture spheroids were in general smaller than equivalent ASC monocultures, they 
remained mechanically stable and viable during prolonged culture. As described for other EC 
coculture systems, the proportion of endothelial cells within the constructs decreased over 
time, but at the same time the ASC supported the formation of endothelial cell networks in 
parts of the spheroids.  
The spheroid coculture model was also successfully applied to investigate the regulatory 
influence of the EC on ASC differentiation. On a functional and also on a molecular level, we 
showed that adipogenesis in cocultures was significantly impaired as compared to ASC 
monocultures. Lipid accumulation was completely absent in close proximity to the EC 
structures, but not in more distant areas, meaning that the inhibitory effect on ASC 
adipogenesis was limited to a region within a short distance from the MVEC. While the 
specific mechanisms involved in this spatially selective inhibition remain to be clarified, our 
results indicate that the Wnt/β-catenin signaling pathway may play a role. Furthermore, 
expression of some pro-angiogenic factors by the ASC was elevated under coculture, which 
in turn could influence EC performance and functions. Thus, our coculture spheroids proved 
to be useful for shedding light onto the complex cellular crosstalk and reciprocal regulation 
between developing adipocytes and endothelial cells within a 3-D microenvironment. 
Apart from that, the spheroids could serve as a tool to generate prevascularized adipose 
tissue for applications in regenerative medicine. Adipose tissue transplants based on our 3-D 
cocultures could help to improve nutrient and oxygen supply within the implanted grafts, as 
the preformed vascular structures within the constructs can connect with the host vasculature 
after implantation. This could prevent necrosis in the center of larger constructs and help to 
overcome limitations regarding transplant size.  
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7.1 Summary 
For many years, the role of fat tissue in humans was considered to be limited to energy 
storage and metabolism. Today, it is well recognized that white adipose tissue also 
represents an important endocrine organ, which is part of a complex signaling network 
involved in the regulation of many physiological and pathophysiological processes. 
Furthermore, an excessive increase in adipose tissue mass, often caused by a shifted 
balance of energy expenditure and intake, leads to obesity, which has been demonstrated to 
be closely associated with common medical conditions such as type 2 diabetes, dyslipidemia 
and hypertension, summarized under the term “metabolic syndrome”. Hence, adipose tissue 
possesses great pharmacological and therapeutic potential and is increasingly considered as 
a promising drug discovery target. To make use of this potential, a thorough understanding of 
adipose tissue development and adipocyte functions is a prerequisite. However, current 
research in this field is largely based on conventional 2-dimensional (2-D) in vitro models, 
which cannot fully capture the complex microenvironment present in vivo, including the 
extensive cell-cell and cell-matrix interactions (Chapter 1). Therefore, this thesis was 
focused on the establishment and characterization of a 3-dimensional (3-D) human adipose 
tissue model. Such a model system would not only be useful for basic research, but could 
ideally also be applied in tissue engineering and regenerative medicine, as well as in drug 
screening assays. 
The generation of multicellular spheroids as a 3-D culture system for 3T3-L1 preadipocytes 
was previously developed by our group. Based on the experiences with this mouse cell line, 
in this work a spheroid model using human adipose-derived stem cells (ASC) was 
successfully established (Chapter 3). With this 3-D culture system, it was possible to 
produce mechanically stable spheroids of defined size, in which ASC could be induced to 
undergo adipogenic differentiation. Culture conditions and protocols were optimized 
regarding basic media, FBS supplementation and hormonal induction cocktail in order to 
facilitate practical handling and subsequent analytics, to enhance flexibility, and to improve 
cost effectiveness for routine culture. Cryoconservation and multiple passaging at least up to 
P4 did not impair cell performance and adipogenic differentiation. By varying seeding 
density, it could be demonstrated that spheroids made from up to 5000 cells still exhibited a 
homogeneous lipid accumulation throughout the constructs after induction with an 
adipogenic hormonal cocktail. 
Whereas it is well established that adipogenic differentiation involves a complex, highly 
regulated cascade of gene expression events, which has been extensively investigated in 
many studies using conventional 2-D culture, the role and influence of a tissue-like 3-D 
environment with respect to this process is still largely unknown. The newly developed hASC 
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spheroid model was therefore applied to characterize the process of adipogenesis in a 
scaffold-free 3-D culture system on a functional and molecular level, with a special focus on 
the comparison to conventional 2-D culture (Chapter 4). It was found that the application of a 
short-term induction protocol was sufficient to induce a strong adipogenic response in the 
3-D spheroids, while lipid accumulation was only minimal under the same conditions in 2-D. 
A gene expression array revealed that these differences were also reflected on the molecular 
level, with many fat cell markers and adipokines, as well as important transcription factors, 
being expressed at much higher levels in 3-D than in 2-D. Similarly, both histology and gene 
expression data indicated that hormonal induction without either 3-isobutyl-methylxanthine 
(IBMX) or indomethacin was sufficient for the development of functional adipocytes in 3-D 
spheroids, but not in 2-D monolayers. These findings demonstrated that adipogenesis within 
the 3-D environment provided by the spheroids was less dependent on exogenous 
stimulation than in conventional 2-D monolayers. 
In vivo, adipogenesis is closely associated with angiogenesis. The reciprocal regulation and 
the intensive cellular crosstalk between (pre-)adipocytes and endothelial cells is of great 
importance for adipose tissue development as well as for the continuous expansion and 
regression that WAT can undergo in vivo. Up to now, however, almost all of our knowledge 
regarding the interdependence of adipogenesis and vascular growth is based on studies 
using various 2-D coculture systems. Therefore, it was the aim of the second part of this 
thesis to establish and characterize a 3-D coculture model of human ASC and human 
microvascular endothelial cells (MVEC) based on the monoculture spheroids developed in 
the first part of this work. In a first step, suitable culture conditions had to be found, which 
would provide suitable conditions to guarantee viability and proliferation of both cell types, 
without inhibiting the process of adipogenic differentiation after hormonal induction 
(Chapter 5). To achieve this goal, in a series of experiments various media mixtures and 
culture protocols were tested in 2-D and 3-D cocultures. After first attempts resulted in a 
strongly impaired lipid accumulation, EGF (which was part of the endothelial cell basal 
medium) could be identified as the factor responsible for the reduced adipogenesis. 
Furthermore, it could be demonstrated that components of the adipogenic induction cocktail 
compromised MVEC viability. Consequently, the elimination of EGF from the culture medium 
as well as the application of a short-term adipogenic induction protocol, which had been 
demonstrated to be sufficient within the 3-D spheroid system in Chapter 4, led to a strongly 
improved adipocyte conversion without affecting MVEC viability and proliferation. Using 
these newly established conditions, it was possible to successfully maintain ASC/MVEC 
coculture spheroids and differentiate them towards the adipogenic lineage. 
This spheroid model was subsequently not only characterized with regard to cellular self-
organization, but was also applied to investigate the cross-talk between the two cell types in 
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a 3-D environment (Chapter 6). The coculture spheroids, while being smaller in size than the 
equivalent ASC monocultures, remained viable and mechanically stable during prolonged 
culture. The endothelial cells, which at first could be found preferentially on the surface of the 
constructs, began to accumulate in specific regions of the spheroids after several days. 
While the overall proportion of MVEC decreased over time, the formation of network-like 
structures could be detected in those parts of the spheroids via immunohistochemistry and 
confocal microscopy. Importantly, with the focus being on the regulatory interplay between 
ASC and MVEC, our data demonstrated that in the coculture spheroids adipogenesis was 
significantly impaired as compared to ASC monocultures. This was not only shown by a 
reduced triglyceride accumulation, but also on the molecular level by performing a gene 
expression array after spheroid dissociation and magnetic bead-based separation of the cell 
types, with many adipogenic marker genes being less strongly expressed in the cocultures 
than in the monocultures after hormonal induction. Finally, immunostaining of cryosections 
revealed that lipid accumulation was completely absent only in close proximity to the MVEC 
structures, but not in more distant regions, which suggests a local inhibitory effect of the 
endothelial cells on adipogenic differentiation. 
 
7.2 Conclusion 
In this work, a 3-D spheroid model of human adipose tissue could be successfully 
established. This hASC-based model can serve as a valuable tool to investigate the 
development of adipose tissue in a 3-D microenvironment, as specific tissue-inherent factors 
such as cell-cell and cell-ECM interactions are much more closely resembled in the 
spheroids than in conventional 2-D monolayers. Our results could already demonstrate on a 
functional and molecular level that adipogenic differentiation appeared to be less dependent 
on exogenous hormonal stimulation in the 3-D spheroids than in 2-D culture. Furthermore, 
after adjusting culture conditions, the spheroid model proved to be suitable for coculturing 
ASC with endothelial cells as well, which opens up the possibility to study the cellular cross-
talk between these two cell types during adipose tissue development, which is closely 
associated with angiogenesis and vascularization, in a more in vivo-like system. In this 
context, endothelial cells could be shown to form network-like structures within the 3-D 
constructs, while at the same time locally inhibiting the process of adipogenesis.  
The spheroid system has the advantage of being flexible and easy to handle, while the small 
size guarantees sufficient nutrient and oxygen supply and allows for a homogeneous 
differentiation. Moreover, the absence of scaffold materials eliminates the often unknown 
influence of these substances on cellular performance.  
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The mono- and coculture spheroids not only represent a versatile tool for basic research, but 
could also be used for applications in drug screening. It is well known that in the commonly 
employed 2-D assays cellular response to specific agents may vary considerably from the 
corresponding in vivo effects. Therefore, our spheroid model could serve as a basis for the 
development and improvement of 3-D screening systems for drug discovery. 
Apart from basic research and drug screening, the 3-D adipose tissue model developed in 
this thesis could also be useful for applications in tissue engineering and regenerative 
medicine.  Specifically, the spheroids could function as building blocks for the regeneration of 
soft tissue defects, e.g. after incorporation into hydrogels, which would subsequently be 
implanted or injected into the host tissue. Here, the ASC/MVEC coculture spheroids appear 
to be especially promising, as their application in an in vitro prevascularization approach 
might help to overcome the problem of insufficient nutrient and oxygen supply in engineered 
tissue constructs after transplantation.  
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List of Abbreviations 
 
2-D two-dimensional 
3-D three-dimensional 
ANOVA analysis of variance 
ASC adipose-derived stem cell(s) 
AT adipose tissue 
BAT brown adipose tissue 
bFGF basic fibroblast growth factor 
BMSC bone-marrow derived stem cell(s) 
BSA bovine serum albumin 
BP bandpass 
cAMP cyclic adenosine monophosphate 
CCD charge-coupled device 
cDNA complementary deoxyribonucleic acid 
CLSM confocal laser scanning microscopy 
Ct cycle threshold 
CTRL control 
d… day 
DAB 3,3'-Diaminobenzidine 
DAPI 4',6-diamidino-2-phenylindole 
DEPC diethylpyrocarbonate 
DMEM Dulbecco’s Modified Eagle’s Medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
EC endothelial cell(s) 
ECM extracellular matrix 
EDTA ethylenediaminetetraacetic acid 
EGF Epidermal growth factor 
EBM2 Endothelial Cell Basal Medium 2 
EGM2 Endothelial Cell Growth Medium 2 
EthD-III ethidium homodimer III 
FBS fetal bovine serum 
FFA free fatty acids 
GM growth medium 
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h… human (cell types) 
HC hormonal cocktail 
HGF hepatocyte growth factor 
hOB human osteoblasts 
HRP horseradish peroxidase 
HTS high-throughput screening 
HUVEC human umbilical vein endothelial cell(s) 
IFATS International Fat Applied Technology Society 
IBMX 3-isobutyl-1-methylxanthine 
IGF insulin-like growth factor 
IM induction medium 
IND-P permanent induction protocol 
IND-S short-term induction protocol 
LDA low density array 
LP longpass 
MEM alpha Minimum Essential Medium alpha modification 
MMP matrix metalloproteinase 
MOPS 3-(N-morpholino)propanesulfonic acid 
mRNA messenger ribonucleic acid 
MSC mesenchymal stem cell(s) 
MVEC microvascular endothelial cells 
NIH National Institutes of Health 
ORO Oil Red O 
P… passage 
PBS phosphate buffered saline 
PEG polyethylene glycol 
PBM2 Preadipocyte Basal Medium 2 
PGM2 Preadipocyte Growth Medium 2 
PLGA poly(lactic-co-glycolic acid) 
qRT-PCR quantitative real time polymerase chain reaction 
RNA ribonucleic acid 
rpm revolutions per minute 
RQ relative expression level 
RT room temperature 
SQ SingleQuots 
SVF stromal-vascular fraction 
TE tissue engineering 
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TG triglyceride 
TGFβ transforming growth factor beta 
Tris tris(hydroxymethyl)aminomethane 
TZD thiazolidinedione 
U units 
VEGF vascular endothelial growth factor 
WAT white adipose tissue 
w/o without 
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